EurekaMag PDF full texts Chapter 53,770

Yang, J-C.; Lee, P-I.; Hsueh, P-R. 2010: In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 29(11): 1369-1375

Bérenger, R.; Bourdon, N.; Auzou, M.; Leclercq, R.; Cattoir, V. 2011: In vitro activity of new antimicrobial agents against glycopeptide-resistant Enterococcus faecium clinical isolates from France between 2006 and 2008. Medecine et Maladies Infectieuses 41(8): 405-409

Held, J.; Soomro, S.A.; Kremsner, P.G.; Jansen, F.H.; Mordmüller, B. 2011: In vitro activity of new artemisinin derivatives against Plasmodium falciparum clinical isolates from Gabon. International Journal of Antimicrobial Agents 37(5): 485-488

Green, K.; McGeer, A.; Rudnick, W.; Pong-Porter, S.; Patel, S.N.; Low, D.E. 2014: In vitro activity of new cephalosporins vs Streptococcus pneumoniae from the Canadian Bacterial Surveillance Network: 2008-2011. Current microbiology 69(5): 763-767

Gazanion, E.; Vergnes, B.; Seveno, M.; Garcia, D.; Oury, B.; Ait-Oudhia, K.; Ouaissi, A.; Sereno, D. 2011: In vitro activity of nicotinamide/antileishmanial drug combinations. Parasitology International 60(1): 19-24

Kresken, M.; Körber-Irrgang, B. 2014: In vitro activity of nitroxoline against Escherichia coli urine isolates from outpatient departments in Germany. Antimicrobial Agents and ChemoTherapy 58(11): 7019-7020

Netto, Bárbara.; Vieira, B.J.; Hermes, D.M.; Ribeiro, V.B.; Zavascki, A.P. 2013: In vitro activity of non-bactericidal concentrations of polymyxin B in combination with other antimicrobials against OXA-23-producing carbapenem-resistant Acinetobacter baumannii. Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 17(4): 502-504

Anandkumar, H.; Dayanand, A.; Vinodkumar, C.S.; Kapur, I. 2003: In vitro activity of norfloxacin against uropathogens and drug efficacy in simulated bladder model under diabetic conditions. Indian Journal of Medical Microbiology 21(1): 37-42

Romani, A.A.; Baroni, M.C.; Taddei, S.; Ghidini, F.; Sansoni, P.; Cavirani, S.; Cabassi, C.S. 2013: In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens. Journal of Peptide Science: An Official Publication of the European Peptide Society 19(9): 554-565

Lei, H.; Jiang, Y.; Wang, D.; Gong, P.; Li, Y.; Dong, Y.; Dong, M. 2014: In vitro activity of novel oxazolidinone analogs and 13 conventional antimicrobial agents against clinical isolates of Staphylococcus aureus in Beijing, China. Japanese Journal of Infectious Diseases 67(5): 402-404

Karlowsky, J.A.; Walkty, A.J.; Baxter, M.R.; Adam, H.J.; Zhanel, G.G. 2014: In vitro activity of oritavancin against Gram-positive pathogens isolated in Canadian hospital laboratories from 2011 to 2013. Diagnostic Microbiology and Infectious Disease 80(4): 311-315

Saravolatz, L.D.; Pawlak, J.; Johnson, L.B. 2010: In vitro activity of oritavancin against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA). International Journal of Antimicrobial Agents 36(1): 69-72

Breugelmans, B.; van Hoef, V.; Simonet, G.; Van Soest, S.; Smagghe, G.; Vanden Broeck, J. 2011: In vitro activity of pacifastin-like inhibitors in relation to their structural characteristics. Peptides 32(3): 539-544

Grare, M.; Mourer, M.; Fontanay, Séphane.; Regnouf-de-Vains, J-Bernard.; Finance, C.; Duval, Rël.Emmanuel. 2007: In vitro activity of para-guanidinoethylcalix[4]arene against susceptible and antibiotic-resistant Gram-negative and Gram-positive bacteria. Journal of Antimicrobial ChemoTherapy 60(3): 575-581

Endimiani, A.; Bethel, C.; Choudhary, Y.; Bonomo, R.A. 2010: In vitro activity of penem-1 in combination with beta-lactams against blaKPC-possessing Klebsiella pneumoniae isolates. Antimicrobial Agents and ChemoTherapy 54(4): 1650-1651

Rolain, J.-M.; Fenollar, F.; Raoult, D. 2011: In vitro activity of pentamidine against Tropheryma whipplei. International Journal of Antimicrobial Agents 38(6): 545-547

Galgóczy, László.; Papp, Tás.; Kovács, L.; Ordögh, L.; Vágvölgyi, C. 2009: In vitro activity of phenothiazines and their combinations with amphotericin B against Zygomycetes causing rhinocerebral zygomycosis. Medical Mycology 47(3): 331-335

Schiffner, U.; Cachovan, G.; Bastian, J.; Sculean, A.; Eick, S. 2014: In vitro activity of photoactivated disinfection using a diode laser in infected root canals. Acta Odontologica Scandinavica 72(8): 673-680

Zuo, G.-Y.; Meng, F.-Y.; Han, J.; Hao, X.-Y.; Wang, G.-C.; Zhang, Y.-L.; Zhang, Q. 2011: In vitro activity of plant extracts and alkaloids against clinical isolates of extended-spectrum β-lactamase (ESBL)-producing strains. Molecules 16(7): 5453-5459

Walkty, A.; Adam, H.; Baxter, M.; Denisuik, A.; Lagacé-Wiens, P.; Karlowsky, J.A.; Hoban, D.J.; Zhanel, G.G. 2014: In vitro activity of plazomicin against 5,015 gram-negative and gram-positive clinical isolates obtained from patients in canadian hospitals as part of the CANWARD study, 2011-2012. Antimicrobial agents and chemotherapy 58(5): 2554-2563

Wise, L.N.; Ueti, M.W.; Kappmeyer, L.S.; Hines, M.T.; White, S.N.; Davis, W.; Knowles, D.P. 2012: In vitro activity of ponazuril against Theileria equi. Veterinary Parasitology 185(2-4): 282-285

Noviello, S.; Ianniello, F.; Leone, S.; Esposito, S. 2006: In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens. Le Infezioni in Medicina 14(1): 24-28

Kurth, F.; Pongratz, P.; Bélard, S.; Mordmüller, B.; Kremsner, P.G.; Ramharter, M. 2009: In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays. Malaria Journal 8: 79

Price, R.N.; Marfurt, J.; Chalfein, F.; Kenangalem, E.; Piera, K.A.; Tjitra, E.; Anstey, N.M.; Russell, B. 2010: In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax. Antimicrobial Agents and ChemoTherapy 54(12): 5146-5150

Downey, A.S.; Graczyk, T.K.; Sullivan, D.J. 2009: In vitro activity of pyrvinium pamoate against Entamoeba histolytica and Giardia intestinalis using radiolabelled thymidine incorporation and an SYBR Green I-based fluorescence assay. Journal of Antimicrobial ChemoTherapy 64(4): 751-754

Woodford, N.; Afzal-Shah, M.; Warner, M.; Livermore, D.M. 2008: In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin. Journal of Antimicrobial ChemoTherapy 62(4): 766-768

Candel, F.J.; Morales, G.; Picazo, J.J. 2011: In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates. Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 24(3): 127-130

Majewski, P.; Wieczorek, P.; Ojdana, D.; Sacha, P.ł T.; Wieczorek, A.; Tryniszewska, E.żb.A. 2014: In vitro activity of rifampicin alone and in combination with imipenem against multidrug-resistant Acinetobacter baumannii harboring the blaOXA-72 resistance gene. Scandinavian Journal of Infectious Diseases 46(4): 260-264

Pignanelli, S.; Shurdhi, A. 2011: In vitro activity of rifaximin against Chlamydia suis. Veterinary Record 169(22): 584

Hopkins, K.L.; Mushtaq, S.; Richardson, J.F.; Doumith, M.; de Pinna, E.; Cheasty, T.; Wain, J.; Livermore, D.M.; Woodford, N. 2014: In vitro activity of rifaximin against clinical isolates of Escherichia coli and other enteropathogenic bacteria isolated from travellers returning to the UK. International Journal of Antimicrobial Agents 43(5): 431-437

Pistiki, A.; Galani, I.; Pyleris, E.; Barbatzas, C.; Pimentel, M.; Giamarellos-Bourboulis, E.J. 2014: In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth. International Journal of Antimicrobial Agents 43(3): 236-241

Marín, C.; Clares, M.P.; Ramírez-Macías, I.; Blasco, S.; Olmo, F.; Soriano, C.; Verdejo, B.ña.; Rosales, M.ía.J.é; Gomez-Herrera, D.; García-España, E.; Sánchez-Moreno, M. 2013: In vitro activity of scorpiand-like azamacrocycle derivatives in promastigotes and intracellular amastigotes of Leishmania infantum and Leishmania braziliensis. European Journal of Medicinal Chemistry 62: 466-477

De Backer, E.; Dubreuil, L.; Brauman, M.; Acar, J.; Vaneechoutte, M. 2010: In vitro activity of secnidazole against Atopobium vaginae, an anaerobic pathogen involved in bacterial vaginosis. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 16(5): 470-472

Diekema, D.J.; Messer, S.A.; Boyken, L.B.; Hollis, R.J.; Kroeger, J.; Tendolkar, S.; Pfaller, M.A. 2009: In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSi broth microdilution methods. Journal of Clinical Microbiology 47(10): 3170-3177

Thamlikitkul, V.; Trakulsomboon, S. 2011: In vitro activity of sitafloxacin against Burkholderia pseudomallei. International Journal of Antimicrobial Agents 38(4): 364

Thamlikitkul, V.; Tiengrim, S. 2013: In vitro activity of sitafloxacin against carbapenem-resistant Acinetobacter baumannii. International Journal of Antimicrobial Agents 42(3): 284-285

Amano, A.; Matsuzaki, K.; Kishi, N.; Saika, T.; Hasegawa, M.; Ikeda, F.; Matsumoto, T.; Yamaguchi, H.; Kanda, Y.; Shiozawa, T. 2010: In vitro activity of sitafloxacin against clinical isolates in 2009. Japanese Journal of Antibiotics 63(6): 411-430

Amano, A.; Matsuzaki, K.; Kishi, N.; Koyama, H.; Hasegawa, M.; Ikeda, F.; Matsumoto, T.; Yamaguchi, H.; Okutani, Y. 2013: In vitro activity of sitafloxacin against clinical isolates in 2012. Japanese Journal of Antibiotics 66(6): 311-330

Lu, X.; Yang, X.; Li, X.; Lu, Y.; Ren, Z.; Zhao, L.; Hu, X.; Jiang, J.; You, X. 2013: In vitro activity of sodium new houttuyfonate alone and in combination with oxacillin or netilmicin against methicillin-resistant Staphylococcus aureus. Plos one 8(7): E68053

Piccinelli, G.; Fernandes, P.; Bonfanti, C.; Caccuri, F.; Caruso, A.; De Francesco, M.A. 2014: In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae. Antimicrobial Agents and ChemoTherapy 58(3): 1693-1698

Ji, J.; Du, X.; Chen, Y.; Fu, Y.; Wang, H.; Yu, Y. 2013: In vitro activity of sulbactam in combination with imipenem, meropenem, panipenem or cefoperazone against clinical isolates of Acinetobacter baumannii. International Journal of Antimicrobial Agents 41(4): 400-401

Kamysz, W.; Nadolski, P.; Kedzia, A.; Cirioni, O.; Barchiesi, F.; Giacometti, A.; Scalise, G.; Lukasiak, J.; Okrój, M. 2006: In vitro activity of synthetic antimicrobial peptides against Candida. Polish Journal of Microbiology 55(4): 303-307

Yuan, R.; Diao, Y.; Zhang, W.; Lin, Y.; Huang, S.; Zhang, H.; Ma, L. 2014: In vitro activity of taurine-5-bromosalicylaldehyde Schiff base against planktonic and biofilm cultures of methicillin-resistant Staphylococcus aureus. Journal of Microbiology and Biotechnology 24(8): 1059-1064

Seenama, C.; Tiengrim, S.; Thamlikitkul, V. 2013: In vitro activity of tebipenem against Burkholderia pseudomallei. International Journal of Antimicrobial Agents 42(4): 375

Kishii, K.; Chiba, N.; Morozumi, M.; Ono, A.; Ida, T.; Ubukata, K. 2010: In vitro activity of tebipenem, a new oral carbapenem antibiotic, against beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae. Antimicrobial Agents and ChemoTherapy 54(9): 3970-3973

Rodríguez-Avial, I.; Culebras, E.; Betriu, C.; Morales, G.; Pena, I.; Picazo, J.J. 2012: In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci. Journal of Antimicrobial ChemoTherapy 67(1): 167-169

Wareham, D.W.; Gordon, N.C.; Hornsey, M. 2011: In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii. Journal of Antimicrobial ChemoTherapy 66(5): 1047-1051

Krause, K.M.; Barriere, S.L.; Kitt, M.M.; Benton, B.M. 2010: In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies. Diagnostic Microbiology and Infectious Disease 68(2): 181-185

Mendes, R.E.; Moet, G.J.; Janechek, M.J.; Jones, R.N. 2010: In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates. Antimicrobial Agents and ChemoTherapy 54(6): 2704-2706

Farrell, D.J.; Krause, K.M.; Benton, B.M. 2011: In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococci. Diagnostic Microbiology and Infectious Disease 69(3): 275-279

Woodford, N.; Pike, R.; Meunier, D.; Loy, R.; Hill, R.; Hopkins, K.L. 2014: In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase. Journal of Antimicrobial ChemoTherapy 69(2): 564-567

Van Acker, H.; Van Snick, E.; Nelis, H.J.; Coenye, T. 2010: In vitro activity of temocillin against planktonic and sessile Burkholderia cepacia complex bacteria. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society 9(6): 450-454

Glupczynski, Y.; Huang, T.-D.; Berhin, C.; Claeys, G.; Delmée, M.; Ide, L.; Ieven, G.; Pierard, D.; Rodriguez-Villalobos, H.; Struelens, M.; Vaneldere, J. 2007: In vitro activity of temocillin against prevalent extended-spectrum beta-lactamases producing Enterobacteriaceae from Belgian intensive care units. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 26(11): 777-783

Grisold, A.J.; Wendelin, I.; Presterl, E.; Raggam, R.B.; Masoud, L.; Badura, A.; Marth, E. 2007: In vitro activity of ten antibiotics, including tigecycline, against Bacteroides species in Austria. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 26(7): 525-527

Rufino-González, Y.; Ponce-Macotela, M.; González-Maciel, A.él.; Reynoso-Robles, R.; Jiménez-Estrada, M.; Sánchez-Contreras, Án.; Martínez-Gordillo, M.N. 2012: In vitro activity of the F-6 fraction of oregano against Giardia intestinalis. Parasitology 139(4): 434-440

Karau, M.J.; Piper, K.E.; Steckelberg, J.M.; Kavros, S.J.; Patel, R. 2010: In vitro activity of the Qoustic Wound Therapy System against planktonic and biofilm bacteria. Advances in Skin and Wound Care 23(7): 316-320

Zapor, M.J.; Barber, M.; Summers, A.; Miller, G.H.; Feeney, L.Ann.; Eberly, L.E.; Wortmann, G. 2010: In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center. Antimicrobial Agents and ChemoTherapy 54(7): 3015-3017

De Macedo-Silva, S.T.; Urbina, J.A.; de Souza, W.; Rodrigues, J.C.F. 2013: In vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis. Plos one 8(12): E83247

Ciok-Pater, E.; Gospodarek, E.; Modzelewska-Banachiewicz, B.; Ucherek, M.; Prazyńska, M.łg. 2012: In vitro activity of the azole compounds against clinical fungal strains. Acta Poloniae Pharmaceutica 69(3): 565-567

Blanco, O.; Lugones, Y.; Díaz, E.; Monzote, L. 2011: In vitro activity of the clinical pulmonary surfactant Surfacen® against Leishmania amazonensis. Revista do Instituto de Medicina Tropical de Sao Paulo 53(4): 235-238

Santin, M.R.; dos Santos, A.O.; Nakamura, C.V.; Dias Filho, B.P.; Ferreira, I.C.P.; Ueda-Nakamura, T.ân. 2009: In vitro activity of the essential oil of Cymbopogon citratus and its major component (citral) on Leishmania amazonensis. Parasitology Research 105(6): 1489-1496

Wierzbowski, A.K.; Karlowsky, J.A.; Hoban, D.J.; Zhanel, G.G. 2009: In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS). Journal of Antimicrobial ChemoTherapy 63(3): 620-622

Kamysz, E.; Simonetti, O.; Cirioni, O.; Arzeni, D.; Ganzetti, G.; Campanati, A.; Giacometti, A.; Gabrielli, E.; Silvestri, C.; Kamysz, W.; Offidani, A.; Barchiesi, F. 2011: In vitro activity of the lipopeptide PAL-Lys-Lys-NH2, alone and in combination with antifungal agents, against clinical isolates of Candida spp. Peptides 32(1): 99-103

Simonetti, O.; Arzeni, D.; Ganzetti, G.; Silvestri, C.; Cirioni, O.; Gabrielli, E.; Castelletti, S.; Kamysz, W.; Kamysz, E.; Scalise, G.; Offidani, A.; Barchiesi, F. 2009: In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytes. British Journal of Dermatology 161(2): 249-252

Golparian, D.; Fernandes, P.; Ohnishi, M.; Jensen, Jörgen.S.; Unemo, M. 2012: In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment option for gonorrhea?. Antimicrobial Agents and ChemoTherapy 56(5): 2739-2742

Jensen, J.ør.S.; Fernandes, P.; Unemo, M. 2014: In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains. Antimicrobial Agents and ChemoTherapy 58(6): 3151-3156

Leuthner, K.D.; Vidaillac, C.; Cheung, C.M.; Rybak, M.J. 2010: In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolates. Antimicrobial Agents and ChemoTherapy 54(9): 3799-3803

Sainath Rao, S.; Raghunathan, M. 2009: In vitro activity of the new quinolone derivative RD-3 against clinical isolates of Mycoplasma pneumoniae and Mycoplasma hominis. Journal of Antimicrobial ChemoTherapy 64(6): 1336-1338

Garg, N.; Salazar-Ocampo, L.M.A.; van der Donk, W.A. 2013: In vitro activity of the nisin dehydratase NisB. Proceedings of the National Academy of Sciences of the United States of America 110(18): 7258-7263

Bhagwat, S.S.; McGhee, P.; Kosowska-Shick, K.; Patel, M.V.; Appelbaum, P.C. 2009: In vitro activity of the quinolone WCK 771 against recent U.S. hospital and community-acquired Staphylococcus aureus pathogens with various resistance types. Antimicrobial Agents and ChemoTherapy 53(2): 811-813

Landman, D.; Singh, M.; El-Imad, B.; Miller, E.; Win, T.; Quale, J. 2014: In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from new York City, including multidrug-resistant isolates. International Journal of Antimicrobial Agents 43(6): 527-532

Higgins, P.G.; Stefanik, D.; Page, M.G.P.; Hackel, M.; Seifert, H. 2012: In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii. Journal of Antimicrobial ChemoTherapy 67(5): 1167-1169

Stachyra, Térèse.; Levasseur, P.; Péchereau, M-Claude.; Girard, A-Marie.; Claudon, M.; Miossec, C.; Black, M.T. 2009: In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases. Journal of Antimicrobial ChemoTherapy 64(2): 326-329

Pisano, M.; DE Paola, I.; Nieddu, V.; Sassu, I.; Cossu, S.; Galleri, G.; Del Gatto, A.; Budroni, M.; Cossu, A.; Saviano, M.; Palmieri, G.; Zaccaro, L.; Rozzo, C. 2013: In vitro activity of the αvβ3 integrin antagonist RGDechi-hCit on malignant melanoma cells. Anticancer Research 33(3): 871-879

Herrera, C.; Vallejos, G.A.; Loaiza, R.; Zeledón, R.; Urbina, A.; Sepúlveda-Boza, S. 2009: In vitro activity of thienyl-2-nitropropene compounds against Trypanosoma cruzi. Memorias do Instituto Oswaldo Cruz 104(7): 980-985

Papaparaskevas, J.; Tzouvelekis, L.S.; Tsakris, A.; Pittaras, T.E.; Legakis, N.J.; Papafrangas, E.; Kanellopoulou, M.; Koutsia-Karouzou, C.; Kairis, D.; Toutouza-Giotsa, M.; Epitropaki-Skandami, V.; Malamou-Ladas, H.; Ganteris, G.; Gianneli, D.; Koutsoukou, A.; Tsiplakou, S.; Kouppari, G.; Katsanis, G.; Kanavaki, S.; Moraitou, E.; Kada, E.; Lazaraki, T.; Bethymouti, E.; Varvarou, M.; Kondili, L.; Kontodimou-Trikalioti, A.; Christoforidou-Tsorlini, H.; Aleksiou-Daniel, S.; Tomos, K.; Ktenidou-Kartali, A.; Panopoulou, M.; Mavridis, A.; Levidiotou, S.; Gesouli, H.; Pappa, C.; Kouskouni, E.; Salomidou, P.; Vogiatzi, A.; Makri, A. 2010: In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints. Diagnostic Microbiology and Infectious Disease 66(2): 187-194

Dhabaan, G.N.; AbuBakar, S.; Shorman, M.A.; Hassan, H. 2012: In vitro activity of tigecycline against Acinetobacter baumannii isolates from a teaching hospital in Malaysia. Journal of ChemoTherapy 24(2): 87-92

Hawser, S.P.; Hackel, M.; Person, M.B.; Higgins, P.G.; Seifert, H.; Dowzicky, M. 2010: In vitro activity of tigecycline against carbapenemase-producing Acinetobacter baumannii. International Journal of Antimicrobial Agents 36(3): 289-290

Ku, Y-Huang.; Chuang, Y-Ching.; Yu, W-Liang. 2008: In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae. Journal of Microbiology Immunology and Infection 41(4): 332-336

Tiengrim, S.; Tribuddharat, C.; Thamlikitkul, V. 2006: In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand. Journal of the Medical Association of Thailand 89(Suppl 5): S102-S105

Pillar, C.M.; Draghi, D.C.; Dowzicky, M.J.; Sahm, D.F. 2008: In vitro activity of tigecycline against gram-positive and gram-negative pathogens as evaluated by broth microdilution and Etest. Journal of Clinical Microbiology 46(9): 2862-2867

Renteria, M.I.; Biedenbach, D.J.; Bouchillon, S.K.; Hoban, D.J.; Raghubir, N.; Sajben, P.; Mokaddas, E. 2014: In vitro activity of tigecycline against isolates collected from complicated skin and skin structure infections and intra-abdominal infections in Africa and Middle East countries: TEST 2007-2012. Diagnostic microbiology and infectious disease 79(1): 54-59

Verkade, E.J.M.; Verhulst, C.J.M.M.; Huijsdens, X.W.; Kluytmans, J.A.J.W. 2010: In vitro activity of tigecycline against methicillin-resistant Staphylococcus aureus, including livestock-associated strains. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 29(5): 503-507

Tunçkanat, F.; Saribaş, Z.; Ercis, S. 2009: In vitro activity of tigecycline against methicillin-resistant staphylococci. Mikrobiyoloji Bulteni 43(2): 211-215

Ricciardi, R.; Ricciardi, A.M.; Danzi, G. 2009: In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii clinical isolates. Le Infezioni in Medicina 17(4): 236-239

Naesens, R.; Ursi, J.P.; Van Schaeren, J.; Jeurissen, A. 2009: In vitro activity of tigecycline against multidrug-resistant Enterobacteriaceae isolates from a Belgian hospital. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 28(4): 381-384

Gupta, S.; Aruna, C.; Nagaraj, S.; Dias, M.; Muralidharan, S. 2012: In vitro activity of tigecycline against multidrug-resistant Gram-negative blood culture isolates from critically ill patients. Journal of Antimicrobial ChemoTherapy 67(5): 1293-1295

Arikan Akan, O.; Uysal, S. 2008: In vitro activity of tigecycline against multiple resistant Acinetobacter baumannii and carbapenem resistant Klebsiella pneumoniae isolates. Mikrobiyoloji Bulteni 42(2): 209-215

Yang, X.; Nguyen, A.; Qiu, D.; Luft, B.J. 2009: In vitro activity of tigecycline against multiple strains of Borrelia burgdorferi. Journal of Antimicrobial ChemoTherapy 63(4): 709-712

Petersen, P.J.; Ruzin, A.; Tuckman, M.; Jones, C.H. 2010: In vitro activity of tigecycline against patient isolates collected during phase 3 clinical trials for diabetic foot infections. Diagnostic Microbiology and Infectious Disease 66(4): 407-418

Petersen, P.J.; Tuckman, M.; Jones, C.H. 2010: In vitro activity of tigecycline against patient isolates collected during phase 3 clinical trials for hospital acquired pneumonia. Infectious Disease Reports 2(1): E1

Timurkaynak, F.; Arslan, H.; Azap, O.K.; Senger, S.S.; Başaran, O.; Karaman, S.O.; Haberal, M. 2008: In vitro activity of tigecycline against resistant micro-organisms isolated from burn patients. Burns: Journal of the International Society for Burn Injuries 34(7): 1033-1036

Sotto, A.; Bouziges, N.; Jourdan, N.; Richard, J.-L.; Lavigne, J.-P. 2007: In vitro activity of tigecycline against strains isolated from diabetic foot ulcers. Pathologie-Biologie 55(8-9): 398-406

Spiliopoulou, A.; Jelastopulu, E.; Vamvakopoulou, S.; Bartzavali, C.; Kolonitsiou, F.; Anastassiou, E.D.; Christofidou, M. 2015: In vitro activity of tigecycline and colistin against A. baumannii clinical bloodstream isolates during an 8-year period. Journal of ChemoTherapy 27(5): 266-270

Garrison, M.W.; Mutters, R.; Dowzicky, M.J. 2009: In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: tigecycline Evaluation and Surveillance Trial 2004 to 2007. Diagnostic Microbiology and Infectious Disease 65(3): 288-299

Andrasevic, A.Tambic.; Dowzicky, M.J. 2012: In vitro activity of tigecycline and comparators against Gram-negative pathogens isolated from blood in Europe (2004-2009). International journal of antimicrobial agents 39(2): 115-123

Kanj, S.S.; Whitelaw, A.; Dowzicky, M.J. 2014: In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011. International Journal of Antimicrobial Agents 43(2): 170-178

Nagy, E.; Dowzicky, M.J. 2010: In vitro activity of tigecycline and comparators against a European compilation of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (TEST). Scandinavian Journal of Infectious Diseases 42(1): 33-38

Mezzatesta, M.L.; Trovato, G.; Gona, F.; Nicolosi, V.M.; Nicolosi, D.; Carattoli, A.; Fadda, G.; Nicoletti, G.; Stefani, S. 2008: In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy. Annals of Clinical Microbiology and Antimicrobials 7: 4

Mohamed, N.M.; Youssef, A.A.F. 2011: In vitro activity of tigecycline and comparators against gram-negative bacteria isolated from a tertiary hospital in Alexandria, Egypt. Microbial Drug Resistance 17(4): 489-495

Mayne, D.; Dowzicky, M.J. 2012: In vitro activity of tigecycline and comparators against organisms associated with intra-abdominal infections collected as part of TEST (2004-2009). Diagnostic microbiology and infectious disease 74(2): 151-157

Wang, Y.F.W.; Dowzicky, M.J. 2010: In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008. Diagnostic Microbiology and Infectious Disease 68(1): 73-79

Wienke, M.; Pfeifer, Y.; Weissgerber, P.; Marschal, M.; Autenrieth, I.B.; Gröbner, S. 2012: In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany. ChemoTherapy 58(3): 241-248

Bradford, P.A.; Petersen, P.J.; Tuckman, M.; Jones, C.H. 2008: In vitro activity of tigecycline and occurrence of tetracycline resistance determinants in isolates from patients enrolled in phase 3 clinical trials for community-acquired pneumonia. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 14(9): 882-886

Shakoor, S.; Khan, E.; Zafar, A.; Hasan, R. 2010: In vitro activity of tigecycline and other tetracyclines against carbapenem-resistant Acinetobacter species: report from a tertiary care centre in Karachi, Pakistan. ChemoTherapy 56(3): 184-189

Eser, O.K.ös.ğl.; Ergin, A.; Tunçkanat, F.; Hasçelik, G.ül.şe. 2008: In vitro activity of tigecycline as a therapeutic option against multidrug-resistant Acinetobacter spp. New Microbiologica 31(4): 535-542

Held, J.; Zanger, P.; Issifou, S.; Kremsner, P.G.; Mordmüller, B. 2010: In vitro activity of tigecycline in Plasmodium falciparum culture-adapted strains and clinical isolates from Gabon. International Journal of Antimicrobial Agents 35(6): 587-589

Zárate, M.S.; Serruto, G.; Smayevsky, J. 2010: In vitro activity of tigecycline in clinical isolates of multidrug resistant Acinetobacter spp. Comparison of different methods of evaluation. Revista Argentina de Microbiologia 42(1): 53-56

Liu, B.; Bai, Y.; Liu, Y.; Di, X.; Zhang, X.; Wang, R.; Wang, J. 2015: In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii. Journal of ChemoTherapy 27(5): 271-276

McConeghy, K.W.; LaPlante, K.L. 2010: In vitro activity of tigecycline in combination with gentamicin against biofilm-forming Staphylococcus aureus. Diagnostic Microbiology and Infectious Disease 68(1): 1-6

Principe, L.; D'Arezzo, S.; Capone, A.; Petrosillo, N.; Visca, P. 2009: In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii. Annals of Clinical Microbiology and Antimicrobials 8: 18

Bris, C.; Auger, G.; Kowalczyk, F.; Eveillard, M.; Joly-Guillou, M-L.; Kempf, M. 2012: In vitro activity of tigecycline on 760 bacterial strains isolated in the hospital university of Angers--2006-2009 TEST study. Pathologie-biologie 60(6): 336-339

Tanaka, K.; Mikamo, H.; Nakao, K.; Ichiishi, T.; Goto, T.; Yamagishi, Y.; Watanabe, K. 2009: In vitro activity of tomopenem (CS-023/RO4908463) against anaerobic bacteria. Antimicrobial Agents and ChemoTherapy 53(1): 319-322

Tavío, M.M.; Poveda, C.; Assunção, P.; Ramírez, A.S.; Poveda, J.B. 2014: In vitro activity of tylvalosin against Spanish field strains of Mycoplasma hyopneumoniae. Veterinary Record 175(21): 539

Jain, S.; Gaind, R.; Chugh, T.D. 2013: In vitro activity of vancomycin and daptomycin against clinical isolates of Staphylococcus aureus and enterococci from India. International Journal of Antimicrobial Agents 42(1): 94-95

Sharma, V.; Jindal, N. 2011: In vitro activity of vancomycin and teicoplanin against coagulase negative staphylococci. Oman Medical Journal 26(3): 186-188

Sánchez Vargas, L.O.; Eraso, E.; Carrillo-Muñoz, A.J.; Aguirre, J.é M.; Gaitán-Cepeda, L.A.; Quindós, G. 2010: In vitro activity of voriconazole against Mexican oral yeast isolates. Mycoses 53(3): 200-203

Ricciardi, A.M.; Ricciardi, R.; Danzi, M.; Mungiguerra, M.; Pisano, L.; Marino, A. 2009: In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp. Le Infezioni in Medicina 17(1): 24-27

Lentz, C.S.; Sattler, J.M.; Fendler, M.; Gottwalt, S.; Halls, V.S.; Strassel, S.; Arriens, S.; Hannam, J.S.; Specht, S.; Famulok, M.; Mueller, A.-K.; Hoerauf, A.; Pfarr, K.M. 2015: In vitro activity of wALADin benzimidazoles against different life cycle stages of Plasmodium parasites. Antimicrobial Agents and ChemoTherapy 59(1): 654-658

Rukayadi, Y.; Han, S.; Yong, D.; Hwang, J.-K. 2011: In vitro activity of xanthorrhizol against Candida glabrata, C. guilliermondii, and C. parapsilosis biofilms. Medical Mycology 49(1): 1-9

Fera, M.T.; Zummo, S.; DE Sarro, A. 2011: In vitro activity studies of doripenem and two other carbapenems tested against Pseudomonas aeruginosa and other non-fermentative bacilli. Journal of ChemoTherapy 23(6): 335-340

Dumke, J.C.; Qureshi, A.; Hamdan, S.; Rupnik, K.; El-Zahab, B.; Hayes, D.J.; Warner, I.M. 2014: In vitro activity studies of hyperthermal near-infrared nanoGUMBOS in MDA-MB-231 breast cancer cells. Photochemical and Photobiological Sciences: Official Journal of the European Photochemistry Association and the European Society for Photobiology 13(9): 1270-1280

Matsutomo, T.; Stark, T.D.; Hofmann, T. 2013: In vitro activity-guided identification of antioxidants in aged garlic extract. Journal of Agricultural and Food Chemistry 61(12): 3059-3067

Ambruosi, B.; Uranio, M.F.; Sardanelli, A.M.; Pocar, P.; Martino, N.A.; Paternoster, M.S.; Amati, F.; Dell'Aquila, M.E. 2011: In vitro acute exposure to DEHP affects oocyte meiotic maturation, energy and oxidative stress parameters in a large animal model. Plos one 6(11): E27452

Cieśluk, B.; Dzieciatkowski, T.; Majewska, A.; Łuczak, M.ła. 2008: In vitro acyclovir and cidofovir susceptibilities of human herpesvirus type 1 clinical isolates. Medycyna Doswiadczalna i Mikrobiologia 60(2): 163-168

Konoki, K.; Onoda, T.; Watanabe, R.; Cho, Y.; Kaga, S.; Suzuki, T.; Yotsu-Yamashita, M. 2013: In vitro acylation of okadaic acid in the presence of various bivalves' extracts. Marine Drugs 11(2): 300-315

Coutinho, H.D.M.; Costa, J.é G.M.; Falcão-Silva, V.S.; Siqueira-Júnior, J.é P.; Lima, E.O. 2010: In vitro additive effect of Hyptis martiusii in the resistance to aminoglycosides of methicillin-resistant Staphylococcus aureus. Pharmaceutical Biology 48(9): 1002-1006

Park, S.; Woo, Y.; Kim, H.; Lee, Y.C.; Choi, S.; Hyung, W.J.; Noh, S.H. 2010: In vitro adenosine triphosphate based chemotherapy response assay in gastric cancer. Journal of Gastric Cancer 10(4): 155-161

Kang, C.M.; Kim, H.; Cho, Y.; Kim, Y.S.; Hwang, H.K.; Choi, H.J.; Lee, W.J. 2012: In vitro adenosine triphosphate-based chemotherapy response assay (ATP-CRA) in solid pseudopapillary tumor of the pancreas. Pancreas 41(3): 498-500

Machado, A.G.; Komiyama, E.Y.; Santos, S.S.éo.F.D.; Jorge, A.O.C.; Brighenti, F.L.ção.; Koga-Ito, C.Y. 2011: In vitro adherence of Candida albicans isolated from patients with chronic periodontitis. Journal of Applied Oral Science: Revista Fob 19(4): 384-387

Rosentritt, M.; Behr, M.; Bürgers, R.; Feilzer, A.J.; Hahnel, S. 2009: In vitro adherence of oral streptococci to zirconia core and veneering glass-ceramics. Journal of Biomedical Materials Research. Part B Applied Biomaterials 91(1): 257-263

Egawa, M.; Miura, T.; Kato, T.; Saito, A.; Yoshinari, M. 2013: In vitro adherence of periodontopathic bacteria to zirconia and titanium surfaces. Dental Materials Journal 32(1): 101-106

Lazado, C.C.; Caipang, C.M.A.; Brinchmann, M.F.; Kiron, V. 2011: In vitro adherence of two candidate probiotics from Atlantic cod and their interference with the adhesion of two pathogenic bacteria. Veterinary Microbiology 148(2-4): 252-259

Kudva, I.T. 2012: In vitro adherence patterns of Shigella serogroups to bovine recto-anal junction squamous epithelial (RSE) cells are similar to those of Escherichia coli O157. Foodborne Pathogens and Disease 9(4): 346-351

De Souza, E.J.; Kamperman, M.; Castellanos, G.; Kroner, E.; Armbruester, V.; Romann, M.S.; Schick, B.; Arzt, E. 2009: In vitro adhesion measurements between skin and micropatterned poly(dimethylsiloxane) surfaces. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2009: 6018-6021

Reverey, J.F.; Fromme, R.; Leippe, M.; Selhuber-Unkel, C. 2014: In vitro adhesion of Acanthamoeba castellanii to soft contact lenses depends on water content and disinfection procedure. Contact Lens and Anterior Eye: the Journal of the British Contact Lens Association 37(4): 262-266

Ota-Tsuzuki, C.; Martins, F.L.; Giorgetti, A.P.O.; de Freitas, P.íc.M.; Duarte, P.M. 2009: In vitro adhesion of Streptococcus sanguinis to dentine root surface after treatment with Er:YAG laser, ultrasonic system, or manual curette. Photomedicine and Laser Surgery 27(5): 735-741

Passariello, C.; Pera, F.; Gigola, P. 2013: In vitro adhesion of commensal and pathogenic bacteria to commercial titanium implants with different surfaces. International Journal of Immunopathology and Pharmacology 26(2): 453-462

Al Mustafa, M.; Agis, H.; Müller, H.-D.; Watzek, G.; Gruber, R. 2015: In vitro adhesion of fibroblastic cells to titanium alloy discs treated with sodium hydroxide. Clinical Oral Implants Research 26(1): 15-19

Machida-Sano, I.; Matsuda, Y.; Namiki, H. 2009: In vitro adhesion of human dermal fibroblasts on iron cross-linked alginate films. Biomedical Materials 4(2): 025008

Soininen, A.; Levon, J.; Katsikogianni, M.; Myllymaa, K.; Lappalainen, R.; Konttinen, Y.ö T.; Kinnari, T.J.; Tiainen, V.-M.; Missirlis, Y. 2011: In vitro adhesion of staphylococci to diamond-like carbon polymer hybrids under dynamic flow conditions. Journal of Materials Science. Materials in Medicine 22(3): 629-636

Stacey, D.H.; Hanson, S.E.; Lahvis, G.; Gutowski, K.A.; Masters, K.S. 2009: In vitro adipogenic differentiation of preadipocytes varies with differentiation stimulus, culture dimensionality, and scaffold composition. Tissue Engineering. Part a 15(11): 3389-3399

Shanti, R.M.; Janjanin, S.; Li, W.-J.; Nesti, L.J.; Mueller, M.B.; Tzeng, M.B.; Tuan, R.S. 2008: In vitro adipose tissue engineering using an electrospun nanofibrous scaffold. Annals of Plastic Surgery 61(5): 566-571

Rajan, Y.C.; Inbaraj, B.S.; Chen, B.H. 2014: In vitro adsorption of aluminum by an edible biopolymer poly(γ-glutamic acid). Journal of Agricultural and Food Chemistry 62(20): 4803-4811

Carney, F.P.; Morris, C.A.; Milthorpe, B.; Flanagan, J.L.; Willcox, M.D.P. 2009: In vitro adsorption of tear proteins to hydroxyethyl methacrylate-based contact lens materials. Eye and Contact Lens 35(6): 320-328

Miao, Y.; Zhou, J.; Chen, C.; Shen, D.; Song, W.; Feng, Y. 2008: In vitro adsorption revealing an apparent strong interaction between endophyte Pantoea agglomerans YS19 and host rice. Current Microbiology 57(6): 547-551

Spencer, N.D.; Lopez, M.J. 2011: In vitro adult canine adipose tissue-derived stromal cell growth characteristics. Methods in Molecular Biology 702: 47-60

Lopez, M.J.; Spencer, N.D. 2011: In vitro adult rat adipose tissue-derived stromal cell isolation and differentiation. Methods in Molecular Biology 702: 37-46

Siddique, I.; Anis, M.; Aref, I.M. 2010: In vitro adventitious shoot regeneration via indirect organogenesis from petiole explants of Cassia angustifolia Vahl.-a potential medicinal plant. Applied Biochemistry and Biotechnology 162(7): 2067-2074

Wang, H.; Wang, J.J.; Sanderson, B.J.S. 2013: In vitro adverse effects of iron ore dusts on human lymphoblastoid cells in culture. Journal of Toxicology and Environmental Health. Part a 76(14): 874-882

Sébert, P.; Mortelette, Hélène.; Nicolas, J.; Amérand, A.; Belhomme, M.; Moisan, C. 2011: In vitro aerobic and anaerobic muscle capacities in the European eel, Anguilla anguilla: effects of a swimming session. Respiratory Physiology and Neurobiology 176(3): 118-122

Dinh, K.; Myers, D.J.; Glazer, M.; Shmidt, T.; Devereaux, C.; Simis, K.; Noymer, P.D.; He, M.; Choosakul, C.; Chen, Q.; Cassella, J.V. 2011: In vitro aerosol characterization of Staccato(®) Loxapine. International Journal of Pharmaceutics 403(1-2): 101-108

Dinh, K.V.; Myers, D.J.; Noymer, P.D.; Cassella, J.V. 2010: In vitro aerosol deposition in the oropharyngeal region for Staccato loxapine. Journal of Aerosol Medicine and Pulmonary Drug Delivery 23(4): 253-260

Prassler, J.; Steidl, S.; Urlinger, S. 2009: In vitro affinity maturation of HuCAL antibodies: complementarity determining region exchange and RapMAT technology. ImmunoTherapy 1(4): 571-583

Li, B.; Fouts, A.E.; Stengel, K.; Luan, P.; Dillon, M.; Liang, W.-C.; Feierbach, B.; Kelley, R.F.; Hötzel, I. 2014: In vitro affinity maturation of a natural human antibody overcomes a barrier to in vivo affinity maturation. Mabs 6(2): 437-445

Muller, B.H.; Savatier, A.; L'Hostis, G.; Costa, N.; Bossus, M.; Michel, S.; Ott, C.; Becquart, L.; Ruffion, A.; Stura, E.A.; Ducancel, F.éd.ér. 2011: In vitro affinity maturation of an anti-PSA antibody for prostate cancer diagnostic assay. Journal of Molecular Biology 414(4): 545-562

Steidl, S.; Ratsch, O.; Brocks, B.; Dürr, M.; Thomassen-Wolf, E. 2008: In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification. Molecular Immunology 46(1): 135-144

Diamante, L.; Gatti-Lafranconi, P.; Schaerli, Y.; Hollfelder, F. 2013: In vitro affinity screening of protein and peptide binders by megavalent bead surface display. Protein Engineering Design and Selection: Peds 26(10): 713-724

Yunus, A.W.; Awad, W.A.; Kröger, S.; Zentek, J.; Böhm, J. 2010: In vitro aflatoxin B(1) exposure decreases response to carbamylcholine in the jejunal epithelium of broilers. Poultry Science 89(7): 1372-1378

Bruno, M.E.; Sittner, M.; Cabrini, Rómulo.L.; Guglielmotti, Mía.B.; Olmedo, D.G.; Tasat, D.R. 2015: In vitro age dependent response of macrophages to micro and nano titanium dioxide particles. Journal of Biomedical Materials Research. Part a 103(2): 471-478

Ebeling, S.; Labudda, A.; Meinecke, B. 2010: In vitro ageing of porcine oocytes: changes in phosphorylation of the mitogen-activated protein kinase (MAPK) and parthenogenetic activability. Reproduction in Domestic Animals 45(6): E398-E404

Narkiewicz, J.; Giachin, G.; Legname, G. 2014: In vitro aggregation assays for the characterization of α-synuclein prion-like properties. Prion 8(1): 19-32

Arosio, P.; Owczarz, M.; Müller-Späth, T.; Rognoni, P.; Beeg, M.; Wu, H.; Salmona, M.; Morbidelli, M. 2012: In vitro aggregation behavior of a non-amyloidogenic λ light chain dimer deriving from U266 multiple myeloma cells. Plos one 7(3): E33372

Zoico, E.; Di Francesco, V.; Olioso, D.; Fratta Pasini, A.M.; Sepe, A.; Bosello, O.; Cinti, S.; Cominacini, L.; Zamboni, M. 2010: In vitro aging of 3T3-L1 mouse adipocytes leads to altered metabolism and response to inflammation. Biogerontology 11(1): 111-122

Stehouwer, M.C.; Kelder, J.C.; van Oeveren, W.; de Vroege, R. 2014: In vitro air removal characteristics of two neonatal cardiopulmonary bypass systems: filtration may lead to fractionation of bubbles. International Journal of Artificial Organs 37(9): 688-696

Sobukawa, H.; Watanabe, M.; Kano, R.; Ito, T.; Onozaki, M.; Hasegawa, A.; Kamata, H. 2011: In vitro algaecide effect of disinfectants on Prototheca zopfii genotypes 1 and 2. Journal of Veterinary Medical Science 73(11): 1527-1529

Salerno, T.; Ribeiro, M.ár.G.; Langoni, H.él.; Siqueira, A.K.; Costa, E.O.d.; Melville, P.A.; Bueno, V.ál.F.F.él.; Yamamura, A.A.M.; Roesler, U.; da Silva, A.V. 2010: In vitro algaecide effect of sodium hypochlorite and iodine based antiseptics on Prototheca zopfii strains isolated from bovine milk. Research in Veterinary Science 88(2): 211-213

Aliotta, G.; Greca, M.D.; Monaco, P.; Pinto, G.; Pollio, A.; Previtera, L. 1990: In vitro algal growth inhibition by phytotoxins of Typha latifolia L. Journal of Chemical Ecology 16(9): 2637-2646

Weckwerth, P.H.; Zapata, R.O.; Vivan, R.R.; Tanomaru Filho, M.ár.; Maliza, A.G.A.; Duarte, M.A.H. 2013: In vitro alkaline pH resistance of Enterococcus faecalis. Brazilian Dental Journal 24(5): 474-476

Such, E.; Cordón, L.; Sempere, A.; Villamón, E.; Ibañez, M.; Luna, I.; Gómez-Seguí, I.és.; López-Pavía, M.ía.; Alonso, C.; Lo-Coco, F.; Cervera, J.; Sanz, M.A. 2014: In vitro all-trans retinoic acid sensitivity of acute myeloid leukemia blasts with NUP98/RARG fusion gene. Annals of Hematology 93(11): 1931-1933

Whalen, K.A.; Legault, H.; Hang, C.; Hill, A.; Kasaian, M.; Donaldson, D.; Bensch, G.W.; Bensch, G.; Baker, J.; Reddy, P.S.; Wood, N.; Ramarao, M.K.; Ellis, D.K.; Csimma, C.; McKee, C.; Clark, J.D.; Ryan, J.; Dorner, A.J.; O'Toole, M. 2008: In vitro allergen challenge of peripheral blood induces differential gene expression in mononuclear cells of asthmatic patients: inhibition of cytosolic phospholipase A2alpha overcomes the asthma-associated response. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 38(10): 1590-1605

Brehler, R.; Wedi, B. 2010: In vitro allergy diagnosis in dermatology. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 61(11): 935-937

Osguthorpe, J.D. 2014: In vitro allergy testing. International Forum of Allergy and Rhinology 4(Suppl 2): S46-S50

Ashok Kumar, B.S.; Lakshman, K.; Nandeesh, R.; Arun Kumar, P.A.; Manoj, B.; Kumar, V.; Sheshadri Shekar, D. 2011: In vitro alpha-amylase inhibition and in vivo antioxidant potential of Amaranthus spinosus in alloxan-induced oxidative stress in diabetic rats. Saudi Journal of Biological Sciences 18(1): 1-5

Subramanian, R.; Asmawi, M.Z.; Sadikun, A. 2008: In vitro alpha-glucosidase and alpha-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide. Acta Biochimica Polonica 55(2): 391-398

Hanson, K.K.; March, S.; Ng, S.; Bhatia, S.N.; Mota, M.M. 2015: In vitro alterations do not reflect a requirement for host cell cycle progression during Plasmodium liver stage infection. Eukaryotic Cell 14(1): 96-103

Valinoti, A.C.; Pierro, V.S.D.S.; Da Silva, E.M.; Maia, L.C. 2011: In vitro alterations in dental enamel exposed to acidic medicines. International Journal of Paediatric Dentistry 21(2): 141-150

Folarin, O.A.; Bustamante, C.; Gbotosho, G.O.; Sowunmi, A.; Zalis, M.G.; Oduola, A.M.J.; Happi, C.T. 2011: In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria. Acta Tropica 120(3): 224-230

Degerli, S.; Tepe, B.; Celiksoz, A.; Berk, S.; Malatyali, E. 2012: In vitro amoebicidal activity of Origanum syriacum and Origanum laevigatum on Acanthamoeba castellanii cysts and trophozoites. Experimental Parasitology 131(1): 20-24

Goze, I.; Alim, A.; Dag, S.; Tepe, B.; Polat, Z.A. 2009: In vitro amoebicidal activity of Salvia staminea and Salvia caespitosa on Acanthamoeba castellanii and their cytotoxic potentials on corneal cells. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 25(4): 293-298

Polat, Z.A.ın.; Savage, P.B.; Genberg, C. 2011: In vitro amoebicidal activity of a ceragenin, cationic steroid antibiotic-13, against Acanthamoeba castellanii and its cytotoxic potential. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 27(1): 1-5

Leos-Rivas, C.; Verde-Star, M.J.; Torres, L.O.; Oranday-Cardenas, A.; Rivas-Morales, C.; Barron-Gonzalez, M.P.; Morales-Vallarta, M.R.; Cruz-Vega, D.E. 2011: In vitro amoebicidal activity of borage (Borago officinalis) extract on Entamoeba histolytica. Journal of Medicinal Food 14(7-8): 866-869

Álvarez-Pérez, S.; Blanco, J.é L.; Peláez, T.; Cutuli, M.; García, M.E. 2014: In vitro amphotericin B susceptibility of Malassezia pachydermatis determined by the CLSi broth microdilution method and Etest using lipid-enriched media. Antimicrobial Agents and ChemoTherapy 58(7): 4203-4206

Odeón, A.C.; Leunda, M.R.; Faverín, C.; Boynak, N.; Vena, M.M.; Zabal, O. 2009: In vitro amplification of BVDV field strains isolated in Argentina: effect of cell line and culture conditions. Revista Argentina de Microbiologia 41(2): 79-85

Weng, W.-J.; Pan, L.; Fang, J.-P.; Xu, L.-H. 2013: In vitro amplification of CD4(+) CD25(+) regulatory T cells and identification of amplified T cell immunosuppressive function. Zhongguo Shi Yan Xue Ye Xue Za Zhi 21(5): 1266-1270

Mays, C.E.; Yeom, J.; Kang, H.-E.; Bian, J.; Khaychuk, V.; Kim, Y.; Bartz, J.C.; Telling, G.C.; Ryou, C. 2011: In vitro amplification of misfolded prion protein using lysate of cultured cells. Plos one 6(3): E18047

Thorne, L.; Holder, T.; Ramsay, A.; Edwards, J.; Taema, M.M.; Windl, O.; Maddison, B.C.; Gough, K.C.; Terry, L.A. 2012: In vitro amplification of ovine prions from scrapie-infected sheep from Great Britain reveals distinct patterns of propagation. Bmc Veterinary Research 8: 223

Gough, K.C.; Baker, C.A.; Taema, M.; Maddison, B.C. 2009: In vitro amplification of prions from milk in the detection of subclinical infections. Prion 3(4): 236-239

Rambaldi, D.C.; Zattoni, A.; Reschiglian, P.; Colombo, R.; De Lorenzi, E. 2009: In vitro amyloid Abeta(1-42) peptide aggregation monitoring by asymmetrical flow field-flow fractionation with multi-angle light scattering detection. Analytical and Bioanalytical Chemistry 394(8): 2145-2149

Yam, G.H.-F.; Wang, K.; Jhanji, V.; Choy, K.-W.; Baum, L.; Pang, C.-P. 2012: In vitro amyloid aggregate forming ability of TGFBi mutants that cause corneal dystrophies. Investigative Ophthalmology and Visual Science 53(9): 5890-5898

Milojevic, J.; Costa, M.; Ortiz, A.M.; Jorquera, J.I.; Melacini, G. 2014: In vitro amyloid-β binding and inhibition of amyloid-β self-association by therapeutic albumin. Journal of Alzheimer's disease: JAD 38(4): 753-765

Ono, K.; Fujimoto, E.; Fujimoto, N.; Akiyama, M.; Satoh, T.; Maeda, H.; Fujii, N.; Tajima, S. 2014: In vitro amyloidogenic peptides of galectin-7: possible mechanism of amyloidogenesis of primary localized cutaneous amyloidosis. Journal of Biological Chemistry 289(42): 29195-29207

Sproule-Willoughby, K.M.; Stanton, M.M.; Rioux, K.P.; McKay, D.M.; Buret, A.G.; Ceri, H. 2010: In vitro anaerobic biofilms of human colonic microbiota. Journal of Microbiological Methods 83(3): 296-301

Nichols, J.E.; Cortiella, J.; Lee, J.; Niles, J.A.; Cuddihy, M.; Wang, S.; Bielitzki, J.; Cantu, A.; Mlcak, R.; Valdivia, E.; Yancy, R.; McClure, M.L.; Kotov, N.A. 2009: In vitro analog of human bone marrow from 3D scaffolds with biomimetic inverted colloidal crystal geometry. Biomaterials 30(6): 1071-1079

Monaghan-Benson, E.; Wittchen, E.S. 2011: In vitro analyses of endothelial cell permeability. Methods in Molecular Biology 763: 281-290

Zeng, R.; Li, M.; Chen, Q.; Wang, L.; Zhan, P.; Wang, C.; Lv, G.; Shen, Y.; Liu, W. 2014: In vitro analyses of mild heat stress in combination with antifungal agents against Aspergillus fumigatus biofilm. Antimicrobial Agents and ChemoTherapy 58(3): 1443-1450

Seet, L.-F.; Su, R.; Toh, L.Z.; Wong, T.T. 2012: In vitro analyses of the anti-fibrotic effect of SPARC silencing in human Tenon's fibroblasts: comparisons with mitomycin C. Journal of Cellular and Molecular Medicine 16(6): 1245-1259

Miceli, M.H.; Bernardo, S.M.; Lee, S.A. 2009: In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms. International Journal of Antimicrobial Agents 34(4): 326-332

Groppe, J.C.; Wu, J.; Shore, E.M.; Kaplan, F.S. 2011: In vitro analyses of the dysregulated R206H ALK2 kinase-FKBP12 interaction associated with heterotopic ossification in FOP. Cells Tissues Organs 194(2-4): 291-295

Daliry, A.; Da Silva, P.íc.B.; Da Silva, C.F.; Batista, M.M.; De Castro, S.L.; Tidwell, R.R.; Soeiro, M.d.N.é C. 2009: In vitro analyses of the effect of aromatic diamidines upon Trypanosoma cruzi. Journal of Antimicrobial ChemoTherapy 64(4): 747-750

Bonnamain, V.; Neveu, I.; Naveilhan, P. 2011: In vitro analyses of the immunosuppressive properties of neural stem/progenitor cells using anti-CD3/CD28-activated T cells. Methods in Molecular Biology 677: 233-243

Zhang, M.-M.; Jia, G.-Q.; Cheng, J.-Q.; Yang, P.; Lu, Y.-R.; Wu, X.-T. 2012: In vitro analysis and in vivo tracing of BrdU-labeled rat bone marrow mesenchymal stem cells. Sichuan da Xue Xue Bao. Yi Xue Ban 43(2): 266-270

Vaneycken, I.; Govaert, J.; Vincke, C.éc.; Caveliers, V.; Lahoutte, T.; De Baetselier, P.; Raes, G.; Bossuyt, A.; Muyldermans, S.; Devoogdt, N. 2010: In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 51(7): 1099-1106

Ergun, A.; Yu, X.; Valdevit, A.; Ritter, A.; Kalyon, D.M. 2011: In vitro analysis and mechanical properties of twin screw extruded single-layered and coextruded multilayered poly(caprolactone) scaffolds seeded with human fetal osteoblasts for bone tissue engineering. Journal of Biomedical Materials Research. Part a 99(3): 354-366

Beitz, E.; Becker, D.; von Bülow, J.; Conrad, C.; Fricke, N.; Geadkaew, A.; Krenc, D.; Song, J.; Wree, D.; Wu, B. 2009: In vitro analysis and modification of aquaporin pore selectivity. Handbook of Experimental Pharmacology 190: 77-92

Xu, C.; Desta, Z. 2013: In vitro analysis and quantitative prediction of efavirenz inhibition of eight cytochrome P450 (CYP) enzymes: major effects on CYPs 2B6, 2C8, 2C9 and 2C19. Drug Metabolism and Pharmacokinetics 28(4): 362-371

Garza, R.M.; Sato, B.K.; Hampton, R.Y. 2009: In vitro analysis of Hrd1p-mediated retrotranslocation of its multispanning membrane substrate 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase. Journal of Biological Chemistry 284(22): 14710-14722

Saffra, N.; Agarwal, S.; Enin, J.; Werner, L.; Mamalis, N. 2012: In vitro analysis of Nd:YAG laser damage to hydrophilic intraocular lenses. Ophthalmic Surgery Lasers and Imaging: the Official Journal of the International Society for Imaging in the Eye 43(1): 45-49

Wu, Y.; Wang, S.; Li, C. 2012: In vitro analysis of PDZ-dependent CFTR macromolecular signaling complexes. Journal of Visualized Experiments: Jove 2012(66)

Comolli, N.; Neuhuber, B.; Fischer, I.; Lowman, A. 2009: In vitro analysis of PNIPAAm-PEG, a novel, injectable scaffold for spinal cord repair. Acta Biomaterialia 5(4): 1046-1055

Hrit, J.; Raynard, N.; Van Etten, J.; Sankar, K.; Petterson, A.; Goldstrohm, A.C. 2014: In vitro analysis of RNA degradation catalyzed by deadenylase enzymes. Methods in Molecular Biology 1125: 325-339

Lin, Y.L.; Dutta, A. 2001: In vitro analysis of SV40 DNA replication. Current Protocols in Cell Biology Chapter 11: Unit 11.5

Carraro, A.; Hsu, W.-M.; Kulig, K.M.; Cheung, W.S.; Miller, M.L.; Weinberg, E.J.; Swart, E.F.; Kaazempur-Mofrad, M.; Borenstein, J.T.; Vacanti, J.P.; Neville, C. 2008: In vitro analysis of a hepatic device with intrinsic microvascular-based channels. Biomedical Microdevices 10(6): 795-805

Cohen, M.S.; Stern, J.M.; Vanni, A.J.; Kelley, R.S.; Baumgart, E.; Field, D.; Libertino, J.A.; Summerhayes, I.C. 2007: In vitro analysis of a nanocrystalline silver-coated surgical mesh. Surgical Infections 8(3): 397-403

Bachelder, E.M.; Beaudette, T.T.; Broaders, K.E.; Fréchet, J.M.J.; Albrecht, M.T.; Mateczun, A.J.; Ainslie, K.M.; Pesce, J.T.; Keane-Myers, A.M. 2010: In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants. Molecular Pharmaceutics 7(3): 826-835

Dos Santos, T.ân.R.B.; Pappen, F.G.; da Rosa Farias, N.A.él.; da Silva Vaz Junior, I. 2009: In vitro analysis of amitraz efficacy against Rhipicephalus (Boophilus) microplus (Canestrini, 1887) populations of southern region of Rio Grande do Sul state. Revista Brasileira de Parasitologia Veterinaria 18(Suppl 1): 54-57

Dines, J.S.; Cross, M.B.; Dines, D.; Pantazopoulos, C.; Kim, H.J.; Razzano, P.; Grande, D. 2011: In vitro analysis of an rhGDF-5 suture coating process and the effects of rhGDF-5 on rat tendon fibroblasts. Growth Factors 29(1): 1-7

Kallemeier, P.M.; Beaubien, B.P.; Buttermann, G.R.; Polga, D.J.; Wood, K.B. 2008: In vitro analysis of anterior and posterior fixation in an experimental unstable burst fracture model. Journal of Spinal Disorders and Techniques 21(3): 216-224

Ahmed, D.; Zara, S.; Baig, H. 2012: In vitro analysis of antioxidant activities of Oxalis corniculata Linn. fractions in various solvents. African Journal of Traditional Complementary and Alternative Medicines: Ajtcam 10(1): 158-165

De Sousa, N.T.A.; Guirro, R.R.d.J.; Santana, H.F.; Silva, C.C.M. 2012: In vitro analysis of bacterial morphology by atomic force microscopy of low level laser therapy 660, 830 and 904 nm. Photomedicine and Laser Surgery 30(5): 281-285

Garcia, E.J.; Gomes, O.M.M.; Gomes, J.ão.C. 2009: In vitro analysis of bond strength of self-etching adhesives applied on superficial and deep dentin. Acta Odontologica Latinoamericana: Aol 22(1): 57-62

Smart, C.E.; Morrison, B.J.; Saunus, J.M.; Vargas, A.C.; Keith, P.; Reid, L.; Wockner, L.; Askarian-Amiri, M.; Amiri, M.A.; Sarkar, D.; Simpson, P.T.; Clarke, C.; Schmidt, C.W.; Reynolds, B.A.; Lakhani, S.R.; Lopez, J.A. 2013: In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity. Plos one 8(6): E64388

Hagen, A.; Poust, S.; de Rond, T.; Yuzawa, S.; Katz, L.; Adams, P.D.; Petzold, C.J.; Keasling, J.D. 2014: In vitro analysis of carboxyacyl substrate tolerance in the loading and first extension modules of borrelidin polyketide synthase. Biochemistry 53(38): 5975-5977

Hynes, J.; O'Riordan, T.ás.C.; Zhdanov, A.V.; Uray, G.; Will, Y.; Papkovsky, D.B. 2009: In vitro analysis of cell metabolism using a long-decay pH-sensitive lanthanide probe and extracellular acidification assay. Analytical Biochemistry 390(1): 21-28

Nagarsheth, N.P.; Fenske, S.Silverman.; Shah, A.; Moshier, E.; Stahl, R.; Shander, A. 2013: In vitro analysis of cell salvage blood collection with a laparoscopic suction device. Journal of Minimally Invasive Gynecology 20(1): 104-106

Sixt, M.; Lämmermann, T. 2011: In vitro analysis of chemotactic leukocyte migration in 3D environments. Methods in Molecular Biology 769: 149-165

Smith, M.D.; Schnell, D.J.; Fitzpatrick, L.; Keegstra, K. 2003: In vitro analysis of chloroplast protein import. Current Protocols in Cell Biology Chapter 11: Unit 11.16

Babincov, M.; Altanerov, V.; Altaner, C.; Bergemann, C.; Babinec, P. 2008: In vitro analysis of cisplatin functionalized magnetic nanoparticles in combined cancer chemotherapy and electromagnetic hyperthermia. IEEE Transactions on Nanobioscience 7(1): 15-19

Hang, H.; Shi, X.; Gu, G.x.; Wu, Y.; Gu, J.; Ding, Y. 2010: In vitro analysis of cryopreserved alginate-poly-L-lysine-alginate-microencapsulated human hepatocytes. Liver International: Official Journal of the International Association for the Study of the Liver 30(4): 611-622

Salazar, G.M.; Faintuch, S.; Gladstone, S.R.; Lang, E.V. 2009: In vitro analysis of downstream particulates with mechanical thrombectomy devices: comparison of 20-kHz sonothrombolytic and rotating dispersion wire systems. Journal of Vascular and Interventional Radiology: Jvir 20(5): 634-639

Allan, B.B.; Balch, W.E. 2001: In vitro analysis of endoplasmic-reticulum-to-golgi transport in mammalian cells. Current Protocols in Cell Biology Chapter 11: Unit 11.3

Bell, C.G.R.; Weinrauch, P.; Pearcy, M.; Crawford, R. 2007: In vitro analysis of exeter stem torsional stability. Journal of Arthroplasty 22(7): 1024-1030

Rajasekharan, S.; Martens, L.; Vanhove, C.; Aps, J. 2014: In vitro analysis of extracted dens invaginatus using various radiographic imaging techniques. European Journal of Paediatric Dentistry 15(3): 265-270

Chavez-Dozal, A.A.; Lown, L.; Jahng, M.; Walraven, C.J.; Lee, S.A. 2014: In vitro analysis of finasteride activity against Candida albicans urinary biofilm formation and filamentation. Antimicrobial Agents and ChemoTherapy 58(10): 5855-5862

Chavez-Dozal, A.A.; Jahng, M.; Rane, H.S.; Asare, K.; Kulkarny, V.V.; Bernardo, S.M.; Lee, S.A. 2014: In vitro analysis of flufenamic acid activity against Candida albicans biofilms. International Journal of Antimicrobial Agents 43(1): 86-91

Iwamuro, M.; Kawai, Y.; Shiraha, H.; Takaki, A.; Okada, H.; Yamamoto, K. 2014: In vitro analysis of gastric phytobezoar dissolubility by coca-cola, coca-cola zero, cellulase, and papain. Journal of Clinical Gastroenterology 48(2): 190-191

Müller, B.; Anders, M.; Reinstein, J. 2014: In vitro analysis of human immunodeficiency virus particle dissociation: gag proteolytic processing influences dissociation kinetics. Plos one 9(6): E99504

Tsubokawa, M.; Sato, S. 2014: In vitro analysis of human periodontal microvascular endothelial cells. Journal of Periodontology 85(8): 1135-1142

De Alencar Mollo, M.ár.; Frigo, L.; Favero, G.M.; Lopes-Martins, R.A.B.ão.; Brugnera Junior, A. 2011: In vitro analysis of human tooth pulp chamber temperature after low-intensity laser therapy at different power outputs. Lasers in Medical Science 26(2): 143-147

Thomé, T.ís.; Mayer, M.P.A.; Imazato, S.; Geraldo-Martins, V.íc.R.; Marques, M.ár.M. 2009: In vitro analysis of inhibitory effects of the antibacterial monomer MDPB-containing restorations on the progression of secondary root caries. Journal of Dentistry 37(9): 705-711

Zhang, W.-Y.; Liu, H.-C.; Wu, X.; E, L.-L.; Lü, Y.; Zhang, J. 2009: In vitro analysis of intake of minocycline by mature rat mandibular osteoblasts. Zhonghua Kou Qiang Yi Xue Za Zhi 44(1): 28-31

Sadikovic, B.; Yoshimoto, M.; Al-Romaih, K.; Maire, G.; Zielenska, M.; Squire, J.A. 2008: In vitro analysis of integrated global high-resolution DNA methylation profiling with genomic imbalance and gene expression in osteosarcoma. Plos one 3(7): E2834

Goessler, U.R.; Bugert, P.; Bieback, K.; Stern-Straeter, J.; Bran, G.; Sadick, H.; Hörmann, K.; Riedel, F. 2009: In vitro analysis of integrin expression in stem cells from bone marrow and cord blood during chondrogenic differentiation. Journal of Cellular and Molecular Medicine 13(6): 1175-1184

Mladěnka, P.ře.; Macáková, K.ři.; Filipský, T.áš; Zatloukalová, L.še.; Jahodář, L.ěk.; Bovicelli, P.; Silvestri, I.P.; Hrdina, R.ír.; Saso, L. 2011: In vitro analysis of iron chelating activity of flavonoids. Journal of Inorganic Biochemistry 105(5): 693-701

Reich, S.; Trentzsch, L.; Gozdowski, S.; Krey, K.-F. 2009: In vitro analysis of laboratory-processed and CAD/CAM-generated occlusal onlay surfaces. International Journal of Prosthodontics 22(6): 620-622

Romo, A.; Badel, P.; Duprey, A.; Favre, J.-P.; Avril, S.ép. 2014: In vitro analysis of localized aneurysm rupture. Journal of Biomechanics 47(3): 607-616

Ito, K.; Fujita, K. 2011: In vitro analysis of mouse mesencephalic neural crest development. Current Protocols in Neuroscience Chapter 3: Unit 3.23

Skoczen, S.L.; Potter, T.M.; Dobrovolskaia, M.A. 2011: In vitro analysis of nanoparticle uptake by macrophages using chemiluminescence. Methods in Molecular Biology 697: 255-261

Uskoković, V.; Desai, T.A. 2014: In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis. Journal of Pharmaceutical Sciences 103(2): 567-579

Ziegler, S.; Bekeredjian-Ding, I. 2014: In vitro analysis of nucleic acid recognition in B lymphocytes. Methods in Molecular Biology 1169: 87-96

Philippot, R.; Chouteau, J.; Testa, R.; Moyen, B. 2010: In vitro analysis of patellar kinematics: validation of an opto-electronic cinematic analysis protocol. Knee Surgery Sports Traumatology Arthroscopy: Official Journal of the Esska 18(2): 161-166

Safran, M.R.; Lopomo, N.; Zaffagnini, S.; Signorelli, C.; Vaughn, Z.D.; Lindsey, D.P.; Gold, G.; Giordano, G.; Marcacci, M. 2013: In vitro analysis of peri-articular soft tissues passive constraining effect on hip kinematics and joint stability. Knee Surgery Sports Traumatology Arthroscopy: Official Journal of the Esska 21(7): 1655-1663

Terlecky, S.R. 2002: In vitro analysis of peroxisomal protein import. Current Protocols in Cell Biology Chapter 11: Unit 11.15

Larisch, P.; Verwanger, T.; Onder, K.; Krammer, B. 2013: In vitro analysis of photosensitizer accumulation for assessment of applicability of fluorescence diagnosis of squamous cell carcinoma of epidermolysis bullosa patients. Biomed Research International 2013: 521281

Broekema, F.I.; van Oeveren, W.; Zuidema, J.; Visscher, S.H.; Bos, R.R.M. 2011: In vitro analysis of polyurethane foam as a topical hemostatic agent. Journal of Materials Science. Materials in Medicine 22(4): 1081-1086

Cashman, P.M.; Schneider, R.L.; Schneider, G.B.; Stanford, C.M.; Clancy, J.M.; Qian, F. 2011: In vitro analysis of post-fatigue reverse-torque values at the dental abutment/implant interface for a unitarian abutment design. Journal of Prosthodontics: Official Journal of the American College of Prosthodontists 20(7): 503-509

Saggio, G.; Bianchi, L.; Castelli, S.; Santucci, M.B.; Fraziano, M.; Desideri, A. 2014: In vitro analysis of pyrogenicity and cytotoxicity profiles of flex sensors to be used to sense human joint postures. Sensors 14(7): 11672-11681

Goessler, U.R.; Bugert, P.; Kassner, S.; Stern-Straeter, J.; Bran, G.; Sadick, H.; Hörmann, K.; Riedel, F. 2010: In vitro analysis of radiation-induced dermal wounds. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 142(6): 845-850

Borelli, B.; Sorrentino, R.; Goracci, C.; Zarone, F.; Ferrari, M. 2013: In vitro analysis of residual tooth structure of maxillary anterior teeth after different prosthetic finish line preparations for full-coverage single crowns. Journal of Oral Science 55(1): 79-84

Murmura, G.; Di Iorio, D.; Cicchetti, A.R.; Sinjari, B.; Caputi, S. 2013: In vitro analysis of resistance to cyclic load and preload distribution of two implant/abutment screwed connections. Journal of Oral Implantology 39(3): 293-301

Vandebrouck, A.él.; Domazetovska, A.; Mokbel, N.; Cooper, S.T.; Ilkovski, B.; North, K.N. 2010: In vitro analysis of rod composition and actin dynamics in inherited myopathies. Journal of Neuropathology and Experimental Neurology 69(5): 429-441

Neves, M.G.; Brandão, G.A.ôn.M.; de Almeida, H.A.; Brandão, A.M.M.; de Azevedo, D.ár.R. 2013: In vitro analysis of shear bond strength and adhesive remnant index comparing light curing and self-curing composites. Dental Press Journal of Orthodontics 18(3): 124-129

Ulzi, G.; Sansone, V.A.; Magri, F.; Corti, S.; Bresolin, N.; Comi, G.P.; Lucchiari, S. 2014: In vitro analysis of splice site mutations in the CLCN1 gene using the minigene assay. Molecular Biology Reports 41(5): 2865-2874

Perez-Olmeda, M.; Garcia-Perez, J.; Mateos, E.; Spijkers, S.; Ayerbe, M.C.; Carcas, A.; Alcami, J. 2009: In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication. Journal of Medical Virology 81(2): 211-216

Karatsa-Dodgson, M.; Wörmann, M.E.; Gründling, A. 2010: In vitro analysis of the Staphylococcus aureus lipoteichoic acid synthase enzyme using fluorescently labeled lipids. Journal of Bacteriology 192(20): 5341-5349

Lee, K-Jai.; An, J.Hee.; Chun, J-Ran.; Chung, K-Hyun.; Park, W-Yoon.; Shin, J-Soo.; Kim, D-Hee.; Bahk, Y.Yil. 2013: In vitro analysis of the anti-cancer activity of mitoxantrone loaded on magnetic nanoparticles. Journal of Biomedical Nanotechnology 9(6): 1071-1075

Vergallo, C.; Dini, L.; Szamosvölgyi, Z.; Tenuzzo, B.A.; Carata, E.; Panzarini, E.; László, J.án.F. 2013: In vitro analysis of the anti-inflammatory effect of inhomogeneous static magnetic field-exposure on human macrophages and lymphocytes. Plos one 8(8): E72374

Grenho, L.; Monteiro, F.J.; Pia Ferraz, M. 2014: In vitro analysis of the antibacterial effect of nanohydroxyapatite-ZnO composites. Journal of Biomedical Materials Research. Part a 102(10): 3726-3733

Moser, M.; Panahandeh, S.; Holzapfel, E.; Müller, M. 2007: In vitro analysis of the bacterial twin-arginine-dependent protein export. Methods in Molecular Biology 390: 63-79

Storm, D.W.; Koff, S.A.; Horvath, D.J.; Li, B.; Justice, S.S. 2011: In vitro analysis of the bactericidal activity of Escherichia coli Nissle 1917 against pediatric uropathogens. Journal of Urology 186(4 Suppl): 1678-1683

Garcia, L.d.F.R.; Consani, S.; Pires-de-Souza, F.d.C.P.; de Almeida, G.L. 2009: In vitro analysis of the cement film thickness of two endodontic sealers in the apical region. Indian Journal of Dental Research: Official Publication of Indian Society for Dental Research 20(3): 390

Lee, S.M.; Park, H.H. 2014: In vitro analysis of the complete CIDE domain interactions of the Drep system in fly. Apoptosis: An International Journal on Programmed Cell Death 19(3): 428-435

Bladen, C.L.; Tzu-Yin, L.; Fisher, J.; Tipper, J.L. 2013: In vitro analysis of the cytotoxic and anti-inflammatory effects of antioxidant compounds used as additives in ultra high-molecular weight polyethylene in total joint replacement components. Journal of Biomedical Materials Research. Part B Applied Biomaterials 101(3): 407-413

Yamaguchi, F.; Watanabe, S.-I.; Harada, F.; Miyake, M.; Yoshida, M.; Okano, T. 2014: In vitro analysis of the effect of alkyl-chain length of anionic surfactants on the skin by using a reconstructed human epidermal model. Journal of Oleo Science 63(10): 995-1004

Park, J.-B.; Jang, Y.J.; Koh, M.; Choi, B.-K.; Kim, K.-K.; Ko, Y. 2013: In vitro analysis of the efficacy of ultrasonic scalers and a toothbrush for removing bacteria from resorbable blast material titanium disks. Journal of Periodontology 84(8): 1191-1198

Ortega-Villaizan, M.; Chico, V.; Martinez-Lopez, A.; Falco, A.; Perez, L.; Coll, J.M.; Estepa, A. 2011: In vitro analysis of the factors contributing to the antiviral state induced by a plasmid encoding the viral haemorrhagic septicaemia virus glycoprotein G in transfected trout cells. Vaccine 29(4): 737-743

Kubota, K.; Ohnishi, H.; Teramoto, T.; Matsui, E.; Murase, K.; Kanoh, H.; Kato, Z.; Kaneko, H.; Seishima, M.; Kondo, N. 2013: In vitro analysis of the functional effects of an NLRP3 G809S variant with the co-existence of MEFV haplotype variants in atypical autoinflammatory syndrome. Journal of Clinical Immunology 33(2): 325-334

Seely, D.; Kennedy, D.A.; Myers, S.P.; Cheras, P.A.; Lin, D.; Li, R.; Cattley, T.; Brent, P.-A.P.; Mills, E.; Leonard, B.J.N. 2007: In vitro analysis of the herbal compound Essiac. Anticancer Research 27(6b): 3875-3882

Ahn, Y.; Jung, J.Y.; Chung, Y.H.; Chae, M.; Jeon, C.O.; Cerniglia, C.E. 2012: In vitro analysis of the impact of enrofloxacin residues on the human intestinal microbiota using H-NMR spectroscopy. Journal of Molecular Microbiology and Biotechnology 22(5): 317-325

Hagmann, S.; Kirsch, J.; Kretzer, J.P.; Moradi, B. 2013: In vitro analysis of the impact of metal ions on human lymphocyte cultures. Der Orthopade 42(8): 643-650

Mazzo, C.R.; Reis, A.éa.C.ân.d.; Shimano, A.C.; Valente, M.L.d.C. 2012: In vitro analysis of the influence of surface treatment of dental implants on primary stability. Brazilian Oral Research 26(4): 313-317

Borges, Jörg.; Müller, M.C.; Momeni, A.; Stark, G.Björn.; Torio-Padron, N. 2007: In vitro analysis of the interactions between preadipocytes and endothelial cells in a 3D fibrin matrix. Minimally Invasive Therapy and Allied Technologies: Mitat: Official Journal of the Society for Minimally Invasive Therapy 16(3): 141-148

Moon, S.-J.; Kwon, M.; Choi, D.; Won, K.; Kim, Y.H.; Choi, I.-G.; Choi, J.W. 2012: In vitro analysis of the monolignol coupling mechanism using dehydrogenative polymerization in the presence of peroxidases and controlled feeding ratios of coniferyl and sinapyl alcohol. Phytochemistry 82: 15-21

Miceli, M.H.; Bernardo, S.M.; Lee, S.A. 2009: In vitro analysis of the occurrence of a paradoxical effect with different echinocandins and Candida albicans biofilms. International Journal of Antimicrobial Agents 34(5): 500-502

Ferreira, R.; Bombana, A.C.; Sayeg, I.J. 2008: In vitro analysis of the penetration of methylene blue dye in human radicular dentin using different methods of impregnation. Australian Endodontic Journal: the Journal of the Australian Society of Endodontology Inc 34(3): 110-114

Menzies, K.L.; Jones, L. 2011: In vitro analysis of the physical properties of contact lens blister pack solutions. Optometry and Vision Science: Official Publication of the American Academy of Optometry 88(4): 493-501

Feilke, K.; Yu, Q.; Beyer, P.; Sétif, P.; Krieger-Liszkay, A. 2014: In vitro analysis of the plastid terminal oxidase in photosynthetic electron transport. Biochimica et Biophysica Acta 1837(10): 1684-1690

Soares, C.J.é; Santana, F.R.; Fonseca, R.B.; Martins, L.R.M.; Neto, F.H. 2007: In vitro analysis of the radiodensity of indirect composites and ceramic inlay systems and its influence on the detection of cement overhangs. Clinical Oral Investigations 11(4): 331-336

Gansukh, T.; Donizy, P.; Halon, A.; Lage, H.; Surowiak, P. 2013: In vitro analysis of the relationships between metallothionein expression and cisplatin sensitivity of non-small cellular lung cancer cells. Anticancer Research 33(12): 5255-5260

Lindsey-Boltz, L.A.; Reardon, J.T.; Wold, M.S.; Sancar, A. 2012: In vitro analysis of the role of replication protein a (RPA) and RPA phosphorylation in ATR-mediated checkpoint signaling. Journal of Biological Chemistry 287(43): 36123-36131

Bellecave, P.; Malato, L.; Calmels, C.; Reigadas, S.; Parissi, V.; Andreola, M.-L.; Fleury, H.é 2014: In vitro analysis of the susceptibility of HIV-1 subtype a and CRF01_AE integrases to raltegravir. International Journal of Antimicrobial Agents 44(2): 168-172

Amiott, E.A.; Jaehning, J.A. 2007: In vitro analysis of the yeast mitochondrial RNA polymerase. Methods in Molecular Biology 372: 193-206

Michelotto, A.é L.d.C.; Moura-Netto, C.; Araki, A.T.; Akisue, E.; Moura, A.íl.A.M.ão.; Sydney, G.B. 2010: In vitro analysis of thermocompaction time and gutta-percha type on quality of main canal and lateral canals filling. Brazilian Oral Research 24(3): 290-295

Nagaike, T.; Manley, J.L. 2014: In vitro analysis of transcriptional activators and polyadenylation. Methods in Molecular Biology 1125: 65-74

Satterwhite, T.S.; Chong, A.K.; Luo, J.; Pham, H.; Costa, M.; Longaker, M.T.; Wyss-Coray, T.; Chang, J. 2007: In vitro analysis of transforming growth factor-beta1 inhibition in novel transgenic SBE-luciferase mice. Annals of Plastic Surgery 59(2): 207-213

Rakotondrafara, Aélie.M.; Miller, W.Allen. 2008: In vitro analysis of translation enhancers. Methods in Molecular Biology 451: 113-124

Knowles, M.; Pellisar, T.; Murphy, E.H.; Stanley, G.A.; Hashmi, A.F.; Arko, M.Zachary.; Arko, F.R. 2011: In vitro analysis of type II endoleaks and aneurysm sac pressurization on longitudinal stent-graft displacement. Journal of Endovascular Therapy: An Official Journal of the International Society of Endovascular Specialists 18(4): 601-606

Zhang, W.; Tang, Y. 2009: In vitro analysis of type Ii polyketide synthase. Methods in Enzymology 459: 367-393

Marcus, P.I.; Ngunjiri, J.M.; Sekellick, M.J.; Wang, L.; Lee, C-Won. 2010: In vitro analysis of virus particle subpopulations in candidate live-attenuated influenza vaccines distinguishes effective from ineffective vaccines. Journal of Virology 84(21): 10974-10981

Stuart, R.A.; Koehler, C.M. 2007: In vitro analysis of yeast mitochondrial protein import. Current Protocols in Cell Biology Chapter 11: Unit 11.19

Gutiérrez, J.; Vallejo, B.; Barbosa, H.; Pinzón, J.; Delgado, G. 2013: In vitro analysis regarding the safety of components used in a film-based therapeutic system loaded with meglumine antimoniate and its activity toward Leishmania major experimental infections: a preliminary study. Immunopharmacology and Immunotoxicology 35(3): 321-328

Yamanaka, H.; Kondo, S. 2014: In vitro analysis suggests that difference in cell movement during direct interaction can generate various pigment patterns in vivo. Proceedings of the National Academy of Sciences of the United States of America 111(5): 1867-1872

Sreenivasan, S.; Ravichandran, S.; Vetrivel, U.; Krishnakumar, S. 2012: In vitro and in silico studies on inhibitory effects of curcumin on multi drug resistance associated protein (MRP1) in retinoblastoma cells. Bioinformation 8(1): 13-19

Liu, L.; Zhang, J.; Su, X.; Mason, R.P. 2008: In vitro and in vivo Assessment of CdTe and CdHgTe Toxicity and Clearance. Journal of Biomedical Nanotechnology 4(4): 524-528

Vijaya, R.; Ruckmani, K. 2011: In vitro and in vivo characterization of the transdermal delivery of sertraline hydrochloride Films. Daru: Journal of Faculty of Pharmacy Tehran University of Medical Sciences 19(6): 424-432

Kang, H-Won.; Walvick, R.; Bogdanov, A. 2009: In vitro and In vivo imaging of antivasculogenesis induced by Noggin protein expression in human venous endothelial cells. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 23(12): 4126-4134

Mollinedo, F.; de la Iglesia-Vicente, J.; Gajate, C.; Estella-Hermoso de Mendoza, A.; Villa-Pulgarin, J.A.; de Frias, M.è; Roué, G.ël.; Gil, J.; Colomer, D.; Campanero, M.A.; Blanco-Prieto, M.J. 2010: In vitro and in vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 16(7): 2046-2054

Nam, I.S.; Choi, J.H.; Seo, K.M.; Ahn, J.H. 2014: In vitro and Lactation Responses in Mid-lactating Dairy Cows Fed Protected Amino Acids and Fat. Asian-Australasian Journal of Animal Sciences 27(12): 1705-1711

Bartalis, J.; Halaweish, F.T. 2011: In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines. Bioorganic and Medicinal Chemistry 19(8): 2757-2766

Heo, S.-J.; Kim, S.-E.; Wei, J.; Kim, D.H.; Hyun, Y.-T.; Yun, H.-S.; Kim, H.K.; Yoon, T.R.; Kim, S.-H.; Park, S.-A.; Shin, J.W.; Shin, J.-W. 2009: In vitro and animal study of novel nano-hydroxyapatite/poly(epsilon-caprolactone) composite scaffolds fabricated by layer manufacturing process. Tissue Engineering. Part a 15(5): 977-989

Polyak, A.; Palade, E.Alina.; Balogh, L.; Postenyi, Z.; Haasz, V.; Janoki, G.; Janoki, G.A. 2011: In vitro and biodistribution examinations of Tc-99m-labelled doxorubicin-loaded nanoparticles. Nuclear Medicine Review. Central and Eastern Europe 14(2): 55-62

Jain, A.; Jain, S.K. 2008: In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 35(5): 404-416

Slominska, E.M.; Borkowski, T.; Rybakowska, I.; Abramowicz-Glinka, M.; Orlewska, Cława.; Smolenski, R.T. 2014: In vitro and cellular effects of 4-pyridone-3-carboxamide riboside on enzymes of nucleotide metabolism. Nucleosides Nucleotides and Nucleic Acids 33(4-6): 353-357

Medina-Morales, A.; Perez, A.; Brodin, J.D.; Tezcan, F.A. 2013: In vitro and cellular self-assembly of a Zn-binding protein cryptand via templated disulfide bonds. Journal of the American Chemical Society 135(32): 12013-12022

Panzeri, H.; Lara, E.H.G.ãe.; Paranhos, H.d.F.O.; Lovato da Silva, C.H.; de Souza, R.F.; de Souza Gugelmin, M.C.M.; Tirapelli, C.; Cruz, P.íc.C.; de Andrade, I.M. 2009: In vitro and clinical evaluation of specific dentifrices for complete denture hygiene. Gerodontology 26(1): 26-33

Demarest, J.F.; Sparks, S.S.; Schell, K.; Shibayama, S.; McDanal, C.B.; Fang, L.; Adkison, K.K.; Shachoy-Clark, A.; Piscitelli, S.C. 2008: In vitro and clinical investigation of the relationship between CCR5 receptor occupancy and anti-HIV activity of Aplaviroc. Journal of Clinical Pharmacology 48(10): 1179-1188

Li, Y.; Li, L.-J.; Zhang, S.-T.; Wang, L.-J.; Zhang, Z.; Gao, N.; Zhang, Y.-Y.; Chen, Q.-M. 2009: In vitro and clinical studies of gene therapy with recombinant human adenovirus-p53 injection for oral leukoplakia. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(21): 6724-6731

Mythili, A.; Babu Singh, Y.R.; Priya, R.; Shafeeq Hassan, A.; Manikandan, P.; Panneerselvam, K.; Narendran, V.; Shobana, C.S. 2014: In vitro and comparative study on the extracellular enzyme activity of molds isolated from keratomycosis and soil. International Journal of Ophthalmology 7(5): 778-784

Martins, M.; Azoia, N.G.; Ribeiro, A.; Shimanovich, U.; Silva, C.; Cavaco-Paulo, A. 2013: In vitro and computational studies of transdermal perfusion of nanoformulations containing a large molecular weight protein. Colloids and Surfaces. B Biointerfaces 108: 271-278

Corbett, S.C.; Ajdari, A.; Coskun, A.U.; N-Hashemi, H. 2010: In vitro and computational thrombosis on artificial surfaces with shear stress. Artificial Organs 34(7): 561-569

Sharma, A.; Sharma, S.; Khuller, G.K.; Kanwar, A.J. 2009: In vitro and ex vivo activity of peptide deformylase inhibitors against Mycobacterium tuberculosis H37Rv. International Journal of Antimicrobial Agents 34(3): 226-230

Dobrescu, I.; Levast, B.; Lai, K.; Delgado-Ortega, M.; Walker, S.; Banman, S.; Townsend, H.; Simon, G.; Zhou, Y.; Gerdts, V.; Meurens, F. 2014: In vitro and ex vivo analyses of co-infections with swine influenza and porcine reproductive and respiratory syndrome viruses. Veterinary Microbiology 169(1-2): 18-32

Doyle, G.A.; Wang, M.-J.; Chou, A.D.; Oleynick, J.U.; Arnold, S.E.; Buono, R.J.; Ferraro, T.N.; Berrettini, W.H. 2011: In vitro and ex vivo analysis of CHRNA3 and CHRNA5 haplotype expression. Plos one 6(8): E23373

Zhu, J.; Cui, W.; Liu, X.; Ying, J.; Hu, C.; Zhang, Y. 2013: In vitro and ex vivo angiogenic effects of roxarsone on rat endothelial cells. Toxicology Letters 223(2): 175-182

Keshavarz, M.; Mostafaie, A.; Mansouri, K.; Bidmeshkipour, A.; Motlagh, H.R.M.; Parvaneh, S. 2010: In vitro and ex vivo antiangiogenic activity of Salvia officinalis. PhytoTherapy Research: Ptr 24(10): 1526-1531

Santos, W.P.; da Silva Carvalho, A.C.; dos Santos Estevam, C.; Santana, A.ôn.E.éb.G.; Marçal, R.M. 2012: In vitro and ex vivo anticholinesterase activities of Erythrina velutina leaf extracts. Pharmaceutical Biology 50(7): 919-924

Monzavi, A.; Eshraghi, S.; Hashemian, R.; Momen-Heravi, F. 2015: In vitro and ex vivo antimicrobial efficacy of nano-MgO in the elimination of endodontic pathogens. Clinical Oral Investigations 19(2): 349-356

Calderone, R.A. 2009: In vitro and ex vivo assays of virulence in Candida albicans. Methods in Molecular Biology 499: 85-93

Gackenheimer, S.L.; Gehlert, D.R. 2011: In vitro and ex vivo autoradiography of the NK-1 antagonist [³H]-LY686017 in Guinea pig brain. Neuropeptides 45(2): 157-164

Ndesendo, V.M.K.; Pillay, V.; Choonara, Y.E.; Khan, R.A.; Meyer, L.; Buchmann, E.; Rosin, U. 2009: In vitro and ex vivo bioadhesivity analysis of polymeric intravaginal caplets using physicomechanics and computational structural modeling. International Journal of Pharmaceutics 370(1-2): 151-159

Yeboah, K.G.; Akande, J.; Addo, R.T.; Siwale, R.C.; Aninkorah-Yeboah, K.; Siddig, A. 2014: In vitro and ex vivo characterization of lectin-labeled Mycobacterium tuberculosis antigen-containing microspheres for enhanced oral delivery. Journal of Drug Targeting 22(1): 34-47

Colabufo, N.A.; Contino, M.; Inglese, C.; Niso, M.; Perrone, R.; Roperto, S.; Roperto, F. 2009: In vitro and ex vivo characterization of sigma-1 and sigma-2 receptors: agonists and antagonists in biological assays. Central Nervous System Agents in Medicinal Chemistry 9(3): 161-171

Lonze, B.E.; Holzer, H.T.; Knabel, M.K.; Locke, J.E.; DiCamillo, G.A.; Karhadkar, S.S.; Montgomery, R.A.; Sun, Z.; Warren, D.S.; Cameron, A.M. 2012: In vitro and ex vivo delivery of short hairpin RNAs for control of hepatitis C viral transcript expression. Archives of Surgery 147(4): 384-387

Luquita, A.; Urli, L.; Svetaz, M.J.; Gennaro, A.M.; Giorgetti, M.E.; Pistone, G.; Volpintesta, R.; Palatnik, S.; Rasia, M. 2010: In vitro and ex vivo effect of hyaluronic acid on erythrocyte flow properties. Journal of Biomedical Science 17: 8

Tang, X.-D.; Guo, S.-L.; Wang, G.-Z.; Li, N.; Wu, Y.-Y.; Fang, D.-C.; Fan, Y.-H.; Yang, S.-M. 2014: In vitro and ex vivo evaluation of a multi-epitope heparinase vaccine for various malignancies. Cancer Science 105(1): 9-17

Ham, A.S.; Lustig, W.; Yang, L.; Boczar, A.; Buckheit, K.W.; Buckheit, R.W. 2013: In vitro and ex vivo evaluations on transdermal delivery of the HIV inhibitor IQP-0410. Plos one 8(9): E75306

Gruber, J.V.; Holtz, R.; Sikkink, S.K.; Tobin, D.J. 2014: In vitro and ex vivo examination of topical Pomiferin treatments. Fitoterapia 94: 164-171

Hui, S.W.; Li, L.H. 2000: In vitro and ex vivo gene delivery to cells by electroporation. Methods in Molecular Medicine 37: 157-171

Schmid, V.B.; Seewald, W.; Lees, P.; King, J.N. 2010: In vitro and ex vivo inhibition of COX isoforms by robenacoxib in the cat: a comparative study. Journal of Veterinary Pharmacology and Therapeutics 33(5): 444-452

King, J.N.; Rudaz, C.; Borer, L.; Jung, M.; Seewald, W.; Lees, P. 2010: In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study. Research in Veterinary Science 88(3): 497-506

Hukezalie, K.R.; Thumati, N.R.; Côté, H.él.èn.C.F.; Wong, J.M.Y. 2012: In vitro and ex vivo inhibition of human telomerase by anti-HIV nucleoside reverse transcriptase inhibitors (NRTIs) but not by non-NRTIs. Plos one 7(11): E47505

Markopoulos, C.; Imanidis, G.; Vertzoni, M.; Symillides, M.; Parrott, N.; Reppas, C. 2013: In vitro and ex vivo investigation of the impact of luminal lipid phases on passive permeability of lipophilic small molecules using PAMPA. Pharmaceutical Research 30(12): 3145-3153

Lazado, C.C.; Kumaratunga, H.P.S.; Nagasawa, K.; Babiak, I.; Caipang, C.M.A.; Fernandes, J.M.O. 2014: In vitro and ex vivo models indicate that the molecular clock in fast skeletal muscle of Atlantic cod is not autonomous. Molecular Biology Reports 41(10): 6679-6689

Cronin, J.; Alhamdani, A.; Griffiths, A.P.; Baxter, J.N.; Brown, T.; Jenkins, G.J.S. 2011: In vitro and ex vivo models of extended reflux exposure demonstrate that weakly acidic mixed reflux heightens NF-kB-mediated gene expression. Diseases of the Esophagus: Official Journal of the International Society for Diseases of the Esophagus 24(5): 360-370

Blume, C.; Davies, D.E. 2013: In vitro and ex vivo models of human asthma. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 84(2): 394-400

Tas, C.; Ozkan, Y.; Okyar, A.; Savaser, A. 2007: In vitro and ex vivo permeation studies of etodolac from hydrophilic gels and effect of terpenes as enhancers. Drug Delivery 14(7): 453-459

Rezzola, S.; Belleri, M.; Gariano, G.; Ribatti, D.; Costagliola, C.; Semeraro, F.; Presta, M. 2014: In vitro and ex vivo retina angiogenesis assays. Angiogenesis 17(3): 429-442

Marton, S.; Reyes-Darias, Jé.A.; Sánchez-Luque, F.J.; Romero-López, C.; Berzal-Herranz, A. 2010: In vitro and ex vivo selection procedures for identifying potentially therapeutic DNA and RNA molecules. Molecules 15(7): 4610-4638

Sokolova, E.V.; Barabanova, A.O.; Homenko, V.A.; Solov'eva, T.F.; Bogdanovich, R.N.; Yermak, I.M. 2011: In vitro and ex vivo studies of antioxidant activity of carrageenans, sulfated polysaccharides from red algae. Bulletin of Experimental Biology and Medicine 150(4): 426-428

Rohan, L.C.; Moncla, B.J.; Kunjara Na Ayudhya, R.P.; Cost, M.; Huang, Y.; Gai, F.; Billitto, N.; Lynam, J.D.; Pryke, K.; Graebing, P.; Hopkins, N.; Rooney, J.F.; Friend, D.; Dezzutti, C.S. 2010: In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide. Plos one 5(2): E9310

Paranjpe, M.; Neuhaus, V.; Finke, J.H.; Richter, C.; Gothsch, T.; Kwade, A.; Büttgenbach, S.; Braun, A.; Müller-Goymann, C.C. 2013: In vitro and ex vivo toxicological testing of sildenafil-loaded solid lipid nanoparticles. Inhalation Toxicology 25(9): 536-543

Kovacs-Nolan, J.; Rupa, P.; Matsui, T.; Tanaka, M.; Konishi, T.; Sauchi, Y.; Sato, K.; Ono, S.; Mine, Y. 2014: In vitro and ex vivo uptake of glutathione (GSH) across the intestinal epithelium and fate of oral GSH after in vivo supplementation. Journal of Agricultural and Food Chemistry 62(39): 9499-9506

George, A.; Ng, C.P.; O'Callaghan, M.; Jensen, G.S.; Wong, H.J. 2014: In vitro and ex-vivo cellular antioxidant protection and cognitive enhancing effects of an extract of Polygonum minus Huds (Lineminus™) demonstrated in a Barnes Maze animal model for memory and learning. Bmc Complementary and Alternative Medicine 14: 161

Reimão, J.Q.; Colombo, F.áb.A.; Pereira-Chioccola, V.L.; Tempone, A.é G. 2011: In vitro and experimental therapeutic studies of the calcium channel blocker bepridil: detection of viable Leishmania (L.) chagasi by real-time PCR. Experimental Parasitology 128(2): 111-115

Locher, N.; Al-Rasheid, K.A.S.; Abdel-Ghaffar, F.; Mehlhorn, H. 2010: In vitro and field studies on the contact and fumigant toxicity of a neem-product (Mite-Stop) against the developmental stages of the poultry red mite Dermanyssus gallinae. Parasitology Research 107(2): 417-423

Funakoshi, T.; Suenaga, N.; Sano, H.; Oizumi, N.; Minami, A. 2008: In vitro and finite element analysis of a novel rotator cuff fixation technique. Journal of Shoulder and Elbow Surgery 17(6): 986-992

Virani, N.A.; Harman, M.; Li, K.; Levy, J.; Pupello, D.R.; Frankle, M.A. 2008: In vitro and finite element analysis of glenoid bone/baseplate interaction in the reverse shoulder design. Journal of Shoulder and Elbow Surgery 17(3): 509-521

Allinson, M.; Shiraishi, F.; Salzman, S.A.; Allinson, G. 2010: In vitro and immunological assessment of the estrogenic activity and concentrations of 17beta-estradiol, estrone, and ethinyl estradiol in treated effluent from 45 wastewater treatment plants in Victoria, Australia. Archives of Environmental Contamination and Toxicology 58(3): 576-586

Gurulingappa, P.; Mc Gee, P.; Sword, G.A. 2011: In vitro and in planta compatibility of insecticides and the endophytic entomopathogen, Lecanicillium lecanii. Mycopathologia 172(2): 161-168

Greineder, C.F.; Nelson, P.W.; Dressel, A.L.; Erba, H.P.; Younger, J.G. 2007: In vitro and in silico analysis of annexin V binding to lymphocytes as a biomarker in emergency department sepsis studies. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine 14(9): 763-771

Esperón, P.; Scazzocchio, C.; Paulino, M. 2014: In vitro and in silico analysis of the Aspergillus nidulans DNA-CreA repressor interactions. Journal of Biomolecular Structure and Dynamics 32(12): 2033-2041

Sivajothi, V.; Dakappa, S.S. 2014: In vitro and in silico antidiabetic activity of pyran ester derivative isolated from Tragia cannabina. Asian Pacific Journal of Tropical Biomedicine 4(Suppl 1): S455-S459

Makam, P.; Thakur, P.K.; Kannan, T. 2014: In vitro and in silico antimalarial activity of 2-(2-hydrazinyl)thiazole derivatives. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 52: 138-145

Sugibayashi, K.; Todo, H.; Kadhum, W.R. 2014: In vitro and in silico approaches to evaluate usefulness and safety of chemical compounds applied or exposed on skin. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 134(1): 27-32

Na Nakorn, P.; Treesuwan, W.; Choowongkomon, K.; Hannongbua, S.; Boonyalai, N. 2011: In vitro and in silico binding study of the peptide derived from HIV-1 CA-CTD and LysRS as a potential HIV-1 blocking site. Journal of Theoretical Biology 270(1): 88-97

Roede, J.R.; Carbone, D.L.; Doorn, J.A.; Kirichenko, O.V.; Reigan, P.; Petersen, D.R. 2008: In vitro and in silico characterization of peroxiredoxin 6 modified by 4-hydroxynonenal and 4-oxononenal. Chemical Research in Toxicology 21(12): 2289-2299

Ghorbanzadeh, M.; van Ede, K.I.; Larsson, M.; van Duursen, M.B.M.; Poellinger, L.; Lücke-Johansson, S.; Machala, M.; Pěnčíková, K.ři.; Vondráček, J.; van den Berg, M.; Denison, M.S.; Ringsted, T.; Andersson, P.L. 2014: In vitro and in silico derived relative effect potencies of ah-receptor-mediated effects by PCDD/Fs and PCBs in rat, mouse, and guinea pig CALUX cell lines. Chemical Research in Toxicology 27(7): 1120-1132

Pitchai, D.; Roy, A.; Banu, S. 2014: In vitro and in silico evaluation of NF-κB targeted costunolide action on estrogen receptor-negative breast cancer cells--a comparison with normal breast cells. PhytoTherapy Research: Ptr 28(10): 1499-1505

Thelingwani, R.S.; Zvada, S.P.; Dolgos, H.; Ungell, A.-L.B.; Masimirembwa, C.M. 2009: In vitro and in silico identification and characterization of thiabendazole as a mechanism-based inhibitor of CYP1A2 and simulation of possible pharmacokinetic drug-drug interactions. Drug Metabolism and Disposition: the Biological Fate of Chemicals 37(6): 1286-1294

Reitmaier, S.; Shirazi-Adl, A.; Bashkuev, M.; Wilke, H.-J.; Gloria, A.; Schmidt, H. 2012: In vitro and in silico investigations of disc nucleus replacement. Journal of the Royal Society Interface 9(73): 1869-1879

Wang, Y.-Q.; Tan, C.-Y.; Zhuang, S.-L.; Zhai, P.-Z.; Cui, Y.; Zhou, Q.-H.; Zhang, H.-M.; Fei, Z. 2014: In vitro and in silico investigations of the binding interactions between chlorophenols and trypsin. Journal of Hazardous Materials 278: 55-65

Almerico, A.M.; Tutone, M.; Guarcello, A.; Lauria, A. 2012: In vitro and in silico studies of polycondensed diazine systems as anti-parasitic agents. Bioorganic and Medicinal Chemistry Letters 22(2): 1000-1004

Haque, M.Anzarul.; Zaidi, S.; Ubaid-Ullah, S.; Prakash, A.; Hassan, M.Imtaiyaz.; Islam, A.; Batra, J.K.; Ahmad, F. 2015: In vitro and in silico studies of urea-induced denaturation of yeast iso-1-cytochrome c and its deletants at pH 6.0 and 25 °C. Journal of Biomolecular Structure and Dynamics 33(7): 1493-1502

Rohe, A.; Erdmann, F.; Bäßler, C.; Wichapong, K.; Sippl, W.; Schmidt, M. 2012: In vitro and in silico studies on substrate recognition and acceptance of human PKMYT1, a Cdk1 inhibitory kinase. Bioorganic and Medicinal Chemistry Letters 22(2): 1219-1223

Byju, K.; Anuradha, V.; Vasundhara, G.; Nair, S.M.; Kumar, N.C. 2014: In vitro and in silico studies on the anticancer and apoptosis-inducing activities of the sterols identified from the soft coral, subergorgia reticulata. Pharmacognosy Magazine 10(Suppl 1): S65-S71

Hamzeh-Mivehroud, M.; Rahmani, S.; Feizi, M.-A.H.; Dastmalchi, S.; Rashidi, M.-R. 2014: In vitro and in silico studies to explore structural features of flavonoids for aldehyde oxidase inhibition. Archiv der Pharmazie 347(10): 738-747

Sasidharan, S.; Darah, I.; Jain, K. 2011: In vitro and in situ antiyeast activity of Gracilaria changii methanol extract against Candida albicans. European Review for Medical and Pharmacological Sciences 15(9): 1020-1026

West, N.X.; Davies, M.; Amaechi, B.T. 2011: In vitro and in situ erosion models for evaluating tooth substance loss. Caries Research 45(Suppl 1): 43-52

Fong, Y.Kau.; Li, C.Rui.; Wo, S.Kwan.; Wang, S.; Zhou, L.; Zhang, L.; Lin, G.; Zuo, Z. 2012: In vitro and in situ evaluation of herb-drug interactions during intestinal metabolism and absorption of baicalein. Journal of Ethnopharmacology 141(2): 742-753

Layer, T.M. 2010: In vitro and in situ evidence supporting the utility of a bioadhesive fluoridated rinse in the management of dental erosion. Journal of Dentistry 38(Suppl 3): S1-S3

Fournier, A.J.; Rajbhandari, L.; Shrestha, S.; Venkatesan, A.; Ramesh, K.T. 2014: In vitro and in situ visualization of cytoskeletal deformation under load: traumatic axonal injury. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 28(12): 5277-5287

Joseph, J.; Bindhu, A.R.; Aleykutty, N.A. 2013: In vitro and in vivo Antiinflammatory Activity of Clerodendrum paniculatum Linn. Leaves. Indian Journal of Pharmaceutical Sciences 75(3): 376-379

Chen, J.; Yang, X.-Q.; Meng, Y.-Z.; Huang, H.-H.; Qin, M.-Y.; Yan, D.-M.; Zhao, Y.-D.; Ma, Z.-Y. 2014: In vitro and in vivo CT imaging using bismuth sulfide modified with a highly biocompatible Pluronic F127. Nanotechnology 25(29): 295103

Varghese, A.; Pandita, N.; Gaud, R.S. 2014: In vitro and in vivo Evaluation of CYP1A Interaction Potential of Terminalia Arjuna Bark. Indian Journal of Pharmaceutical Sciences 76(2): 138-147

De Santis, S.; Rebuzzi, M.; Di Pietro, G.; Fasano, F.; Maraviglia, B.; Capuani, S. 2010: In vitro and in vivo MR evaluation of internal gradient to assess trabecular bone density. Physics in Medicine and Biology 55(19): 5767-5785

Sapet, C.éd.; Laurent, N.; Le Gourrierec, L.ïc.; Augier, S.év.; Zelphati, O. 2010: In vitro and in vivo Magnetofection : a move towards gene therapy. Annales de Biologie Clinique 68(2): 133-142

Hebert, C.G.; Valdes, J.J.; Bentley, W.E. 2009: In vitro and in vivo RNA interference mediated suppression of Tn-caspase-1 for improved recombinant protein production in High Five cell culture with the baculovirus expression vector system. Biotechnology and Bioengineering 104(2): 390-399

Mantell, S.J.; Gibson, K.R.; Osborne, S.A.; Maw, G.N.; Rees, H.; Dodd, P.G.; Greener, B.; Harbottle, G.W.; Million, W.A.; Poinsard, C.; England, S.; Carnell, P.; Betts, A.M.; Monhemius, R.; Prime, R.L. 2009: In vitro and in vivo SAR of pyrido[3,4-d]pyramid-4-ylamine based mGluR1 antagonists. Bioorganic and Medicinal Chemistry Letters 19(8): 2190-2194

Henkes, H.; Brew, S.; Felber, S.; Miloslavski, E.; Mogilevski, G.; Tavrovski, I.; Kühne, D. 2004: In vitro and in vivo Studies of the Extent of Electrothrombotic Deposition of Blood Elements on the Surface of Electrolytically Detachable Coils. Interventional Neuroradiology: Journal of Peritherapeutic Neuroradiology Surgical Procedures and Related Neurosciences 10(3): 189-201

Amiri, A.; Dugas, R.; Pichot, A.L.; Bompeix, G. 2008: In vitro and in vivo [corrected] activity of eugenol oil (Eugenia caryophylata) against four important postharvest apple pathogens. International Journal of Food Microbiology 126(1-2): 13-19

George, D.R.; Shiel, R.S.; Appleby, W.G.C.; Knox, A.; Guy, J.H. 2010: In vitro and in vivo acaricidal activity and residual toxicity of spinosad to the poultry red mite, Dermanyssus gallinae. Veterinary Parasitology 173(3-4): 307-316

Chagas, A.C.S.; Domingues, L.F.; Fantatto, R.R.; Giglioti, R.; Oliveira, M.ár.C.S.; Oliveira, D.H.; Mano, R.A.; Jacob, R.G. 2014: In vitro and in vivo acaricide action of juvenoid analogs produced from the chemical modification of Cymbopogon spp. and Corymbia citriodora essential oil on the cattle tick Rhipicephalus (Boophilus) microplus. Veterinary Parasitology 205(1-2): 277-284

García-Matas, S.; de Vera, N.úr.; Aznar, A.O.; Marimon, J.M.; Adell, A.; Planas, A.M.; Cristòfol, R.; Sanfeliu, C. 2010: In vitro and in vivo activation of astrocytes by amyloid-beta is potentiated by pro-oxidant agents. Journal of Alzheimer's Disease: Jad 20(1): 229-245

Salomão, K.; de Souza, E.M.; Carvalho, S.A.; da Silva, E.F.; Fraga, C.A.M.; Barbosa, H.S.; de Castro, S.L. 2010: In vitro and in vivo activities of 1,3,4-thiadiazole-2-arylhydrazone derivatives of megazol against Trypanosoma cruzi. Antimicrobial Agents and ChemoTherapy 54(5): 2023-2031

Bajohr, L.L.; Ma, L.; Platte, C.; Liesenfeld, O.; Tietze, L.F.; Gross, U.; Bohne, W. 2010: In vitro and in vivo activities of 1-hydroxy-2-alkyl-4(1H)quinolone derivatives against Toxoplasma gondii. Antimicrobial Agents and ChemoTherapy 54(1): 517-521

Wildum, S.; Paulsen, D.; Thede, K.; Ruebsamen-Schaeff, H.; Zimmermann, H. 2013: In vitro and in vivo activities of AIC292, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor. Antimicrobial Agents and ChemoTherapy 57(11): 5320-5329

Denys, G.A.; Davis, J.C.; O'Hanley, P.D.; Stephens, J.T. 2011: In vitro and in vivo activities of E-101 solution against Acinetobacter baumannii isolates from U.S. military personnel. Antimicrobial Agents and ChemoTherapy 55(7): 3603-3608

Gavrish, E.; Shrestha, B.; Chen, C.; Lister, I.; North, E.J.; Yang, L.; Lee, R.E.; Han, A.; Williams, B.; Charnuska, D.; Coleman, K.; Lewis, K.; LaFleur, M.D. 2014: In vitro and in vivo activities of HPi1, a selective antimicrobial against Helicobacter pylori. Antimicrobial Agents and ChemoTherapy 58(6): 3255-3260

Jeong, J.-W.; Jung, S.-J.; Lee, H.-H.; Kim, Y.-Z.; Park, T.-K.; Cho, Y.-L.; Chae, S.-E.; Baek, S.-Y.; Woo, S.-H.; Lee, H.-S.; Kwak, J.-H. 2010: In vitro and in vivo activities of LCB01-0371, a new oxazolidinone. Antimicrobial Agents and ChemoTherapy 54(12): 5359-5362

Rahimi-Moghaddam, P.; Ebrahimi, S.A.; Ourmazdi, H.; Selseleh, M.; Karjalian, M.; Haj-Hassani, G.; Alimohammadian, M.H.; Mahmoudian, M.; Shafiei, M. 2011: In vitro and in vivo activities of Peganum harmala extract against Leishmania major. Journal of Research in Medical Sciences: the Official Journal of Isfahan University of Medical Sciences 16(8): 1032-1039

Lu, J.; Yue, J.; Wu, J.; Luo, R.; Hu, Z.; Li, J.; Bai, Y.; Tang, Z.; Xian, Q.; Zhang, X.; Wang, H. 2010: In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis. Pharmacology 85(6): 365-371

Mahajan, G.; Thomas, B.; Parab, R.; Patel, Z.E.; Kuldharan, S.; Yemparala, V.; Mishra, P.D.; Ranadive, P.; D'Souza, L.; Pari, K.; Sivaramkrishnan, H. 2013: In vitro and in vivo activities of antibiotic PM181104. Antimicrobial Agents and ChemoTherapy 57(11): 5315-5319

Wu, X.; Wang, Z.; Li, X.; Fan, Y.; He, G.; Wan, Y.; Yu, C.; Tang, J.; Li, M.; Zhang, X.; Zhang, H.; Xiang, R.; Pan, Y.; Liu, Y.; Lu, L.; Yang, L. 2014: In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method. Antimicrobial Agents and ChemoTherapy 58(9): 5342-5349

El Ridi, R.; Aboueldahab, M.; Tallima, H.; Salah, M.; Mahana, N.; Fawzi, S.; Mohamed, S.H.; Fahmy, O.M. 2010: In vitro and in vivo activities of arachidonic acid against Schistosoma mansoni and Schistosoma haematobium. Antimicrobial Agents and ChemoTherapy 54(8): 3383-3389

Ribes, S.; Pachón-Ibáñez, M.E.; Domínguez, M.A.; Fernández, R.; Tubau, F.; Ariza, J.; Gudiol, F.; Cabellos, C. 2010: In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 29(11): 1361-1367

Bionda, N.; Pastar, I.; Davis, S.C.; Cudic, P. 2014: In vitro and in vivo activities of novel cyclic lipopeptides against staphylococcal biofilms. Protein and Peptide Letters 21(4): 352-356

Kohno, Y.; Ohno, H.; Miyazaki, Y.; Higashiyama, Y.; Yanagihara, K.; Hirakata, Y.; Fukushima, K.; Kohno, S. 2007: In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan. Antimicrobial Agents and ChemoTherapy 51(11): 4071-4076

Harada, Y.; Morinaga, Y.; Kaku, N.; Nakamura, S.; Uno, N.; Hasegawa, H.; Izumikawa, K.; Kohno, S.; Yanagihara, K. 2014: In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 20(11): O831-O839

Spreghini, E.; Orlando, F.; Giannini, D.; Barchiesi, F. 2010: In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility. Journal of Antimicrobial ChemoTherapy 65(10): 2158-2163

Li, D.-D.; Zhao, L.-X.; Mylonakis, E.; Hu, G.-H.; Zou, Y.; Huang, T.-K.; Yan, L.; Wang, Y.; Jiang, Y.-Y. 2014: In vitro and in vivo activities of pterostilbene against Candida albicans biofilms. Antimicrobial Agents and ChemoTherapy 58(4): 2344-2355

Ma, Y.; Yu, Y.-Z.; Zhu, Y.-F.; Xu, Q.; Sun, Z.-W. 2013: In vitro and in vivo activities of recombinant anthrax protective antigen co-expressed with thioredoxin in Escherichia coli. Human Vaccines and Immunotherapeutics 9(11): 2371-2377

Pavan, F.R.; Poelhsitz, G.V.; da Cunha, L.V.P.; Barbosa, M.I.F.; Leite, S.R.A.; Batista, A.A.; Cho, S.H.; Franzblau, S.G.; de Camargo, M.S.; Resende, F.áv.A.; Varanda, E.A.; Leite, C.Q.F. 2013: In vitro and in vivo activities of ruthenium(II) phosphine/diimine/picolinate complexes (SCAR) against Mycobacterium tuberculosis. Plos one 8(5): E64242

Upton, A.M.; Cho, S.; Yang, T.J.; Kim, Y.; Wang, Y.; Lu, Y.; Wang, B.; Xu, J.; Mdluli, K.; Ma, Z.; Franzblau, S.G. 2015: In vitro and in vivo activities of the nitroimidazole TBA-354 against Mycobacterium tuberculosis. Antimicrobial Agents and ChemoTherapy 59(1): 136-144

Lischka, P.; Hewlett, G.; Wunberg, T.; Baumeister, J.; Paulsen, D.; Goldner, T.; Ruebsamen-Schaeff, H.; Zimmermann, H. 2010: In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246. Antimicrobial Agents and ChemoTherapy 54(3): 1290-1297

Zhang, M.; Sala, C.; Dhar, N.; Vocat, A.; Sambandamurthy, V.K.; Sharma, S.; Marriner, G.; Balasubramanian, V.; Cole, S.T. 2014: In vitro and in vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosis. Antimicrobial Agents and ChemoTherapy 58(6): 3217-3223

Gharib, A.; Faezizadeh, Z.; Godarzee, M. 2012: In vitro and in vivo activities of ticarcillin-loaded nanoliposomes with different surface charges against Pseudomonas aeruginosa (ATCC 29248). Daru: Journal of Faculty of Pharmacy Tehran University of Medical Sciences 20(1): 41

Betts, J.W.; Phee, L.M.; Hornsey, M.; Woodford, N.; Wareham, D.W. 2014: In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae. Antimicrobial Agents and ChemoTherapy 58(6): 3541-3546

Indenbaum, V.; Bin, H.; Makarovsky, D.; Weil, M.; Shulman, L.M.; Albeck, M.; Sredni, B.; Mendelson, E. 2012: In vitro and in vivo activity of AS101 against West Nile virus (WNV). Virus Research 166(1-2): 68-76

Cafarchia, C.; Immediato, D.; Paola, G.D.; Magliani, W.; Ciociola, T.; Conti, S.; Otranto, D.; Polonelli, L. 2014: In vitro and in vivo activity of a killer peptide against Malassezia pachydermatis causing otitis in dogs. Medical Mycology 52(4): 350-355

De Almeida, V.R.; Xavier, F.R.; Osório, R.E.H.M.B.; Bessa, L.M.; Schilling, E.L.; Costa, T.G.; Bortolotto, T.; Cavalett, A.él.; Castro, F.A.V.; Vilhena, F.; Alves, O.C.; Terenzi, H.án.; Eleutherio, E.C.A.; Pereira, M.D.; Haase, W.; Tomkowicz, Z.; Szpoganicz, B.; Bortoluzzi, A.J.; Neves, A. 2013: In vitro and in vivo activity of a new unsymmetrical dinuclear copper complex containing a derivative ligand of 1,4,7-triazacyclononane: catalytic promiscuity of [Cu2(L)Cl3. Dalton Transactions 42(19): 7059-7073

Wong, S.S.W.; Kao, R.Y.T.; Yuen, K.Y.; Wang, Y.; Yang, D.; Samaranayake, L.P.; Seneviratne, C.J. 2014: In vitro and in vivo activity of a novel antifungal small molecule against Candida infections. Plos one 9(1): E85836

Di Martino, M.T.; Gullà, A.; Gallo Cantafio, M.E.; Altomare, E.; Amodio, N.; Leone, E.; Morelli, E.; Lio, S.G.; Caracciolo, D.; Rossi, M.; Frandsen, N.M.; Tagliaferri, P.; Tassone, P. 2014: In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells. Plos one 9(2): E89659

Paladi, C.d.S.; Pimentel, I.A.S.; Katz, S.; Cunha, R.L.O.R.; Judice, W.A.d.S.; Caires, A.C.F.; Barbiéri, C.L.úc. 2012: In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensis. Plos Neglected Tropical Diseases 6(5): E1626

Salerno Pimentel, I.A.; Paladi, C.d.S.; Katz, S.; de Souza Júdice, W.A.; Cunha, R.L.O.R.; Barbiéri, C.L.úc. 2012: In vitro and in vivo activity of an organic tellurium compound on Leishmania (Leishmania) chagasi. Plos one 7(11): E48780

Bentzien, F.; Zuzow, M.; Heald, N.; Gibson, A.; Shi, Y.; Goon, L.; Yu, P.; Engst, S.; Zhang, W.; Huang, D.; Zhao, L.; Vysotskaia, V.; Chu, F.; Bautista, R.; Cancilla, B.; Lamb, P.; Joly, A.H.; Yakes, F.M. 2013: In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer. Thyroid: Official Journal of the American Thyroid Association 23(12): 1569-1577

Xu, J.; Lu, Y.; Fu, L.; Zhu, H.; Wang, B.; Mdluli, K.; Upton, A.M.; Jin, H.; Zheng, M.; Zhao, W.; Li, P. 2012: In vitro and in vivo activity of clofazimine against Mycobacterium tuberculosis persisters. International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 16(8): 1119-1125

Harris, B.M.; Blatz, P.J.; Hinkle, M.K.; McCall, S.; Beckius, M.L.; Mende, K.; Robertson, J.L.; Griffith, M.E.; Murray, C.K.; Hospenthal, D.R. 2011: In vitro and in vivo activity of first generation cephalosporins against Leptospira. American Journal of Tropical Medicine and Hygiene 85(5): 905-908

Huang, P.-J.; Hseu, Y.-C.; Lee, M.-S.; Senthil Kumar, K.J.; Wu, C.-R.; Hsu, L.-S.; Liao, J.-W.; Cheng, I.-S.; Kuo, Y.-T.; Huang, S.-Y.; Yang, H.-L. 2012: In vitro and in vivo activity of gallic acid and Toona sinensis leaf extracts against HL-60 human premyelocytic leukemia. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 50(10): 3489-3497

Montrieux, E.; Perera, W.H.; García, M.; Maes, L.; Cos, P.; Monzote, L. 2014: In vitro and in vivo activity of major constituents from Pluchea carolinensis against Leishmania amazonensis. Parasitology Research 113(8): 2925-2932

Morais-Teixeira, E.d.; Carvalho, A.S.d.; Costa, J.C.S.d.; Duarte, S.L.; Mendonça, J.S.; Boechat, N.úb.; Rabello, A. 2008: In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasi and L (Viannia) braziliensis. Memorias do Instituto Oswaldo Cruz 103(4): 358-362

Huelves, L.; Del Prado, G.; Gracia, M.; Rodríguez-Cerrato, V.; Ponte, C. 2008: In vitro and in vivo activity of miltefosine against penicillin-sensitive and -resistant Streptococcus pneumoniae strains. Journal of ChemoTherapy 20(4): 441-444

Moses, S.A.; Ali, M.A.; Zuohe, S.; Du-Cuny, L.; Zhou, L.L.; Lemos, R.; Ihle, N.; Skillman, A.G.; Zhang, S.; Mash, E.A.; Powis, G.; Meuillet, E.J. 2009: In vitro and in vivo activity of novel small-molecule inhibitors targeting the pleckstrin homology domain of protein kinase B/AKT. Cancer Research 69(12): 5073-5081

Safronetz, D.; Haddock, E.; Feldmann, F.; Ebihara, H.; Feldmann, H. 2011: In vitro and in vivo activity of ribavirin against Andes virus infection. Plos one 6(8): E23560

Wittlin, S.; Ekland, E.; Craft, J.C.; Lotharius, J.; Bathurst, I.; Fidock, D.A.; Fernandes, P. 2012: In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium species. Antimicrobial Agents and ChemoTherapy 56(2): 703-707

Silva, C.F.ça.d.; Batista, D.d.G.J.; Batista, M.M.; Lionel, J.; Hammer, E.R.; Brun, R.; Soeiro, M.d.N.é C. 2014: In vitro and in vivo activity of the chloroaryl-substituted imidazole viniconazole against Trypanosoma cruzi. Parasitology 141(3): 367-373

Wang, L.; Zhang, H.; Jia, Z.; Ma, Q.; Dong, N.; Shan, A. 2014: In vitro and in vivo activity of the dimer of PMAP-36 expressed in Pichia pastoris. Journal of Molecular Microbiology and Biotechnology 24(4): 234-240

Hollevoet, K.; Mason-Osann, E.; Liu, X.-f.; Imhof-Jung, S.; Niederfellner, G.; Pastan, I. 2014: In vitro and in vivo activity of the low-immunogenic antimesothelin immunotoxin RG7787 in pancreatic cancer. Molecular Cancer Therapeutics 13(8): 2040-2049

Navarro-Moll, M.C.ón.; Romero, M.C.; Montilla, M.P.; Valero, A. 2011: In vitro and in vivo activity of three sesquiterpenes against L(3) larvae of Anisakis type i. Experimental Parasitology 127(2): 405-408

Kasabri, V.; Afifi, F.U.; Hamdan, I. 2011: In vitro and in vivo acute antihyperglycemic effects of five selected indigenous plants from Jordan used in traditional medicine. Journal of Ethnopharmacology 133(2): 888-896

Na, N.; Guo, H.; Zhang, S.; Li, Z.; Yin, L. 2009: In vitro and in vivo acute toxicity of fenpyroximate to flounder Paralichthys olivaceus and its gill cell line FG. Aquatic Toxicology 92(2): 76-85

Duo, J.; Stenken, J.A. 2011: In vitro and in vivo affinity microdialysis sampling of cytokines using heparin-immobilized microspheres. Analytical and Bioanalytical Chemistry 399(2): 783-793

Hands, S.; Sajjad, M.U.; Newton, M.J.; Wyttenbach, A. 2011: In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production. Journal of Biological Chemistry 286(52): 44512-44520

Hasenkrug, K.J.; Myers, L.M. 2011: In vitro and in vivo analyses of regulatory T cell suppression of CD8+ T cells. Methods in Molecular Biology 707: 45-54

Lambert, E.A.; Sherry, N.; Popham, D.L. 2012: In vitro and in vivo analyses of the Bacillus anthracis spore cortex lytic protein SleL. Microbiology 158(Part 5): 1359-1368

Pinto, S.C.S.; Pochapski, M.ár.T.; Wambier, D.S.; Pilatti, G.L.; Santos, F.áb.A. 2010: In vitro and in vivo analyses of the effects of desensitizing agents on dentin permeability and dentinal tubule occlusion. Journal of Oral Science 52(1): 23-32

Nishimura, T.; Yamaguchi, O.; Takatani, N.; Maeda, S.-I.; Omata, T. 2014: In vitro and in vivo analyses of the role of the carboxysomal β-type carbonic anhydrase of the cyanobacterium Synechococcus elongatus in carboxylation of ribulose-1,5-bisphosphate. Photosynthesis Research 121(2-3): 151-157

Tanaka, Y.; Maeshima, K.; Maeshima, Y.; Yamaoka, K. 2012: In vitro and in vivo analysis of a JAK inhibitor in rheumatoid arthritis. Annals of the Rheumatic Diseases 71(Suppl 2): I70-I74

Ueng, S.W.N.; Yuan, L.-J.; Lin, S.-S.; Liu, S.-J.; Chan, E.-C.; Chen, K.-T.; Lee, M.S. 2011: In vitro and in vivo analysis of a biodegradable poly(lactide-co-glycolide) copolymer capsule and collagen composite system for antibiotics and bone cells delivery. Journal of Trauma 70(6): 1503-1509

Chen, Z.C.C.; Ekaputra, A.K.; Gauthaman, K.; Adaikan, P.G.; Yu, H.; Hutmacher, D.W. 2008: In vitro and in vivo analysis of co-electrospun scaffolds made of medical grade poly(epsilon-caprolactone) and porcine collagen. Journal of Biomaterials Science. Polymer Edition 19(5): 693-707

Vanneaux, V.ér.; El-Ayoubi, F.; Delmau, C.; Driancourt, C.; Lecourt, S.év.; Grelier, A.; Cras, A.; Cuccuini, W.; Soulier, J.; Lataillade, J.-J.; Lebousse-Kerdiles, M.-C.; Oury, J.F.ço.; Sibony, O.; Marolleau, J.-P.; Benbunan, M.; Uzan, G.; Larghero, J.ér.ôm. 2010: In vitro and in vivo analysis of endothelial progenitor cells from cryopreserved umbilical cord blood: are we ready for clinical application?. Cell Transplantation 19(9): 1143-1155

Piccinato, C.A.; Sartori, R.; Sangsritavong, S.; Souza, A.H.; Grummer, R.R.; Luchini, D.; Wiltbank, M.C. 2010: In vitro and in vivo analysis of fatty acid effects on metabolism of 17beta-estradiol and progesterone in dairy cows. Journal of Dairy Science 93(5): 1934-1943

Zhou, Y.; Kim, Y.-S.; Milenic, D.E.; Baidoo, K.E.; Brechbiel, M.W. 2014: In vitro and in vivo analysis of indocyanine green-labeled panitumumab for optical imaging-a cautionary tale. Bioconjugate Chemistry 25(10): 1801-1810

Stumpff, J.; Cooper, J.; Domnitz, S.; Moore, A.T.; Rankin, K.E.; Wagenbach, M.; Wordeman, L. 2007: In vitro and in vivo analysis of microtubule-destabilizing kinesins. Methods in Molecular Biology 392: 37-49

Esteban, P.F.; Caprari, P.; Yoon, H.-Y.; Randazzo, P.A.; Tessarollo, L. 2008: In vitro and in vivo analysis of neurotrophin-3 activation of Arf6 and Rac-1. Methods in Enzymology 438: 171-183

Lass, C.; Merfort, I.; Martin, S.F. 2010: In vitro and in vivo analysis of pro- and anti-inflammatory effects of weak and strong contact allergens. Experimental Dermatology 19(11): 1007-1013

Alvarez, A.án.F.; Georgellis, D. 2010: In vitro and in vivo analysis of the ArcB/A redox signaling pathway. Methods in Enzymology 471: 205-228

Sathler, Pínio.Cunha.; Lourenço, Aé.Luiz.; Rodrigues, C.Rangel.; da Silva, L.Cláudio.Rodrigues.Pereira.; Cabral, L.Mendes.; Jordão, A.Kappel.; Cunha, A.Cláudia.; Vieira, M.Cecília.Bastos.; Ferreira, V.Francisco.; Carvalho-Pinto, C.Eponina.; Kang, H.Chung.; Castro, H.Carla. 2014: In vitro and in vivo analysis of the antithrombotic and toxicological profile of new antiplatelets N-acylhydrazone derivatives and development of nanosystems: determination of novel NAH derivatives antiplatelet and nanotechnological approach. Thrombosis Research 134(2): 376-383

Kocher, O.; Birrane, G.; Tsukamoto, K.; Fenske, S.; Yesilaltay, A.; Pal, R.; Daniels, K.; Ladias, J.A.A.; Krieger, M. 2010: In vitro and in vivo analysis of the binding of the C terminus of the HDL receptor scavenger receptor class B, type i (SR-BI), to the PDZ1 domain of its adaptor protein PDZK1. Journal of Biological Chemistry 285(45): 34999-35010

Xing, L.; Niu, M.; Kleiman, L. 2012: In vitro and in vivo analysis of the interaction between RNA helicase a and HIV-1 RNA. Journal of Virology 86(24): 13272-13280

Murata, T. 2009: In vitro and in vivo angiogenesis assays. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 133(5): 261-265

Neve, A.; Cantatore, F.P.; Corrado, A.; Gaudio, A.; Ruggieri, S.; Ribatti, D. 2013: In vitro and in vivo angiogenic activity of osteoarthritic and osteoporotic osteoblasts is modulated by VEGF and vitamin D3 treatment. Regulatory Peptides 184: 81-84

Ma, J.; Yang, F.; Both, S.K.; Prins, H.-J.; Helder, M.N.; Pan, J.; Cui, F.-Z.; Jansen, J.A.; van den Beucken, J.J.J.P. 2014: In vitro and in vivo angiogenic capacity of BM-MSCs/HUVECs and AT-MSCs/HUVECs cocultures. Biofabrication 6(1): 015005

Dong, Q.; Deng, S.; Wang, R.; Yuan, J. 2011: In vitro and in vivo animal models in priapism research. Journal of Sexual Medicine 8(2): 347-359

Harris, G.L.; Creason, M.B.; Brulte, G.B.; Herr, D.R. 2012: In vitro and in vivo antagonism of a G protein-coupled receptor (S1P3) with a novel blocking monoclonal antibody. Plos one 7(4): E35129

Errakhi, R.; Lebrihi, A.; Barakate, M. 2009: In vitro and in vivo antagonism of actinomycetes isolated from Moroccan rhizospherical soils against Sclerotium rolfsii: a causal agent of root rot on sugar beet (Beta vulgaris L.). Journal of Applied Microbiology 107(2): 672-681

Cai, J.; Kim, T.-S.; Jang, J.Y.; Kim, J.; Shin, K.; Lee, S.-P.; Choi, E.-K.; Kim, S.-H.; Park, M.; Kim, J.B.; Kim, Y.-B. 2014: In vitro and in vivo anti-Helicobacter pylori activities of FEMY-R7 composed of fucoidan and evening primrose extract. Laboratory Animal Research 30(1): 28-34

Souza, M.do.Carmo.; Beserra, A.Márcia.Selhorst.; Martins, D.Cristina.; Real, Vânia.Villa.; Santos, Rério.Alexandre.Nunes.Dos.; Rao, V.Satyanarayana.; Silva, R.Matos.da.; Martins, D.Tabajara.de.Oliveira. 2009: In vitro and in vivo anti-Helicobacter pylori activity of Calophyllum brasiliense Camb. Journal of Ethnopharmacology 123(3): 452-458

Tan, P.V.; Boda, M.; Etoa, F.ço.-X. 2010: In vitro and in vivo anti-Helicobacter/Campylobacter activity of the aqueous extract of Enantia chlorantha. Pharmaceutical Biology 48(3): 349-356

Hayashi, E.; Mokudai, T.; Yamada, Y.; Nakamura, K.; Kanno, T.; Sasaki, K.; Niwano, Y. 2012: In vitro and in vivo anti-Staphylococcus aureus activities of a new disinfection system utilizing photolysis of hydrogen peroxide. Journal of Bioscience and Bioengineering 114(2): 193-197

Maeda-Yamamoto, M.; Ema, K.; Shibuichi, I. 2007: In vitro and in vivo anti-allergic effects of 'benifuuki' green tea containing O-methylated catechin and ginger extract enhancement. Cytotechnology 55(2-3): 135-142

Seyfi, P.; Mostafaie, A.; Mansouri, K.; Arshadi, D.; Mohammadi-Motlagh, H.-R.; Kiani, A. 2010: In vitro and in vivo anti-angiogenesis effect of shallot (Allium ascalonicum): a heat-stable and flavonoid-rich fraction of shallot extract potently inhibits angiogenesis. Toxicology in Vitro: An International Journal Published in Association with Bibra 24(6): 1655-1661

Chintalapati, M.; Truax, R.; Stout, R.; Portier, R.; Losso, J.N. 2009: In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate. Journal of Agricultural and Food Chemistry 57(12): 5201-5210

Lai, S.-L.; Cheah, S.-C.; Wong, P.-F.; Noor, S.M.; Mustafa, M.R. 2012: In vitro and in vivo anti-angiogenic activities of Panduratin a. Plos one 7(5): E38103

Lopes, F.áv.C.M.; Ferreira, R.; Albuquerque, D.éi.M.; Silveira, A.él.A.A.; Costa, R.; Soares, R.; Costa, F.F.; Conran, N. 2014: In vitro and in vivo anti-angiogenic effects of hydroxyurea. Microvascular Research 94: 106-113

Jin, Y.-m.; Xu, T.-m.; Zhao, Y.-h.; Wang, Y.-c.; Cui, M.-h. 2014: In vitro and in vivo anti-cancer activity of formononetin on human cervical cancer cell line Hela. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(3): 2279-2284

Zhu, X.; Huang, S.; Huang, H.; Zhang, Y.; Xie, Y.; Hou, L.; Zhang, H.; Shi, J.; Zhang, Z. 2014: In vitro and in vivo anti-cancer effects of targeting and photothermal sensitive solid lipid nanoparticles. Journal of Drug Targeting 22(9): 822-828

Lowe, H.I.C.; Toyang, N.J.; Bryant, J. 2013: In vitro and in vivo anti-cancer effects of tillandsia recurvata (ball moss) from Jamaica. West Indian Medical Journal 62(3): 177-180

Liu, S.; Wei, W.; Shi, K.; Cao, X.; Zhou, M.; Liu, Z. 2014: In vitro and in vivo anti-hepatitis B virus activities of the lignan niranthin isolated from Phyllanthus niruri L. Journal of Ethnopharmacology 155(2): 1061-1067

Liu, S.; Wei, W.; Li, Y.; Lin, X.; Shi, K.; Cao, X.; Zhou, M. 2014: In vitro and in vivo anti-hepatitis B virus activities of the lignan nirtetralin B isolated from Phyllanthus niruri L. Journal of Ethnopharmacology 15(7): 62-68

Jo, S.-H.; Ha, K.-S.; Moon, K.-S.; Lee, O.-H.; Jang, H.-D.; Kwon, Y.-I. 2011: In vitro and in vivo anti-hyperglycemic effects of Omija (Schizandra chinensis) fruit. International Journal of Molecular Sciences 12(2): 1359-1370

Yang, Y.; Yu, T.; Jang, H-Jae.; Byeon, S.Eun.; Song, S-Yi.; Lee, B-Hee.; Rhee, M.Hee.; Kim, T.Woong.; Lee, J.; Hong, S.; Cho, J.Youl. 2012: In vitro and in vivo anti-inflammatory activities of Polygonum hydropiper methanol extract. Journal of Ethnopharmacology 139(2): 616-625

Ibrahim Abdelwahab, S.; Syaed Koko, W.; Mohamed Elhassan Taha, M.; Mohan, S.; Achoui, M.; Ameen Abdulla, M.; Rais Mustafa, M.; Ahmad, S.; Ibrahim Noordin, M.; Lip Yong, C.; Roslan Sulaiman, M.; Othman, R.; Amir Hassan, A. 2012: In vitro and in vivo anti-inflammatory activities of columbin through the inhibition of cycloxygenase-2 and nitric oxide but not the suppression of NF-κB translocation. European Journal of Pharmacology 678(1-3): 61-70

Achoui, M.; Appleton, D.; Abdulla, M.A.; Awang, K.; Mohd, M.A.; Mustafa, M.R. 2010: In vitro and in vivo anti-inflammatory activity of 17-O-acetylacuminolide through the inhibition of cytokines, NF-κB translocation and IKKβ activity. Plos one 5(12): E15105

Lee, J.H.; Lee, K.-R.; Su, Z.-Y.; Boyanapalli, S.S.-S.; Barman, D.N.; Huang, M.-T.; Chen, L.; Magesh, S.; Hu, L.; Kong, A.-N.T. 2014: In vitro and in vivo anti-inflammatory effects of a novel 4,6-bis ((E)-4-hydroxy-3-methoxystyryl)-1-phenethylpyrimidine-2(1H)-thione. Chemical Research in Toxicology 27(1): 34-41

Abu-Ghefreh, A.'a.A.; Canatan, H.; Ezeamuzie, C.I. 2009: In vitro and in vivo anti-inflammatory effects of andrographolide. International Immunopharmacology 9(3): 313-318

Yu, T.; Lee, J.; Lee, Y.Gyu.; Byeon, S.Eun.; Kim, M.Ho.; Sohn, E-Hwa.; Lee, Y.Jin.; Lee, S.Gu.; Cho, J.Youl. 2010: In vitro and in vivo anti-inflammatory effects of ethanol extract from Acer tegmentosum. Journal of Ethnopharmacology 128(1): 139-147

Sawamura, R.; Shimizu, T.; Sun, Y.; Yasukawa, K.; Miura, M.; Toriyama, M.; Motohashi, S.; Watanabe, W.; Konno, K.; Kurokawa, M. 2010: In vitro and in vivo anti-influenza virus activity of diarylheptanoids isolated from Alpinia officinarum. Antiviral Chemistry and ChemoTherapy 21(1): 33-41

Gao, R.-m.; Li, X.-q.; He, W.-y.; Jiang, J.-d.; Li, Y.-h. 2010: In vitro and in vivo anti-influenza virus activity of ribavirin injection. Yao Xue Xue Bao 45(3): 403-407

Ramazani, A.; Zakeri, S.; Sardari, S.; Khodakarim, N.; Djadidt, N.D. 2010: In vitro and in vivo anti-malarial activity of Boerhavia elegans and Solanum surattense. Malaria Journal 9: 124

Pereira, T.B.; Rocha E Silva, L.F.; Amorim, R.C.N.; Melo, M.ár.R.S.; Zacardi de Souza, R.C.; Eberlin, M.N.; Lima, E.S.; Vasconcellos, M.C.; Pohlit, A.M. 2014: In vitro and in vivo anti-malarial activity of limonoids isolated from the residual seed biomass from Carapa guianensis (andiroba) oil production. Malaria Journal 13: 317

Sahu, R.; Walker, L.A.; Tekwani, B.L. 2014: In vitro and in vivo anti-malarial activity of tigecycline, a glycylcycline antibiotic, in combination with chloroquine. Malaria Journal 13: 414

Janjetovic, K.; Harhaji-Trajkovic, L.; Misirkic-Marjanovic, M.; Vucicevic, L.; Stevanovic, D.; Zogovic, N.; Sumarac-Dumanovic, M.; Micic, D.; Trajkovic, V. 2011: In vitro and in vivo anti-melanoma action of metformin. European Journal of Pharmacology 668(3): 373-382

Chiu, T-Man.; Huang, C-Chen.; Lin, T-Ju.; Fang, J-You.; Wu, N-Lin.; Hung, C-Feng. 2009: In vitro and in vivo anti-photoaging effects of an isoflavone extract from soybean cake. Journal of Ethnopharmacology 126(1): 108-113

Fujisaki, R.; Kamei, K.; Yamamura, M.; Nishiya, H.; Inouye, S.; Takahashi, M.; Abe, S. 2012: In vitro and in vivo anti-plasmodial activity of essential oils, including hinokitiol. Southeast Asian Journal of Tropical Medicine and Public Health 43(2): 270-279

Yepes, E.; Varela-M, R.én.E.; López-Abán, J.; Dakir, E.H.; Dakir, E.L.H.; Mollinedo, F.; Muro, A. 2014: In vitro and in vivo anti-schistosomal activity of the alkylphospholipid analog edelfosine. Plos one 9(10): E109431

Lu, M.; Han, Z.; Xu, Y.; Yao, L. 2013: In vitro and in vivo anti-tobacco mosaic virus activities of essential oils and individual compounds. Journal of Microbiology and Biotechnology 23(6): 771-778

Sloat, B.R.; Sandoval, M.A.; Li, D.; Chung, W-Gye.; Lansakara-P, D.S.P.; Proteau, P.J.; Kiguchi, K.; DiGiovanni, J.; Cui, Z. 2011: In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles. International Journal of Pharmaceutics 409(1-2): 278-288

Di Martino, M.T.; Gullà, A.; Cantafio, M.E.G.; Lionetti, M.; Leone, E.; Amodio, N.; Guzzi, P.H.; Foresta, U.; Conforti, F.; Cannataro, M.; Neri, A.; Giordano, A.; Tagliaferri, P.; Tassone, P. 2013: In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma. Oncotarget 4(2): 242-255

Luo, Q.; Hu, D.; Hu, S.; Yan, M.; Sun, Z.; Chen, F. 2012: In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma. Bmc Cancer 12: 517

Tong, Q.; Li, H.; Li, W.; Chen, H.; Shu, X.; Lu, X.; Wang, G. 2011: In vitro and in vivo anti-tumor effects of gemcitabine loaded with a new drug delivery system. Journal of Nanoscience and Nanotechnology 11(4): 3651-3658

Omokawa, Y.; Miyazaki, T.; Walde, P.; Akiyama, K.; Sugahara, T.; Masuda, S.; Inada, A.; Ohnishi, Y.; Saeki, T.; Kato, K. 2010: In vitro and in vivo anti-tumor effects of novel Span 80 vesicles containing immobilized Eucheuma serra agglutinin. International Journal of Pharmaceutics 389(1-2): 157-167

Moarbess, G.; Deleuze-Masquefa, C.; Bonnard, V.; Gayraud-Paniagua, S.ép.; Vidal, J.-R.ém.; Bressolle, F.ço.; Pinguet, F.éd.ér.; Bonnet, P.-A. 2008: In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives. Bioorganic and Medicinal Chemistry 16(13): 6601-6610

Zhao, Q.; Xue, Y.; Wang, J.-f.; Li, H.; Long, T.-t.; Li, Z.; Wang, Y.-m.; Dong, P.; Xue, C.-h. 2012: In vitro and in vivo anti-tumour activities of echinoside a and ds-echinoside a from Pearsonothuria graeffei. Journal of the Science of Food and Agriculture 92(4): 965-974

Tsai, A.-C.; Pai, H.-C.; Wang, C.-Y.; Liou, J.-P.; Teng, C.-M.; Wang, J.-C.; Pan, S.-L. 2014: In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells. British Journal of Pharmacology 171(1): 122-133

Su, L.; Xu, X.; Zhao, H.; Gu, Q.; Zou, H. 2010: In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2. Biochemical and Biophysical Research Communications 396(4): 1012-1017

Yang, J.; He, S.; Li, S.; Zhang, R.; Peng, A.; Chen, L. 2013: In vitro and in vivo antiangiogenic activity of caged polyprenylated xanthones isolated from Garcinia hanburyi Hook. f. Molecules 18(12): 15305-15313

Selbonne, S.; Azibani, F.; Iatmanen, S.; Boulaftali, Y.; Richard, B.; Jandrot-Perrus, M.; Bouton, M-Christine.; Arocas, Véronique. 2012: In vitro and in vivo antiangiogenic properties of the serpin protease nexin-1. Molecular and Cellular Biology 32(8): 1496-1505

Macone, A.B.; Caruso, B.K.; Leahy, R.G.; Donatelli, J.; Weir, S.; Draper, M.P.; Tanaka, S.K.; Levy, S.B. 2014: In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline. Antimicrobial Agents and ChemoTherapy 58(2): 1127-1135

Mohebi, R.; Ghafourian, S.; Sekawi, Z.; Khosravi, A.; Galehdari, E.A.; Hushmandfar, R.; Ranjbar, R.; Maleki, A.; Mohammadzadeh, M.; Rahbar, M.; Sadeghifard, N. 2011: In vitro and in vivo antibacterial activity of acorn herbal extract against some Gram-negative and Gram-positive bacteria. Roumanian Archives of Microbiology and Immunology 70(4): 149-152

Locher, H.H.; Seiler, P.; Chen, X.; Schroeder, S.; Pfaff, P.; Enderlin, M.; Klenk, A.; Fournier, E.; Hubschwerlen, C.; Ritz, D.; Kelly, C.P.; Keck, W. 2014: In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections. Antimicrobial Agents and ChemoTherapy 58(2): 892-900

Bakkiyaraj, D.; Pandian, S.Karutha. 2010: In vitro and in vivo antibiofilm activity of a coral associated actinomycete against drug resistant Staphylococcus aureus biofilms. Biofouling 26(6): 711-717

Donia, M.; Maksimovic-Ivanic, D.; Mijatovic, S.; Mojic, M.; Miljkovic, D.; Timotijevic, G.; Fagone, P.; Caponnetto, S.; Al-Abed, Y.; McCubrey, J.; Stosic-Grujicic, S.; Nicoletti, F. 2011: In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells. Cell Cycle 10(3): 492-499

Shao, J.-W.; Dai, Y.-C.; Xue, J.-P.; Wang, J.-C.; Lin, F.-P.; Guo, Y.-H. 2011: In vitro and in vivo anticancer activity evaluation of ursolic acid derivatives. European Journal of Medicinal Chemistry 46(7): 2652-2661

Xu, Q.; Huang, K.-C.; Tendyke, K.; Marsh, J.; Liu, J.; Qiu, D.; Littlefield, B.A.; Nomoto, K.; Atasoylu, O.; Risatti, C.A.; Sperry, J.B.; Smith, A.B. 2011: In vitro and in vivo anticancer activity of (+)-spongistatin 1. Anticancer Research 31(9): 2773-2779

Reddy, K.Papi.; Bid, H.K.; Nayak, V.Lakshma.; Chaudhary, P.; Chaturvedi, J.P.; Arya, K.R.; Konwar, R.; Narender, T. 2009: In vitro and in vivo anticancer activity of 2-deacetoxytaxinine J and synthesis of novel taxoids and their in vitro anticancer activity. European Journal of Medicinal Chemistry 44(10): 3947-3953

Hoskins, C.; Ouaissi, M.; Lima, S.C.; Cheng, W.P.; Loureirio, I.ês.; Mas, E.; Lombardo, D.; Cordeiro-da-Silva, A.; Ouaissi, A.; Kong Thoo Lin, P. 2010: In vitro and in vivo anticancer activity of a novel nano-sized formulation based on self-assembling polymers against pancreatic cancer. Pharmaceutical Research 27(12): 2694-2703

Wang, Y.; Ma, Y.; Zheng, Y.; Song, J.; Yang, X.; Bi, C.; Zhang, D.; Zhang, Q. 2013: In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity. International Journal of Pharmaceutics 441(1-2): 728-735

Lin, Y.-S.; Huang, L.-D.; Lin, C.-H.; Huang, P.-H.; Chen, Y.-J.; Wong, F.-H.; Lin, C.-C.; Fu, S.-L. 2011: In vitro and in vivo anticancer activity of a synthetic glycolipid as Toll-like receptor 4 (TLR4) activator. Journal of Biological Chemistry 286(51): 43782-43792

Du, J.; Lu, X.; Long, Z.; Zhang, Z.; Zhu, X.; Yang, Y.; Xu, J. 2013: In vitro and in vivo anticancer activity of aconitine on melanoma cell line B16. Molecules 18(1): 757-767

Palanimuthu, D.; Shinde, S.V.; Somasundaram, K.; Samuelson, A.G. 2013: In vitro and in vivo anticancer activity of copper bis(thiosemicarbazone) complexes. Journal of Medicinal Chemistry 56(3): 722-734

Gandin, V.; Tisato, F.; Dolmella, A.; Pellei, M.; Santini, C.; Giorgetti, M.; Marzano, C.; Porchia, M. 2014: In vitro and in vivo anticancer activity of copper(I) complexes with homoscorpionate tridentate tris(pyrazolyl)borate and auxiliary monodentate phosphine ligands. Journal of Medicinal Chemistry 57(11): 4745-4760

Wang, W.; Rayburn, E.R.; Velu, S.E.; Nadkarni, D.H.; Murugesan, S.; Zhang, R. 2009: In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(10): 3511-3518

Yan, L.L.; Zhang, Y.J.; Gao, W.Y.; Man, S.L.; Wang, Y. 2009: In vitro and in vivo anticancer activity of steroid saponins of Paris polyphylla var. yunnanensis. Experimental Oncology 31(1): 27-32

Venkatasubbu, G.Devanand.; Ramasamy, S.; Reddy, G.Pramod.; Kumar, J. 2013: In vitro and in vivo anticancer activity of surface modified paclitaxel attached hydroxyapatite and titanium dioxide nanoparticles. Biomedical Microdevices 15(4): 711-726

Xie, J-Tian.; Wang, C-Zhi.; Zhang, B.; Mehendale, S.Ram.; Li, X-Li.; Sun, S.; Han, A.Htun.; Du, W.; He, T-Chuan.; Yuan, C-Su. 2009: In vitro and in vivo anticancer effects of American ginseng berry: exploring representative compounds. Biological and Pharmaceutical Bulletin 32(9): 1552-1558

Rajasekar, S.; Park, D.Jung.; Park, C.; Park, S.; Park, Y.Hoon.; Kim, S.Tae.; Choi, Y.Hyun.; Choi, Y.Whan. 2012: In vitro and in vivo anticancer effects of Lithospermum erythrorhizon extract on B16F10 murine melanoma. Journal of Ethnopharmacology 144(2): 335-345

Lee, Y.-P.; Wang, C.-W.; Liao, W.-C.; Yang, C.-R.; Yeh, C.-T.; Tsai, C.-H.; Yang, C.-C.; Tzeng, Y.-M. 2012: In vitro and in vivo anticancer effects of destruxin B on human colorectal cancer. Anticancer Research 32(7): 2735-2745

Ni, J.; Mai, T.; Pang, S.-T.; Haque, I.; Huang, K.; DiMaggio, M.A.; Xie, S.; James, N.S.; Kasi, D.; Chemler, S.R.; Yeh, S. 2009: In vitro and in vivo anticancer effects of the novel vitamin e ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(3): 898-906

Guimarães, F.S.F.; Andrade, L.F.; Martins, S.T.; Abud, A.P.R.; Sene, R.V.; Wanderer, C.; Tiscornia, I.és.; Bollati-Fogolín, M.; Buchi, D.F.; Trindade, E.S. 2010: In vitro and in vivo anticancer properties of a Calcarea carbonica derivative complex (M8) treatment in a murine melanoma model. Bmc Cancer 10: 113

Militão, G.C.G.; Dantas, I.N.F.; Ferreira, P.Michel.P.; Alves, A.Paula.N.N.; Chaves, D.C.; Monte, F.José.Q.; Pessoa, Cáudia.; Odorico de Moraes, M.; Costa-Lotufo, Lícia.V. 2012: In vitro and in vivo anticancer properties of cucurbitacin isolated from Cayaponia racemosa. Pharmaceutical Biology 50(12): 1479-1487

Sahgal, G.; Ramanathan, S.; Sasidharan, S.; Mordi, M.N.; Ismail, S.; Mansor, S.M. 2011: In vitro and in vivo anticandidal activity of Swietenia mahogani methanolic seed extract. Tropical Biomedicine 28(1): 132-137

Li, G.-S.; Jiang, W.-L.; Tian, J.-W.; Qu, G.-W.; Zhu, H.-B.; Fu, F.-H. 2010: In vitro and in vivo antifibrotic effects of rosmarinic acid on experimental liver fibrosis. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 17(3-4): 282-288

Sashidhara, K.V.; Kumar, A.; Rao, K.B.; Kushwaha, V.; Saxena, K.; Murthy, P.K. 2012: In vitro and in vivo antifilarial activity evaluation of 3,6-epoxy [1,5]dioxocines: a new class of antifilarial agents. Bioorganic and Medicinal Chemistry Letters 22(4): 1527-1532

Lakshmi, V.; Srivastava, S.; Kumar Mishra, S.; Misra, S.; Verma, M.; Misra-Bhattacharya, S. 2009: In vitro and in vivo antifilarial potential of marine sponge, Haliclona exigua (Kirkpatrick), against human lymphatic filarial parasite Brugia malayi: antifilarial activity of H. exigua. Parasitology Research 105(5): 1295-1301

Dzoyem, J.P.; Tchuenguem, R.T.; Kuiate, J.R.; Teke, G.N.; Kechia, F.A.; Kuete, V. 2014: In vitro and in vivo antifungal activities of selected Cameroonian dietary spices. Bmc Complementary and Alternative Medicine 14: 58

Soylu, E.M.; Kurt, S.; Soylu, S. 2010: In vitro and in vivo antifungal activities of the essential oils of various plants against tomato grey mould disease agent Botrytis cinerea. International Journal of Food Microbiology 143(3): 183-189

Xu, S.-X.; Li, Y.-C.; Liu, X.; Mao, L.-J.; Zhang, H.; Zheng, X.-D. 2012: In vitro and in vivo antifungal activity of a water-dilutable cassia oil microemulsion against Geotrichum citri-aurantii. Journal of the Science of Food and Agriculture 92(13): 2668-2671

Mugnaini, L.; Nardoni, S.; Pinto, L.; Pistelli, L.; Leonardi, M.; Pisseri, F.; Mancianti, F. 2012: In vitro and in vivo antifungal activity of some essential oils against feline isolates of Microsporum canis. Journal de Mycologie Medicale 22(2): 179-184

Kurt, S.; Güneş, U.; Soylu, E.M. 2011: In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum. Pest Management Science 67(7): 869-875

Popovic, M.M.; Bulajic, A.; Ristic, D.; Krstic, B.; Jankov, R.M.; Gavrovic-Jankulovic, M. 2012: In vitro and in vivo antifungal properties of cysteine proteinase inhibitor from green kiwifruit. Journal of the Science of Food and Agriculture 92(15): 3072-3078

Pastor, F.J.; Ruíz-Cendoya, M.; Pujol, I.; Mayayo, E.; Sutton, D.A.; Guarro, J. 2010: In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella. Antimicrobial Agents and ChemoTherapy 54(11): 4550-4555

Rabito, M.F.; Britta, E.A.; Pelegrini, B.L.; Scariot, D.éb.B.; Almeida, M.B.; Nixdorf, S.L.; Nakamura, C.V.; Ferreira, I.C.P. 2014: In vitro and in vivo antileishmania activity of sesquiterpene lactone-rich dichloromethane fraction obtained from Tanacetum parthenium (L.) Schultz-Bip. Experimental Parasitology 143: 18-23

Galiana-Roselló, C.; Bilbao-Ramos, P.; Dea-Ayuela, M.A.; Rolón, M.; Vega, C.; Bolás-Fernández, F.; García-España, E.; Alfonso, J.; Coronel, C.; González-Rosende, M.E. 2013: In vitro and in vivo antileishmanial and trypanocidal studies of new N-benzene- and N-naphthalenesulfonamide derivatives. Journal of Medicinal Chemistry 56(22): 8984-8998

Mutiso, J.M.; Macharia, J.C.; Barasa, M.; Taracha, E.; Bourdichon, A.J.; Gicheru, M.M. 2011: In vitro and in vivo antileishmanial efficacy of a combination therapy of diminazene and artesunate against Leishmania donovani in BALB/c mice. Revista do Instituto de Medicina Tropical de Sao Paulo 53(3): 129-132

Zhang, R.; Shang, L.; Jin, H.; Ma, C.; Wu, Y.; Liu, Q.; Xia, Z.; Wei, F.; Zhu, X.-Q.; Gao, H. 2010: In vitro and in vivo antileishmanial efficacy of nitazoxanide against Leishmania donovani. Parasitology Research 107(2): 475-479

Kimura, A.; Nishikawa, H.; Nomura, N.; Mitsuyama, J.; Fukumoto, S.; Inoue, N.; Kawazu, S-Ichiro. 2012: In vitro and in vivo antimalarial activities of T-2307, a novel arylamidine. Antimicrobial Agents and ChemoTherapy 56(4): 2191-2193

Silva, L.F.R.e.; Lima, E.S.; Vasconcellos, M.C.d.; Aranha, E.S.P.; Costa, D.S.; Mustafa, E.V.; Morais, S.K.R.d.; Alecrim, M.d.G.ça.C.; Nunomura, S.M.; Struwe, L.; de Andrade-Neto, V.F.; Pohlit, A.M. 2013: In vitro and in vivo antimalarial activity and cytotoxicity of extracts, fractions and a substance isolated from the Amazonian plant Tachia grandiflora (Gentianaceae). Memorias do Instituto Oswaldo Cruz 108(4): 501-507

Ulrich, P.; Gipson, G.R.; Clark, M.A.; Tripathi, A.; Sullivan, D.J.; Cerami, C. 2014: In vitro and in vivo antimalarial activity of amphiphilic naphthothiazolium salts with amine-bearing side chains. American Journal of Tropical Medicine and Hygiene 91(4): 824-832

Mota, M.L.; Lobo, L.T.C.; Costa, J.é M.G.d.; Costa, L.S.; Rocha, H.A.O.; Rocha e Silva, L.F.; Pohlit, A.M.; Neto, V.F.d.A. 2012: In vitro and in vivo antimalarial activity of essential oils and chemical components from three medicinal plants found in northeastern Brazil. Planta Medica 78(7): 658-664

Lusakibanza, M.; Mesia, G.; Tona, G.; Karemere, S.; Lukuka, A.; Tits, M.; Angenot, L.; Frédérich, M. 2010: In vitro and in vivo antimalarial and cytotoxic activity of five plants used in congolese traditional medicine. Journal of Ethnopharmacology 129(3): 398-402

Sathe, M.; Kaushik, M.P. 2010: In vitro and in vivo antimalarial evaluation of semi-synthetic derivatives of gomphostenin. Bioorganic and Medicinal Chemistry Letters 20(14): 4233-4236

Naghibi, F.; Esmaeili, S.; Abdullah, N.R.; Nateghpour, M.; Taghvai, M.; Kamkar, S.; Mosaddegh, M. 2013: In vitro and in vivo antimalarial evaluations of myrtle extract, a plant traditionally used for treatment of parasitic disorders. Biomed Research International 2013: 316185

He, X.; Wang, Y.; Hu, H.; Zhang, Z. 2012: In vitro and in vivo antimammary tumor activities and mechanisms of the apple total triterpenoids. Journal of Agricultural and Food Chemistry 60(37): 9430-9436

Arif, T.; Mandal, T.K.; Kumar, N.; Bhosale, J.D.; Hole, A.; Sharma, G.L.; Padhi, M.M.; Lavekar, G.S.; Dabur, R. 2009: In vitro and in vivo antimicrobial activities of seeds of Caesalpinia bonduc (Lin.) Roxb. Journal of Ethnopharmacology 123(1): 177-180

Chelli-Chentouf, N.; Tir Touil Meddah, A.; Mullié, C.; Aoues, A.; Meddah, B. 2012: In vitro and in vivo antimicrobial activity of Algerian Hoggar Salvadora persica L. extracts against microbial strains from children's oral cavity. Journal of Ethnopharmacology 144(1): 57-66

Lee, B.C.; Kim, M.S.; Choi, S.H.; Kim, K.Y.; Kim, T.S. 2009: In vitro and in vivo antimicrobial activity of water-soluble chitosan oligosaccharides against Vibrio vulnificus. International Journal of Molecular Medicine 24(3): 327-333

Park, J.-H.; Ahn, M.-Y.; Kim, Y.-C.; Kim, S.-A.; Moon, Y.-H.; Ahn, S.-G.; Yoon, J.-H. 2012: In vitro and in vivo antimicrobial effect of photodynamic therapy using a highly pure chlorin e6 against Staphylococcus aureus Xen29. Biological and Pharmaceutical Bulletin 35(4): 509-514

Honda, M.; Kawanobe, Y.; Ishii, K.; Konishi, T.; Mizumoto, M.; Kanzawa, N.; Matsumoto, M.; Aizawa, M. 2013: In vitro and in vivo antimicrobial properties of silver-containing hydroxyapatite prepared via ultrasonic spray pyrolysis route. Materials Science and Engineering. C Materials for Biological Applications 33(8): 5008-5018

Xiong, S.; Pang, H.-d.; Fan, J.; Ge, F.; Yang, X.-x.; Liu, Q.-y.; Liao, X.-j.; Xu, S.-h. 2010: In vitro and in vivo antineoplastic activity of a novel bromopyrrole and its potential mechanism of action. British Journal of Pharmacology 159(4): 909-918

Li, P.; Jia, J.; Zhang, D.; Xie, J.; Xu, X.; Wei, D. 2014: In vitro and in vivo antioxidant activities of a flavonoid isolated from celery (Apium graveolens L. var. dulce). Food and Function 5(1): 50-56

Kang, M.-C.; Kim, S.Y.; Kim, Y.T.; Kim, E.-A.; Lee, S.-H.; Ko, S.-C.; Wijesinghe, W.A.J.P.; Samarakoon, K.W.; Kim, Y.-S.; Cho, J.H.; Jang, H.-S.; Jeon, Y.-J. 2014: In vitro and in vivo antioxidant activities of polysaccharide purified from aloe vera (Aloe barbadensis) gel. Carbohydrate Polymers 99: 365-371

Malomo, S.O.; Ore, A.; Yakubu, M.T. 2011: In vitro and in vivo antioxidant activities of the aqueous extract of Celosia argentea leaves. Indian Journal of Pharmacology 43(3): 278-285

Shen, Q.; Shang, N.; Li, P. 2011: In vitro and in vivo antioxidant activity of Bifidobacterium animalis 01 isolated from centenarians. Current Microbiology 62(4): 1097-1103

Liu, W.; Wang, J.; Zhang, Z.; Xu, J.; Xie, Z.; Slavin, M.; Gao, X. 2014: In vitro and in vivo antioxidant activity of a fructan from the roots of Arctium lappa L. International Journal of Biological Macromolecules 65: 446-453

Luo, A.; Ge, Z.; Fan, Y.; Luo, A.; Chun, Z.; He, X. 2011: In vitro and in vivo antioxidant activity of a water-soluble polysaccharide from Dendrobium denneanum. Molecules 16(2): 1579-1592

Liu, J.; Jia, L.; Kan, J.; Jin, C.-H. 2013: In vitro and in vivo antioxidant activity of ethanolic extract of white button mushroom (Agaricus bisporus). Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 51: 310-316

Wang, X.; Yang, L.; Yang, X.; Tian, Y. 2014: In vitro and in vivo antioxidant and antimutagenic activities of polyphenols extracted from hops (Humulus lupulus L.). Journal of the Science of Food and Agriculture 94(8): 1693-1700

Deepalakshmi, K.; Mirunalini, S.; Krishnaveni, M.; Arulmozhi, V. 2013: In vitro and in vivo antioxidant potentials of an ethanolic extract of Ganoderma lucidum in rat mammary carcinogenesis. Chinese Journal of Natural Medicines 11(6): 621-627

Sato, Y.; Itagaki, S.; Kurokawa, T.; Ogura, J.; Kobayashi, M.; Hirano, T.; Sugawara, M.; Iseki, K. 2011: In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid. International Journal of Pharmaceutics 403(1-2): 136-138

Verma, A.R.; Vijayakumar, M.; Mathela, C.S.; Rao, C.V. 2009: In vitro and in vivo antioxidant properties of different fractions of Moringa oleifera leaves. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 47(9): 2196-2201

Rao, V.; Balachandran, B.; Shen, H.; Logan, A.; Rao, L. 2011: In vitro and in vivo antioxidant properties of the plant-based supplement greens+™. International Journal of Molecular Sciences 12(8): 4896-4908

Caballero, A.B.; Marín, C.; Rodríguez-Diéguez, A.; Ramírez-Macías, I.; Barea, E.; Sánchez-Moreno, M.; Salas, J.M. 2011: In vitro and in vivo antiparasital activity against Trypanosoma cruzi of three novel 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one-based complexes. Journal of Inorganic Biochemistry 105(6): 770-776

Kumar, S.; Raman, R.P.; Kumar, K.; Pandey, P.K.; Kumar, N.; Mohanty, S.; Kumar, A. 2012: In vitro and in vivo antiparasitic activity of Azadirachtin against Argulus spp. in Carassius auratus (Linn. 1758). Parasitology Research 110(5): 1795-1800

Pinmai, K.; Hiriote, W.; Soonthornchareonnon, N.; Jongsakul, K.; Sireeratawong, S.; Tor-Udom, S. 2010: In vitro and in vivo antiplasmodial activity and cytotoxicity of water extracts of Phyllanthus emblica, Terminalia chebula, and Terminalia bellerica. Journal of the Medical Association of Thailand 93(Suppl 7): S120-S126

Magalhães, H.I.F.; Ferreira, P.M.P.; Moura, E.S.; Torres, Márcia.R.; Alves, A.P.N.N.; Pessoa, Oília.D.L.; Costa-Lotufo, Lícia.V.; Moraes, M.O.; Pessoa, Cáudia. 2010: In vitro and in vivo antiproliferative activity of Calotropis procera stem extracts. Anais da Academia Brasileira de Ciencias 82(2): 407-416

Schlie-Guzmán, M.ía.A.; García-Carrancá, A.; González-Esquinca, A.R. 2009: In vitro and in vivo antiproliferative activity of laherradurin and cherimolin-2 of Annona diversifolia Saff. PhytoTherapy Research: Ptr 23(8): 1128-1133

Kimura, Y.; Sumiyoshi, M.; Sakanaka, M.; Taniguchi, M.; Baba, K. 2013: In vitro and in vivo antiproliferative effect of a combination of ultraviolet-A and alkoxy furocoumarins isolated from Umbelliferae medicinal plants, in melanoma cells. Photochemistry and Photobiology 89(5): 1216-1225

Keiser, J.; Vargas, M.; Rubbiani, R.; Gasser, G.; Biot, C. 2014: In vitro and in vivo antischistosomal activity of ferroquine derivatives. Parasites and Vectors 7: 424

Boiani, L.; Gerpe, A.; Arán, V.J.; Torres de Ortiz, S.; Serna, E.; Vera de Bilbao, N.; Sanabria, L.; Yaluff, G.; Nakayama, H.éc.; Rojas de Arias, A.; Maya, J.D.; Morello, J.A.; Cerecetto, H.; González, M. 2009: In vitro and in vivo antitrypanosomatid activity of 5-nitroindazoles. European Journal of Medicinal Chemistry 44(3): 1034-1040

Frezza, M.; Dou, Q.P.; Xiao, Y.; Samouei, H.; Rashidi, M.; Samari, F.; Hemmateenejad, B. 2011: In vitro and in vivo antitumor activities and DNA binding mode of five coordinated cyclometalated organoplatinum(II) complexes containing biphosphine ligands. Journal of Medicinal Chemistry 54(18): 6166-6176

Wang, D-Dong.; Feng, Y.; Li, Z.; Zhang, L.; Wang, S.; Zhang, C-Yang.; Wang, X-Xia.; Liu, Z-Yu. 2014: In vitro and in vivo antitumor activity of Bulbus Fritillariae Cirrhosae and preliminary investigation of its mechanism. Nutrition and Cancer 66(3): 441-452

Huang, X.H.; Xiong, P.C.; Xiong, C.M.; Cai, Y.L.; Wei, A.H.; Wang, J.P.; Liang, X.F.; Ruan, J.L. 2010: In vitro and in vivo antitumor activity of Macrothelypteris torresiana and its acute/subacute oral toxicity. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 17(12): 930-934

Dai, Z.-J.; Gao, J.; Li, Z.-F.; Ji, Z.-Z.; Kang, H.-F.; Guan, H.-T.; Diao, Y.; Wang, B.-F.; Wang, X.-J. 2011: In vitro and in vivo antitumor activity of Scutellaria barbate extract on murine liver cancer. Molecules 16(6): 4389-4400

Hossain, E.; Chakroborty, S.; Milan, A.; Chattopadhyay, P.; Mandal, S.C.; Gupta, J.K. 2012: In vitro and in vivo antitumor activity of a methanol extract of Dregea volubilis leaves with its antioxidant effect. Pharmaceutical Biology 50(3): 338-343

Chauhan, D.; Ray, A.; Viktorsson, K.; Spira, J.; Paba-Prada, C.; Munshi, N.; Richardson, P.; Lewensohn, R.; Anderson, K.C. 2013: In vitro and in vivo antitumor activity of a novel alkylating agent, melphalan-flufenamide, against multiple myeloma cells. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 19(11): 3019-3031

Zhao, H.; Yin, R.; Chen, D.; Ren, J.; Wang, Y.; Zhanga, J.; Deng, H.; Wang, Y.; Qiu, H.; Huang, N.; Zou, Q.; Zhao, J.; Gu, Y. 2014: In vitro and in vivo antitumor activity of a novel hypocrellin B derivative for photodynamic therapy. Photodiagnosis and Photodynamic Therapy 11(2): 204-212

Huan, M.; Zhang, B.; Teng, Z.; Cui, H.; Wang, J.; Liu, X.; Xia, H.; Zhou, S.; Mei, Q. 2012: In vitro and in vivo antitumor activity of a novel pH-activated polymeric drug delivery system for doxorubicin. Plos one 7(9): E44116

Menezes, C.B.A.; Silva, B.P.; Sousa, I.M.O.; Ruiz, A.L.T.G.; Spindola, H.M.; Cabral, E.; Eberlin, M.N.; Tinti, S.V.; Carvalho, J.E.; Foglio, M.A.; Fantinatti-Garboggini, F. 2013: In vitro and in vivo antitumor activity of crude extracts obtained from Brazilian Chromobacterium sp isolates. Brazilian Journal of Medical and Biological Research 46(1): 65-70

Mao, L.; Cheng, Q.; Guardiola-Lemaître, B.éa.; Schuster-Klein, C.; Dong, C.; Lai, L.; Hill, S.M. 2010: In vitro and in vivo antitumor activity of melatonin receptor agonists. Journal of Pineal Research 49(3): 210-221

Lou, H.; Zhang, X.; Gao, L.; Feng, F.; Wang, J.; Wei, X.; Yu, Z.; Zhang, D.; Zhang, Q. 2009: In vitro and in vivo antitumor activity of oridonin nanosuspension. International Journal of Pharmaceutics 379(1): 181-186

Kovala-Demertzi, D.; Papageorgiou, A.; Papathanasis, L.; Alexandratos, A.; Dalezis, P.; Miller, J.R.; Demertzis, M.A. 2009: In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopic study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents. European Journal of Medicinal Chemistry 44(3): 1296-1302

Yang, X.-K.; Xu, M.-Y.; Xu, G.-S.; Zhang, Y.-L.; Xu, Z.-X. 2014: In vitro and in vivo antitumor activity of scutebarbatine a on human lung carcinoma A549 cell lines. Molecules 19(7): 8740-8751

Ivankovic, S.; Stojkovic, R.; Galic, Z.; Galic, B.; Ostojic, J.; Marasovic, M.; Milos, M. 2015: In vitro and in vivo antitumor activity of the halogenated boroxine dipotassium-trioxohydroxytetrafluorotriborate (K2[B3O3F4OH]). Journal of Enzyme Inhibition and Medicinal Chemistry 30(3): 354-359

Janeklang, S.; Nakaew, A.; Vaeteewoottacharn, K.; Seubwai, W.; Boonsiri, P.; Kismali, G.; Suksamrarn, A.; Okada, S.; Wongkham, S. 2014: In vitro and in vivo antitumor activity of tiliacorinine in human cholangiocarcinoma. Asian Pacific Journal of Cancer Prevention: Apjcp 15(17): 7473-7478

Lu, H.; Shi, M.; Wang, M.; Xie, Z.; Hu, M.; Yu, M.; Shen, B.; Ma, Y.; Guo, N. 2008: In vitro and in vivo antitumor effect of a trivalent bispecific antibody targeting ErbB2 and CD16. Cancer Biology and Therapy 7(11): 1744-1750

Pita, J.ão.C.L.R.; Xavier, A.L.; de Sousa, T.K.G.; Mangueira, V.M.; Tavares, J.F.; de Oliveira Júnior, R.J.é; Veras, R.C.; Pessoa, H.d.L.F.; da Silva, M.S.; Morelli, S.; Ávila, V.d.M.R.; da Silva, T.G.ça.; Diniz, M.d.F.át.F.M.; Castello-Branco, M.V.S. 2012: In vitro and in vivo antitumor effect of trachylobane-360, a diterpene from Xylopia langsdorffiana. Molecules 17(8): 9573-9589

Magalhães, H.I.F.; Bezerra, D.P.; Cavalcanti, B.C.; Wilke, D.V.; Rotta, R.; de Lima, D.ên.P.; Beatriz, A.; Alves, A.P.N.N.; Bitencourt, F.áv.d.S.; de Figueiredo, I.S.T.; Alencar, N.M.N.; Costa-Lotufo, L.íc.V.; Moraes, M.O.; Pessoa, C. 2011: In vitro and in vivo antitumor effects of (4-methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone. Cancer ChemoTherapy and Pharmacology 68(1): 45-52

Mukhopadhyay, S.; Panda, P.K.; Behera, B.; Das, C.K.; Hassan, M.K.; Das, D.N.; Sinha, N.; Bissoyi, A.; Pramanik, K.; Maiti, T.K.; Bhutia, S.K. 2014: In vitro and in vivo antitumor effects of Peanut agglutinin through induction of apoptotic and autophagic cell death. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 64: 369-377

Xiong, W.; Luo, G.; Zhou, L.; Zeng, Y.; Yang, W. 2009: In vitro and in vivo antitumor effects of acetylshikonin isolated from Arnebia euchroma (Royle) Johnst (Ruanzicao) cell suspension cultures. Chinese Medicine 4: 14

Yang, G.; Yang, T.; Zhang, W.; Lu, M.; Ma, X.; Xiang, G. 2014: In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome. Journal of Agricultural and Food Chemistry 62(10): 2207-2215

Zhang, B.-z.; Wang, K.-r.; Yan, J.-x.; Zhang, W.; Song, J.-j.; Ni, J.-m.; Wang, R. 2010: In vitro and in vivo antitumor effects of novel actinomycin D analogs with amino acid substituted in the cyclic depsipeptides. Peptides 31(4): 568-573

Watanabe, Y.; Asano, R.; Arai, K.; Shimomura, I.; Ogata, H.; Kawaguchi, H.; Hayashi, H.; Ohtsuka, H.; Yoshida, H.; Katayose, Y.; Egawa, S.; Nakanishi, T.; Umetsu, M.; Yasui, H.; Ishida, T.; Imai, K.; Kudo, T.; Unno, M.; Kumagai, I. 2011: In vitro and in vivo antitumor effects of recombinant bispecific antibodies based on humanized anti-EGFR antibody. Oncology Reports 26(4): 949-955

Britto, A.C.S.; de Oliveira, A.C.A.; Henriques, R.M.; Cardoso, G.M.B.; Bomfim, D.S.; Carvalho, A.A.; Moraes, M.O.; Pessoa, C.; Pinheiro, M.L.B.; Costa, E.V.; Bezerra, D.P. 2012: In vitro and in vivo antitumor effects of the essential oil from the leaves of Guatteria friesiana. Planta Medica 78(5): 409-414

Guo, D.-J.; Han, J.-S.; Li, Y.-S.; Liu, Z.-S.; Lu, S.-Y.; Ren, H.-L. 2012: In vitro and in vivo antitumor effects of the recombinant immunotoxin IL6(T23)-PE38KDEL in multiple myeloma. Oncology Letters 4(2): 311-318

Hou, Z.-B.; Lu, K.-J.; Wu, X.-L.; Chen, C.; Huang, X.-E.; Yin, H.-T. 2014: In vitro and in vivo antitumor evaluation of berbamine for lung cancer treatment. Asian Pacific Journal of Cancer Prevention: Apjcp 15(4): 1767-1769

Kataria, S.; Kaur, D.; Rao, S.Kamalaksha.; Khajuria, R.K. 2013: In vitro and in vivo aphrodisiac properties of Corchorus depressus Linn. on rabbit corpus cavernosum smooth muscle relaxation and sexual behavior of normal male rats. Journal of Ethnopharmacology 148(1): 210-217

Lu, K.-H.; Chang, Y.-F.; Yin, P.-H.; Chen, T.-T.; Ho, Y.-L.; Chang, Y.-S.; Chi, C.-W. 2010: In vitro and in vivo apoptosis-inducing antileukemic effects of Mucuna macrocarpa stem extract on HL-60 human leukemia cells. Integrative Cancer Therapies 9(3): 298-308

Toprak, U.; Baldwin, D.; Erlandson, M.; Gillott, C.; Harris, S.; Hegedus, D.D. 2013: In vitro and in vivo application of RNA interference for targeting genes involved in peritrophic matrix synthesis in a lepidopteran system. Insect Science 20(1): 92-100

Cristina, C.; Annalisa, L.; Amalia, C.; Francesco, C.ò; Del Nobile, M.A. 2013: In vitro and in vivo application of active compounds with anti-yeast activity to improve the shelf life of ready-to-eat table grape. World Journal of Microbiology and Biotechnology 29(6): 1075-1084

Kim, H.; Yoon, S.; Chung, J. 2014: In vitro and in vivo application of anti-cotinine antibody and cotinine-conjugated compounds. Bmb Reports 47(3): 130-134

Zia, M.Hussain.; Codling, E.E.; Scheckel, K.G.; Chaney, R.L. 2011: In vitro and in vivo approaches for the measurement of oral bioavailability of lead (Pb) in contaminated soils: a review. Environmental Pollution 159(10): 2320-2327

Feng, B.; Varma, M.V.; Costales, C.; Zhang, H.; Tremaine, L. 2014: In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery. Expert Opinion on Drug Discovery 9(8): 873-890

Wang, P.; Dalbey, R.E. 2010: In vitro and in vivo approaches to studying the bacterial signal peptide processing. Methods in Molecular Biology 619: 21-37

Mitchell, J.; Newman, S.; Chan, H.-K. 2007: In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review. Aaps Pharmscitech 8(4): E110

Lee, Y.; Kim, V.N. 2007: In vitro and in vivo assays for the activity of Drosha complex. Methods in Enzymology 427: 89-106

Prudent, R.; Sautel, C.él.F.; Moucadel, V.; Laudet, B.éa.; Filhol, O.; Cochet, C. 2010: In vitro and in vivo assays of protein kinase CK2 activity. Methods in Enzymology 485: 597-610

Sawada, K.; Morishige, K.-i.; Mabuchi, S.; Ogata, S.; Kawase, C.; Sakata, M.; Kimura, T. 2008: In vitro and in vivo assays to analyze the contribution of Rho kinase in angiogenesis. Methods in Enzymology 439: 395-412

Wang, X.; Peng, Y.; Jing, X.; Qian, D.; Tang, Y.; Duan, J.-A. 2014: In vitro and in vivo assessment of CYP2C9-mediated herb-herb interaction of Euphorbiae Pekinensis Radix and Glycyrrhizae Radix. Frontiers in Pharmacology 5: 186

Lee, S.Y.; Lee, J.-Y.; Kang, W.; Kwon, K.-i.; Oh, S.J.; Ma, J.Y.; Kim, S.K. 2013: In vitro and in vivo assessment of cytochrome P450-mediated herb-drug interaction of Ssang-hwa-tang. Food Chemistry 136(2): 450-457

Iwata, A.; Watanabe, Y.; Kumagai, N.; Katafuchi-Nagashima, M.; Sugiura, K.; Pillai, R.; Tatsumi, Y. 2014: In vitro and in vivo assessment of dermatophyte acquired resistance to efinaconazole, a novel triazole antifungal. Antimicrobial Agents and ChemoTherapy 58(8): 4920-4922

Bilsky, E.J.; Giuvelis, D.; Osborn, M.D.; Dersch, C.M.; Xu, H.; Rothman, R.B. 2010: In vitro and in vivo assessment of mu opioid receptor constitutive activity. Methods in Enzymology 484: 413-443

Al Ibrahim, N.S.; Tahmassebi, J.F.; Toumba, K.J. 2010: In vitro and in vivo assessment of newly developed slow-release fluoride glass device. European Archives of Paediatric Dentistry: Official Journal of the European Academy of Paediatric Dentistry 11(3): 131-135

Fontanilla, M.R.; Espinosa, L.G. 2012: In vitro and in vivo assessment of oral autologous artificial connective tissue characteristics that influence its performance as a graft. Tissue Engineering. Part a 18(17-18): 1857-1866

Velam, V.; Yalavarthi, P.Raju.; Sundaresan, C.; Vandana, K.; Dudala, T.Bindu.; Kodavatikanti, H.; Vadlamudi, H.Chowdary. 2013: In vitro and in vivo assessment of piroxicam incorporated Aloe vera transgel. International Journal of Pharmaceutical Investigation 3(4): 212-216

Fahmy, B.; Ding, L.; You, D.; Lomnicki, S.; Dellinger, B.; Cormier, S.A. 2010: In vitro and in vivo assessment of pulmonary risk associated with exposure to combustion generated fine particles. Environmental Toxicology and Pharmacology 29(2): 173-182

Badiou, W.; Lavigne, J-Philippe.; Bousquet, P-Jean.; O'Callaghan, D.; Marès, P.; de Tayrac, R. 2011: In vitro and in vivo assessment of silver-coated polypropylene mesh to prevent infection in a rat model. International Urogynecology Journal 22(3): 265-272

Benhabbour, S.Rahima.; Luft, J.Christopher.; Kim, D.; Jain, A.; Wadhwa, S.; Parrott, M.C.; Liu, R.; DeSimone, J.M.; Mumper, R.J. 2012: In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel Heptameric ZEGFR domain. Journal of Controlled Release: Official Journal of the Controlled Release Society 158(1): 63-71

Kayano, A.C.A.V.; Lopes, S.C.P.; Bueno, F.G.; Cabral, E.C.; Souza-Neiras, W.C.; Yamauchi, L.M.; Foglio, M.A.; Eberlin, M.N.; Mello, J.ão.C.P.; Costa, F.T.M. 2011: In vitro and in vivo assessment of the anti-malarial activity of Caesalpinia pluviosa. Malaria Journal 10: 112

Chen, Y.; Yan, J.; Zhao, C.; Zhang, S.; Yu, S.; Wang, Z.; Wang, X.; Zhang, X.; Zheng, Q. 2014: In vitro and in vivo assessment of the biocompatibility of an Mg-6Z(n) alloy in the bile. Journal of Materials Science. Materials in Medicine 25(2): 471-480

Derks, M.; Fowler, S.; Kuhlmann, O. 2009: In vitro and in vivo assessment of the effect of dalcetrapib on a panel of CYP substrates. Current Medical Research and Opinion 25(4): 891-902

Otabe, A.; Fujieda, T.; Masuyama, T. 2011: In vitro and in vivo assessment of the mutagenic activity of N-[N-[3-(3-hydroxy-4-methoxyphenyl) propyl]-α-aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (advantame). Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 49(Suppl 1): S30-S34

Paschalis, E.I.; Chodosh, J.; Spurr-Michaud, S.; Cruzat, A.; Tauber, A.; Behlau, I.; Gipson, I.; Dohlman, C.H. 2013: In vitro and in vivo assessment of titanium surface modification for coloring the backplate of the Boston keratoprosthesis. Investigative Ophthalmology and Visual Science 54(6): 3863-3873

Silion, M.; Hritcu, D.; Jaba, I.M.; Tamba, B.; Ionescu, D.; Mungiu, O.C.; Popa, I.M. 2010: In vitro and in vivo behavior of ketoprofen intercalated into layered double hydroxides. Journal of Materials Science. Materials in Medicine 21(11): 3009-3018

Lusvardi, G.; Zaffe, D.; Menabue, L.; Bertoldi, C.; Malavasi, G.; Consolo, U. 2009: In vitro and in vivo behaviour of zinc-doped phosphosilicate glasses. Acta Biomaterialia 5(1): 419-428

Danoux, C.èn.B.; Barbieri, D.; Yuan, H.; de Bruijn, J.D.; van Blitterswijk, C.A.; Habibovic, P. 2014: In vitro and in vivo bioactivity assessment of a polylactic acid/hydroxyapatite composite for bone regeneration. Biomatter 4: E27664

Hiromoto, S.; Inoue, M.; Taguchi, T.; Yamane, M.; Ohtsu, N. 2015: In vitro and in vivo biocompatibility and corrosion behaviour of a bioabsorbable magnesium alloy coated with octacalcium phosphate and hydroxyapatite. Acta Biomaterialia 11: 520-530

Li, Q.; Xia, Y-Yi.; Tang, J-Cun.; Wang, R-Ying.; Bei, C-Yong.; Zeng, Y. 2011: In vitro and in vivo biocompatibility investigation of diamond-like carbon coated nickel-titanium shape memory alloy. Artificial Cells Blood Substitutes and Immobilization Biotechnology 39(3): 137-142

Múzquiz-Ramos, E.Martha.; Cortés-Hernández, D.A.; Escobedo-Bocardo, J.C.; Zugasti-Cruz, A.; Ramírez-Gómez, X.S.; Osuna-Alarcón, J.G. 2013: In vitro and in vivo biocompatibility of apatite-coated magnetite nanoparticles for cancer therapy. Journal of Materials Science. Materials in Medicine 24(4): 1035-1041

Quan, R.; Yang, D.; Wu, X.; Wang, H.; Miao, X.; Li, W. 2008: In vitro and in vivo biocompatibility of graded hydroxyapatite-zirconia composite bioceramic. Journal of Materials Science. Materials in Medicine 19(1): 183-187

Moisenovich, M.M.; Pustovalova, O.L.; Arhipova, A.Y.; Vasiljeva, T.V.; Sokolova, O.S.; Bogush, V.G.; Debabov, V.G.; Sevastianov, V.I.; Kirpichnikov, M.P.; Agapov, I.I. 2011: In vitro and in vivo biocompatibility studies of a recombinant analogue of spidroin 1 scaffolds. Journal of Biomedical Materials Research. Part a 96(1): 125-131

Ciofani, G.; Raffa, V.; Vittorio, O.; Cuschieri, A.; Pizzorusso, T.; Costa, M.; Bardi, G. 2010: In vitro and in vivo biocompatibility testing of functionalized carbon nanotubes. Methods in Molecular Biology 625: 67-83

Alamri, S.; Hashem, M.; Mostafa, Y.S. 2012: In vitro and in vivo biocontrol of soil-borne phytopathogenic fungi by certain bioagents and their possible mode of action. Biocontrol Science 17(4): 155-167

Feng, H.; Sun, J.; Jiang, P. 2008: In vitro and in vivo biodegradation of sustained-release vehicle poloxamer 407 in situ gel. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 22(1): 28-31

Jonáš, A.; Aas, M.; Karadag, Y.; Manioğlu, S.; Anand, S.; McGloin, D.; Bayraktar, H.; Kiraz, A. 2014: In vitro and in vivo biolasing of fluorescent proteins suspended in liquid microdroplet cavities. Lab on a Chip 14(16): 3093-3100

Broadhead, M.L.; Dass, C.R.; Choong, P.F.M. 2009: In vitro and in vivo biological activity of PEDF against a range of tumors. Expert Opinion on Therapeutic Targets 13(12): 1429-1438

Trávníček, Z.ěk.; Matiková-Mal'arová, M.; Novotná, R.; Vančo, J.án.; Stěpánková, K.; Suchý, P. 2011: In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A. Journal of Inorganic Biochemistry 105(7): 937-948

Timm, B.L.; da Silva, P.íc.B.; Batista, M.M.; da Silva, F.H.G.; da Silva, C.F.ça.; Tidwell, R.R.; Patrick, D.A.; Jones, S.K.; Bakunov, S.A.; Bakunova, S.M.; Soeiro, M.d.N.é C. 2014: In vitro and in vivo biological effects of novel arylimidamide derivatives against Trypanosoma cruzi. Antimicrobial Agents and ChemoTherapy 58(7): 3720-3726

Snima, K.S.; Jayakumar, R.; Lakshmanan, V-Kumar. 2014: In vitro and in vivo biological evaluation of O-carboxymethyl chitosan encapsulated metformin nanoparticles for pancreatic cancer therapy. Pharmaceutical Research 31(12): 3361-3370

Mur Blanch, N.úr.; Chabot, G.G.; Quentin, L.; Scherman, D.; Bourg, S.ép.; Dauzonne, D. 2012: In vitro and in vivo biological evaluation of new 4,5-disubstituted 1,2,3-triazoles as cis-constrained analogs of combretastatin A4. European Journal of Medicinal Chemistry 54: 22-32

Ma, L.; Shi, Y.; Chen, Y.; Zhao, H.; Gao, C.; Han, C. 2007: In vitro and in vivo biological performance of collagen-chitosan/silicone membrane bilayer dermal equivalent. Journal of Materials Science. Materials in Medicine 18(11): 2185-2191

Wilson, K.; Yu, J.; Lee, A.; Wu, J.C. 2008: In vitro and in vivo bioluminescence reporter gene imaging of human embryonic stem cells. Journal of Visualized Experiments: Jove 2008(14)

Liu, J.; Barradas, A.; Fernandes, H.; Janssen, F.; Papenburg, B.; Stamatialis, D.; Martens, A.; van Blitterswijk, C.; de Boer, J. 2010: In vitro and in vivo bioluminescent imaging of hypoxia in tissue-engineered grafts. Tissue Engineering. Part C Methods 16(3): 479-485

Logeart-Avramoglou, D.; Oudina, K.; Bourguignon, M.; Delpierre, L.; Nicola, M.-A.; Bensidhoum, M.; Arnaud, E.; Petite, H. 2010: In vitro and in vivo bioluminescent quantification of viable stem cells in engineered constructs. Tissue Engineering. Part C Methods 16(3): 447-458

Falck, E.; Begrow, F.; Verspohl, E.J.; Wünsch, B. 2014: In vitro and in vivo biotransformation of WMS-1410, a potent GluN2B selective NMDA receptor antagonist. Journal of Pharmaceutical and Biomedical Analysis 94: 36-44

Damianou, C.; Ioannides, K.; Hadjisavvas, V.; Mylonas, N.; Couppis, A.; Iosif, D. 2009: In vitro and in vivo brain ablation created by high-intensity focused ultrasound and monitored by MRi. IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control 56(6): 1189-1198

Chi, X.-J.; Wang, X.-J.; Wang, C.-Y.; Cui, X.-J.; Wang, X.-J. 2014: In vitro and in vivo broad antiviral activity of peptides homologous to fusion glycoproteins of Newcastle disease virus and Marek's disease virus. Journal of Virological Methods 199: 11-16

Bollini, S.; Pozzobon, M.; Nobles, M.; Riegler, J.; Dong, X.; Piccoli, M.; Chiavegato, A.; Price, A.N.; Ghionzoli, M.; Cheung, K.K.; Cabrelle, A.; O'Mahoney, P.R.; Cozzi, E.; Sartore, S.; Tinker, A.; Lythgoe, M.F.; De Coppi, P. 2011: In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cells. Stem Cell Reviews and Reports 7(2): 364-380

Eyrich, D.; Wiese, H.; Maier, G.; Skodacek, D.; Appel, B.; Sarhan, H.; Tessmar, J.; Staudenmaier, R.; Wenzel, M.M.; Goepferich, A.; Blunk, T. 2007: In vitro and in vivo cartilage engineering using a combination of chondrocyte-seeded long-term stable fibrin gels and polycaprolactone-based polyurethane scaffolds. Tissue Engineering 13(9): 2207-2218

Hegde, S.; Hegde, S.; Spergser, J.; Brunthaler, R.é; Rosengarten, R.; Chopra-Dewasthaly, R. 2014: In vitro and in vivo cell invasion and systemic spreading of Mycoplasma agalactiae in the sheep infection model. International Journal of Medical Microbiology: Ijmm 304(8): 1024-1031

Xi, T.; Gao, R.; Xu, B.; Chen, L.; Luo, T.; Liu, J.; Wei, Y.; Zhong, S. 2010: In vitro and in vivo changes to PLGA/sirolimus coating on drug eluting stents. Biomaterials 31(19): 5151-5158

Kikuchi, A.; Furutani, T.; Azami, H.; Watanabe, K.; Niimi, T.; Kamiyama, Y.; Kuromitsu, S.; Baskin-Bey, E.; Heeringa, M.; Ouatas, T.; Enjo, K. 2014: In vitro and in vivo characterisation of ASP9521: a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3). Investigational new Drugs 32(5): 860-870

Redrobe, J.P.; Jørgensen, M.; Christoffersen, C.T.; Montezinho, L.P.; Bastlund, J.F.; Carnerup, M.; Bundgaard, C.; Lerdrup, L.; Plath, N. 2014: In vitro and in vivo characterisation of Lu AF64280, a novel, brain penetrant phosphodiesterase (PDE) 2A inhibitor: potential relevance to cognitive deficits in schizophrenia. Psychopharmacology 231(16): 3151-3167

Logan, A.E.; Wilson, T.R.; Fenning, C.; Cummins, R.; Kay, E.; Johnston, P.G.; Longley, D.B. 2010: In vitro and in vivo characterisation of a novel c-FLIP-targeted antisense phosphorothioate oligonucleotide. Apoptosis: An International Journal on Programmed Cell Death 15(12): 1435-1443

Cheng, W.-P.; Thompson, C.; Ryan, S.éa.M.; Aguirre, T.; Tetley, L.; Brayden, D.J. 2010: In vitro and in vivo characterisation of a novel peptide delivery system: amphiphilic polyelectrolyte-salmon calcitonin nanocomplexes. Journal of Controlled Release: Official Journal of the Controlled Release Society 147(2): 289-297

Berry, L.M.; Adams, R.; Airey, M.; Bracher, M.G.; Bourne, T.; Carrington, B.; Cross, A.S.; Davies, G.C.G.; Finney, H.M.; Foulkes, R.; Gozzard, N.; Griffin, R.A.; Hailu, H.; Lamour, S.D.; Lawson, A.D.; Lightwood, D.J.; McKnight, A.J.; O'Dowd, V.L.; Oxbrow, A.K.F.; Popplewell, A.G.; Shaw, S.; Stephens, P.E.; Sweeney, B.; Tomlinson, K.L.; Uhe, C.; Palframan, R.T. 2009: In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes. International Immunopharmacology 9(2): 201-206

Yazdani, S.K.; Vorpahl, M.; Nakano, M.; Su, S.-H.; Kolodgie, F.D.; Virmani, R. 2011: In vitro and in vivo characterisation of biodegradable polymer-based drug-eluting stent. Eurointervention: Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 7(7): 835-843

Hendrickx, M.L.V.; Zatloukalova, M.; Hassanzadeh-Ghassabeh, G.; Muyldermans, S.; Gils, A.; Declerck, P.J. 2014: In vitro and in vivo characterisation of the profibrinolytic effect of an inhibitory anti-rat TAFi nanobody. Thrombosis and Haemostasis 111(5): 824-832

Barakat, N.S. 2009: In vitro and in vivo characteristics of a thermogelling rectal delivery system of etodolac. Aaps Pharmscitech 10(3): 724-731

Larsen, S.W.; Frost, A.B.; Ostergaard, J.; Thomsen, M.H.; Jacobsen, S.; Skonberg, C.; Hansen, S.H.é; Jensen, H.E.; Larsen, C. 2011: In vitro and in vivo characteristics of celecoxib in situ formed suspensions for intra-articular administration. Journal of Pharmaceutical Sciences 100(10): 4330-4337

Kolanowski, T.J.; Rozwadowska, N.; Malcher, A.; Szymczyk, E.; Kasprzak, J.D.; Mietkiewski, T.; Kurpisz, M. 2014: In vitro and in vivo characteristics of connexin 43-modified human skeletal myoblasts as candidates for prospective stem cell therapy for the failing heart. International Journal of Cardiology 173(1): 55-64

Tamura, M.; Ichinohe, S.; Tamura, A.; Ikeda, Y.; Nagasaki, Y. 2011: In vitro and in vivo characteristics of core-shell type nanogel particles: optimization of core cross-linking density and surface poly(ethylene glycol) density in PEGylated nanogels. Acta Biomaterialia 7(9): 3354-3361

Klink, C.D.; Binnebösel, M.; Lambertz, A.; Alizai, H.P.; Roeth, A.; Otto, J.; Klinge, U.; Neumann, U.P.; Junge, K. 2012: In vitro and in vivo characteristics of gentamicin-supplemented polyvinylidenfluoride mesh materials. Journal of Biomedical Materials Research. Part a 100(5): 1195-1202

Nishimura, M.; Matsuura, K.; Tsukioka, T.; Yamashita, H.; Inagaki, N.; Sugiyama, T.; Itoh, Y. 2009: In vitro and in vivo characteristics of prochlorperazine oral disintegrating film. International Journal of Pharmaceutics 368(1-2): 98-102

Song, J.S.; Kim, S.-O.; Kim, S.-H.; Choi, H.-J.; Son, H.-K.; Jung, H.-S.; Kim, C.-S.; Lee, J.-H. 2012: In vitro and in vivo characteristics of stem cells derived from the periodontal ligament of human deciduous and permanent teeth. Tissue Engineering. Part a 18(19-20): 2040-2051

Jeon, M.; Song, J.S.; Choi, B.-J.; Choi, H.-J.; Shin, D.-M.; Jung, H.-S.; Kim, S.-O. 2014: In vitro and in vivo characteristics of stem cells from human exfoliated deciduous teeth obtained by enzymatic disaggregation and outgrowth. Archives of Oral Biology 59(10): 1013-1023

Sulemankhil, I.; Parent, M.; Jones, M.L.; Feng, Z.; Labbé, A.; Prakash, S. 2012: In vitro and in vivo characterization and strain safety of Lactobacillus reuteri NCIMB 30253 for probiotic applications. Canadian Journal of Microbiology 58(6): 776-787

Strakhova, M.I.; Cuff, C.A.; Manelli, A.M.; Carr, T.L.; Witte, D.G.; Baranowski, J.L.; Vortherms, T.A.; Miller, T.R.; Rundell, L.; McPherson, M.J.; Adair, R.M.; Brito, A.A.; Bettencourt, B.M.; Yao, B.B.; Wetter, J.M.; Marsh, K.C.; Liu, H.; Cowart, M.D.; Brioni, J.D.; Esbenshade, T.A. 2009: In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory properties. British Journal of Pharmacology 157(1): 44-54

Raharjo, W.H.; Logan, B.C.; Wen, S.; Kalb, J.M.; Gaudet, J. 2010: In vitro and in vivo characterization of Caenorhabditis elegans PHA-4/FoxA response elements. Developmental Dynamics: An Official Publication of the American Association of Anatomists 239(8): 2219-2232

De Azevedo, M.; Karczewski, J.; Lefévre, F.ço.; Azevedo, V.; Miyoshi, A.; Wells, J.M.; Langella, P.; Chatel, J.-M. 2012: In vitro and in vivo characterization of DNA delivery using recombinant Lactococcus lactis expressing a mutated form of L. monocytogenes Internalin a. Bmc Microbiology 12: 299

Shoblock, J.R.; Welty, N.; Nepomuceno, D.; Lord, B.; Aluisio, L.; Fraser, I.; Motley, S.Timothy.; Sutton, S.W.; Morton, K.; Galici, R.; Atack, J.R.; Dvorak, L.; Swanson, D.M.; Carruthers, N.I.; Dvorak, C.; Lovenberg, T.W.; Bonaventure, P. 2010: In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor. Psychopharmacology 208(2): 265-277

Cardarelli, P.M.; Moldovan-Loomis, M.-C.; Preston, B.; Black, A.; Passmore, D.; Chen, T.-H.; Chen, S.; Liu, J.; Kuhne, M.R.; Srinivasan, M.; Assad, A.; Witte, A.; Graziano, R.F.; King, D.J. 2009: In vitro and in vivo characterization of MDX-1401 for therapy of malignant lymphoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(10): 3376-3383

Af Forselles, K.J.; Root, J.; Clarke, T.; Davey, D.; Aughton, K.; Dack, K.; Pullen, N. 2011: In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP₂ receptor antagonist. British Journal of Pharmacology 164(7): 1847-1856

Ahmed, K.B.R.; Warner, S.L.; Chen, A.; Gourley, E.S.; Liu, X.; Vankayalapati, H.; Nussenzveig, R.; Prchal, J.T.; Bearss, D.J.; Parker, C.J. 2011: In vitro and in vivo characterization of SGI-1252, a small molecule inhibitor of JAK2. Experimental Hematology 39(1): 14-25

Biegon, A.; Gibbs, A.; Alvarado, M.; Ono, M.; Taylor, S. 2007: In vitro and in vivo characterization of [3H]CNS-5161--a use-dependent ligand for the N-methyl-D-aspartate receptor in rat brain. Synapse 61(8): 577-586

Malm, S.; Walter, K.; Engel, R.; Maass, S.; Pfau, S.; Hübner, G.ör.; Lindner, B.; Holst, O.; Ehlers, S.; Bange, F.-C. 2008: In vitro and in vivo characterization of a Mycobacterium tuberculosis mutant deficient in glycosyltransferase Rv1500. International Journal of Medical Microbiology: Ijmm 298(7-8): 645-655

Hussmann, K.L.; Vandergaast, R.; Ochsner, S.P.; Huang, A.C.; Gale, M.; Fredericksen, B.L. 2014: In vitro and in vivo characterization of a West Nile virus MAD78 infectious clone. Archives of Virology 159(11): 3113-3118

Knorr, M.; Hausding, M.; Pfeffer, A.; Jurk, K.; Jansen, T.; Schwierczek, K.; Oelze, M.; Kröller-Schön, S.; Schulz, E.; Wenzel, P.; Gori, T.; Burgin, K.; Sartor, D.; Scherhag, A.; Münzel, T.; Daiber, A. 2014: In vitro and in vivo characterization of a new organic nitrate hybrid drug covalently bound to pioglitazone. Pharmacology 93(5-6): 203-215

Zhang, H.; Li, Z.-X. 2013: In vitro and in vivo characterization of a novel insect decaprenyl diphosphate synthase: a two-major step catalytic mechanism is proposed. Biochemical and Biophysical Research Communications 442(1-2): 105-111

Lim, G.J.; Ishiuji, Y.; Dawn, A.; Harrison, B.; Kim, D.W.; Atala, A.; Yosipovitch, G. 2008: In vitro and in vivo characterization of a novel liposomal butorphanol formulation for treatment of pruritus. Acta Dermato-Venereologica 88(4): 327-330

Abdrakhmanova, G.R.; Blough, B.E.; Nesloney, C.; Navarro, H.án.A.; Damaj, M.I.; Carroll, F.I. 2010: In vitro and in vivo characterization of a novel negative allosteric modulator of neuronal nAChRs. Neuropharmacology 59(6): 511-517

Zhang, Z.; Lundeen, S.G.; Slayden, O.; Zhu, Y.; Cohen, J.; Berrodin, T.J.; Bretz, J.; Chippari, S.; Wrobel, J.; Zhang, P.; Fensome, A.; Winneker, R.C.; Yudt, M.R. 2007: In vitro and in vivo characterization of a novel nonsteroidal, species-specific progesterone receptor modulator, PRA-910. Ernst Schering Foundation Symposium Proceedings 1: 171-197

Huang, F.; Sun, L.; Zheng, J. 2008: In vitro and in vivo characterization of a silk fibroin-coated polyester vascular prosthesis. Artificial Organs 32(12): 932-941

Thombre, A.G.; Shah, J.C.; Sagawa, K.; Caldwell, W.B. 2012: In vitro and in vivo characterization of amorphous, nanocrystalline, and crystalline ziprasidone formulations. International Journal of Pharmaceutics 428(1-2): 8-17

Mallajosyula, V.V.A.; Citron, M.; Lu, X.; Meulen, J.T.; Varadarajan, R.; Liang, X. 2013: In vitro and in vivo characterization of designed immunogens derived from the CD-helix of the stem of influenza hemagglutinin. Proteins 81(10): 1759-1775

Pavlova, S.P.; Veits, J.; Blohm, U.; Maresch, C.; Mettenleiter, T.C.; Fuchs, W. 2010: In vitro and in vivo characterization of glycoprotein C-deleted infectious laryngotracheitis virus. Journal of General Virology 91(Part 4): 847-857

Melotti, A.; Daga, A.; Marubbi, D.; Zunino, A.; Mutti, L.; Corte, G. 2010: In vitro and in vivo characterization of highly purified human mesothelioma derived cells. Bmc Cancer 10: 54

Tjin Tham Sjin, R.; Lee, K.; Walter, A.O.; Dubrovskiy, A.; Sheets, M.; Martin, T.S.; Labenski, M.T.; Zhu, Z.; Tester, R.; Karp, R.; Medikonda, A.; Chaturvedi, P.; Ren, Y.; Haringsma, H.; Etter, J.; Raponi, M.; Simmons, A.D.; Harding, T.C.; Niu, D.; Nacht, M.; Westlin, W.F.; Petter, R.C.; Allen, A.; Singh, J. 2014: In vitro and in vivo characterization of irreversible mutant-selective EGFR inhibitors that are wild-type sparing. Molecular Cancer Therapeutics 13(6): 1468-1479

Kamrud, K.I.; Coffield, V.M.; Owens, G.; Goodman, C.; Alterson, K.; Custer, M.; Murphy, M.A.; Lewis, W.; Timberlake, S.; Wansley, E.K.; Berglund, P.; Smith, J. 2010: In vitro and in vivo characterization of microRNA-targeted alphavirus replicon and helper RNAs. Journal of Virology 84(15): 7713-7725

Marroquín-Cardona, A.; Deng, Y.; Taylor, J.F.; Hallmark, C.T.; Johnson, N.M.; Phillips, T.D. 2009: In vitro and in vivo characterization of mycotoxin-binding additives used for animal feeds in Mexico. Food Additives and Contaminants. Part A Chemistry Analysis Control Exposure and Risk Assessment 26(5): 733-743

Alexanian, A.R.; Maiman, D.J.; Kurpad, S.N.; Gennarelli, T.A. 2008: In vitro and in vivo characterization of neurally modified mesenchymal stem cells induced by epigenetic modifiers and neural stem cell environment. Stem Cells and Development 17(6): 1123-1130

Hatanaka, J.; Shinme, Y.; Kuriyama, K.; Uchida, A.; Kou, K.; Uchida, S.; Yamada, S.; Onoue, S. 2011: In vitro and in vivo characterization of new formulations of St. John's Wort extract with improved pharmacokinetics and anti-nociceptive effect. Drug Metabolism and Pharmacokinetics 26(6): 551-558

Heiligenstein, S.; Cucchiarini, M.; Laschke, M.W.; Bohle, R.M.; Kohn, D.; Menger, M.D.; Madry, H. 2011: In vitro and in vivo characterization of nonbiomedical- and biomedical-grade alginates for articular chondrocyte transplantation. Tissue Engineering. Part C Methods 17(8): 829-842

Mu, L.; Honer, M.; Becaud, J.; Martic, M.; Schubiger, P.A.; Ametamey, S.M.; Stellfeld, T.; Graham, K.; Borkowski, S.; Lehmann, L.; Dinkelborg, L.; Srinivasan, A. 2010: In vitro and in vivo characterization of novel 18F-labeled bombesin analogues for targeting GRPR-positive tumors. Bioconjugate Chemistry 21(10): 1864-1871

Lockwood, N.A.; Hergenrother, R.W.; Patrick, L.M.; Stucke, S.M.; Steendam, R.; Pacheco, E.; Virmani, R.; Kolodgie, F.D.; Hubbard, B. 2010: In vitro and in vivo characterization of novel biodegradable polymers for application as drug-eluting stent coatings. Journal of Biomaterials Science. Polymer Edition 21(4): 529-552

Wang, C.-l.; Guo, C.; Zhou, Y.; Wang, R. 2009: In vitro and in vivo characterization of opioid activities of C-terminal esterified endomorphin-2 analogs. Peptides 30(9): 1697-1704

Chen, C.; Garber, L.; Smoak, M.; Fargason, C.; Scherr, T.; Blackburn, C.; Bacchus, S.; Lopez, M.J.; Pojman, J.A.; Del Piero, F.; Hayes, D.J. 2015: In vitro and in vivo characterization of pentaerythritol triacrylate-co-trimethylolpropane nanocomposite scaffolds as potential bone augments and grafts. Tissue Engineering. Part a 21(1-2): 320-331

Ait-Kaki, A.; Kacem-Chaouche, N.; Ongena, M.; Kara-Ali, M.; Dehimat, L.; Kahlat, K.; Thonart, P. 2014: In vitro and in vivo characterization of plant growth promoting Bacillus strains isolated from extreme environments of Eastern Algeria. Applied Biochemistry and Biotechnology 172(4): 1735-1746

Pabst, A.M.; Happe, A.; Callaway, A.; Ziebart, T.; Stratul, S.I.; Ackermann, M.; Konerding, M.A.; Willershausen, B.; Kasaj, A. 2014: In vitro and in vivo characterization of porcine acellular dermal matrix for gingival augmentation procedures. Journal of Periodontal Research 49(3): 371-381

Koschwanez, H.E.; Yap, F.Y.; Klitzman, B.; Reichert, W.M. 2008: In vitro and in vivo characterization of porous poly-L-lactic acid coatings for subcutaneously implanted glucose sensors. Journal of Biomedical Materials Research. Part a 87(3): 792-807

Vassiliev, I.; Vassilieva, S.; Beebe, L.F.S.; Harrison, S.J.; McIlfatrick, S.M.; Nottle, M.B. 2010: In vitro and in vivo characterization of putative porcine embryonic stem cells. Cellular Reprogramming 12(2): 223-230

Ansciaux, E.; Burtea, C.; Laurent, S.; Crombez, D.; Nonclercq, D.; Vander Elst, L.; Muller, R.N. 2015: In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. Contrast Media and Molecular Imaging 10(3): 211-224

Yang, Z.; Xu, L.S.; Yin, F.; Shi, Y.Q.; Han, Y.; Zhang, L.; Jin, H.F.; Nie, Y.Z.; Wang, J.B.; Hao, X.; Fan, D.M.; Zhou, X.M. 2012: In vitro and in vivo characterization of silk fibroin/gelatin composite scaffolds for liver tissue engineering. Journal of Digestive Diseases 13(3): 168-178

Terlinden, R.; Kogel, B.Y.; Englberger, W.; Tzschentke, T.M. 2010: In vitro and in vivo characterization of tapentadol metabolites. Methods and Findings in Experimental and Clinical Pharmacology 32(1): 31-38

Rojnik, M.; Kocbek, P.; Moret, F.; Compagnin, C.; Celotti, L.; Bovis, M.J.; Woodhams, J.H.; Macrobert, A.J.; Scheglmann, D.; Helfrich, W.; Verkaik, M.J.; Papini, E.; Reddi, E.; Kos, J. 2012: In vitro and in vivo characterization of temoporfin-loaded PEGylated PLGA nanoparticles for use in photodynamic therapy. Nanomedicine 7(5): 663-677

Fuchs, E.L.; Brutinel, E.D.; Klem, E.R.; Fehr, A.R.; Yahr, T.L.; Wolfgang, M.C. 2010: In vitro and in vivo characterization of the Pseudomonas aeruginosa cyclic AMP (cAMP) phosphodiesterase CpdA, required for cAMP homeostasis and virulence factor regulation. Journal of Bacteriology 192(11): 2779-2790

Menhofer, M.H.; Bartel, D.; Liebl, J.; Kubisch, R.; Busse, J.; Wagner, E.; Müller, R.; Vollmar, A.M.; Zahler, S. 2014: In vitro and in vivo characterization of the actin polymerizing compound chondramide as an angiogenic inhibitor. Cardiovascular Research 104(2): 303-314

Schleiferböck, S.; Scheurer, C.; Ihara, M.; Itoh, I.; Bathurst, I.; Burrows, J.N.; Fantauzzi, P.; Lotharius, J.; Charman, S.A.; Morizzi, J.; Shackleford, D.M.; White, K.L.; Brun, R.; Wittlin, S. 2013: In vitro and in vivo characterization of the antimalarial lead compound SSJ-183 in Plasmodium models. Drug Design Development and Therapy 7: 1377-1384

Fiorenzani, P.; Lamponi, S.; Magnani, A.; Ceccarelli, I.; Aloisi, A.Maria. 2014: In vitro and in vivo characterization of the new analgesic combination Beta-caryophyllene and docosahexaenoic Acid. Evidence-Based Complementary and Alternative Medicine: Ecam 2014: 596312

Perdona', E.; Costantini, V.J.A.; Tessari, M.; Martinelli, P.; Carignani, C.; Valerio, E.; Mok, M.H.Selina.; Zonzini, L.; Visentini, F.; Gianotti, M.; Gordon, L.; Rocheville, M.; Corsi, M.; Capelli, A.Maria. 2011: In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE). Neuropharmacology 61(5-6): 957-966

Roosenburg, S.; Laverman, P.; Joosten, L.; Eek, A.; Rutjes, F.P.J.T.; van Delft, F.L.; Boerman, O.C. 2012: In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging. Molecular Imaging 11(5): 401-407

Stevens, M.C.; Gregory, S.D.; Nestler, F.; Thomson, B.; Choudhary, J.; Garlick, B.; Pauls, J.P.; Fraser, J.F.; Timms, D. 2014: In vitro and in vivo characterization of three different modes of pump operation when using a left ventricular assist device as a right ventricular assist device. Artificial Organs 38(11): 931-939

Padakanti, P.K.; Zhang, X.; Jin, H.; Cui, J.; Wang, R.; Li, J.; Flores, H.P.; Parsons, S.M.; Perlmutter, J.S.; Tu, Z. 2014: In vitro and in vivo characterization of two C-11-labeled pet tracers for vesicular acetylcholine transporter. Molecular Imaging and Biology 16(6): 773-780

Zhi, L.; Chi, X.; Vostal, J.G. 2013: In vitro and in vivo characterization of ultraviolet light C-irradiated human platelets in a 2 event mouse model of transfusion. Plos one 8(11): E79869

Onoue, S.; Sato, H.; Kawabata, Y.; Mizumoto, T.; Hashimoto, N.; Yamada, S. 2009: In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine a for inhalation therapy. Journal of Controlled Release: Official Journal of the Controlled Release Society 138(1): 16-23

Jiang, W.; Lionberger, R.; Yu, L.X. 2011: In vitro and in vivo characterizations of PEGylated liposomal doxorubicin. Bioanalysis 3(3): 333-344

Hu, Z.; Troyk, P.R.; Brawn, T.P.; Margoliash, D.; Cogan, S.F. 2006: In vitro and in vivo charge capacity of AIROF microelectrodes. Conference Proceedings: . Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2006: 886-889

Jaffee, E.G.; Lauber, M.A.; Running, W.E.; Reilly, J.P. 2012: In vitro and in vivo chemical labeling of ribosomal proteins: a quantitative comparison. Analytical Chemistry 84(21): 9355-9361

Simões, M.J.; Gärtner, A.; Shirosaki, Y.; Gil da Costa, R.M.; Cortez, P.P.; Gartnër, F.; Santos, J.D.; Lopes, M.A.; Geuna, S.; Varejão, A.S.P.; Maurício, A.C. 2011: In vitro and in vivo chitosan membranes testing for peripheral nerve reconstruction. Acta Medica Portuguesa 24(1): 43-52

Park, J.Sun.; Yang, H.Na.; Woo, D.Gyun.; Chung, H-Min.; Park, K-Hong. 2009: In vitro and in vivo chondrogenesis of rabbit bone marrow-derived stromal cells in fibrin matrix mixed with growth factor loaded in nanoparticles. Tissue Engineering. Part a 15(8): 2163-2175

Panzarini, E.; Inguscio, V.; Tenuzzo, B.A.; Dini, L. 2013: In vitro and in vivo clearance of Rose Bengal Acetate-PhotoDynamic Therapy-induced autophagic and apoptotic cells. Experimental Biology and Medicine 238(7): 765-778

Lainé, S.éb.; Scarborough, R.J.; Lévesque, D.; Didierlaurent, L.; Soye, K.J.; Mougel, M.èn.; Perreault, J.-P.; Gatignol, A. 2011: In vitro and in vivo cleavage of HIV-1 RNA by new SOFA-HDV ribozymes and their potential to inhibit viral replication. Rna Biology 8(2): 343-353

Ko, C.-Y.; Ku, K.-L.; Yang, S.-R.; Lin, T.-Y.; Peng, S.; Peng, Y.-S.; Cheng, M.-H.; Chu, I.-M. 2016: In vitro and in vivo co-culture of chondrocytes and bone marrow stem cells in photocrosslinked PCL-PEG-PCL hydrogels enhances cartilage formation. Journal of Tissue Engineering and Regenerative Medicine 10(10): E485-E496

Desgrouas, C.; Dormoi, J.ér.ôm.; Chapus, C.; Ollivier, E.; Parzy, D.; Taudon, N. 2014: In vitro and in vivo combination of cepharanthine with anti-malarial drugs. Malaria Journal 13: 90

Pauly, A.; Roubeix, C.; Liang, H.; Brignole-Baudouin, F.ço.; Baudouin, C. 2012: In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation. Investigative Ophthalmology and Visual Science 53(13): 8172-8180

Bauwens, M.; De Saint-Hubert, M.; Cleynhens, J.; Vandeputte, C.; Li, J.; Devos, E. 2013: In vitro and in vivo comparison of 18F and 123I-labeled ML10 with 68Ga-Cys2-AnxA5 for molecular imaging of apoptosis. Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(2): 187-200

Kiss, B.él.; Horti, F.; Bobok, A. 2011: In vitro and in vivo comparison of [³H](+)-PHNO and [³H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: a method to distinguish dopamine D₃ from D₂ receptor sites. Synapse 65(6): 467-478

Nagata, N.; Yuki, M.; Hasegawa, T. 2011: In vitro and in vivo comparison of applanation tonometry and rebound tonometry in dogs. Journal of Veterinary Medical Science 73(12): 1585-1589

Lusch, A.; Abdelshehid, C.; Hidas, G.; Osann, K.E.; Okhunov, Z.; McDougall, E.; Landman, J. 2013: In vitro and in vivo comparison of optics and performance of a distal sensor ureteroscope versus a standard fiberoptic ureteroscope. Journal of Endourology 27(7): 896-902

Rodriguez, C.A.; Agudelo, M.; Zuluaga, A.F.; Vesga, O. 2010: In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin. Bmc Infectious Diseases 10: 153

Dawson, L.A.; Langmead, C.J.; Dada, A.; Watson, J.M.; Wu, Z.; de la Flor, R.úl.; Jones, G.A.; Cluderay, J.E.; Southam, E.; Murkitt, G.S.; Hill, M.D.; Jones, D.N.C.; Davies, C.H.; Hagan, J.J.; Smith, P.W. 2010: In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics. European Journal of Pharmacology 627(1-3): 106-114

Oatts, J.T.; Zhang, Z.; Tseng, H.; Shields, M.B.; Sinard, J.H.; Loewen, N.A. 2013: In vitro and in vivo comparison of two suprachoroidal shunts. Investigative Ophthalmology and Visual Science 54(8): 5416-5423

Noble, J.J.; Keevil, S.F.; Totman, J.; Charles-Edwards, G.D. 2014: In vitro and in vivo comparison of two-, three- and four-point Dixon techniques for clinical intramuscular fat quantification at 3 T. British Journal of Radiology 87(1036): 20130761

Nordmeyer-Massner, J.A.; Wyss, M.; Andreisek, G.; Pruessmann, K.P.; Hodler, J. 2011: In vitro and in vivo comparison of wrist MR imaging at 3.0 and 7.0 tesla using a gradient echo sequence and identical eight-channel coil array designs. Journal of Magnetic Resonance Imaging: Jmri 33(3): 661-667

Saldarriaga Fernández, I.C.; Mei, H.C.v.d.; Metzger, S.; Grainger, D.W.; Engelsman, A.F.; Nejadnik, M.R.; Busscher, H.J. 2010: In vitro and in vivo comparisons of staphylococcal biofilm formation on a cross-linked poly(ethylene glycol)-based polymer coating. Acta Biomaterialia 6(3): 1119-1124

Wang, L.-C.; Wang, S.-E.; Wang, J.-J.; Tsai, T.-Y.; Lin, C.-H.; Pan, T.-M.; Lee, C.-L. 2012: In vitro and in vivo comparisons of the effects of the fruiting body and mycelium of Antrodia camphorata against amyloid β-protein-induced neurotoxicity and memory impairment. Applied Microbiology and Biotechnology 94(6): 1505-1519

Merkel, O.M.; Urbanics, R.; Bedocs, P.; Rozsnyay, Zán.; Rosivall, László.; Toth, Mós.; Kissel, T.; Szebeni, J. 2011: In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymers. Biomaterials 32(21): 4936-4942

Wong, C.C.; Meinl, W.; Glatt, H.-R.; Barron, D.; Stalmach, A.él.; Steiling, H.; Crozier, A.; Williamson, G. 2010: In vitro and in vivo conjugation of dietary hydroxycinnamic acids by UDP-glucuronosyltransferases and sulfotransferases in humans. Journal of Nutritional Biochemistry 21(11): 1060-1068

Deshmukh, P.K.; Gattani, S.G. 2013: In vitro and in vivo consideration of novel environmentally responsive ophthalmic drug delivery system. Pharmaceutical Development and Technology 18(4): 950-956

Kim, J.-I.; Cho, S.-M.; Cui, J.-H.; Cao, Q.-R.; Oh, E.; Lee, B.-J. 2013: In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex. International Journal of Pharmaceutics 455(1-2): 31-39

Park, K. 2013: In vitro and in vivo correlation of paclitaxel-loaded polymeric microparticles. Journal of Controlled Release: Official Journal of the Controlled Release Society 172(3): 1162

Chen, Y.; Yan, J.; Wang, Z.; Yu, S.; Wang, X.; Yuan, Z.; Zhang, X.; Zhao, C.; Zheng, Q. 2014: In vitro and in vivo corrosion measurements of Mg-6Zn alloys in the bile. Materials Science and Engineering. C Materials for Biological Applications 42: 116-123

Drynda, A.; Hassel, T.; Bach, F.W.; Peuster, M. 2015: In vitro and in vivo corrosion properties of new iron-manganese alloys designed for cardiovascular applications. Journal of Biomedical Materials Research. Part B Applied Biomaterials 103(3): 649-660

Chou, D.-T.; Hong, D.; Saha, P.; Ferrero, J.; Lee, B.; Tan, Z.; Dong, Z.; Kumta, P.N. 2013: In vitro and in vivo corrosion, cytocompatibility and mechanical properties of biodegradable Mg-Y-Ca-Zr alloys as implant materials. Acta Biomaterialia 9(10): 8518-8533

Digkas, E.N.; Chrisafi, S.; Passadaki, T.; Tsalkidis, A.; Hatzimichail, A.; Vargemezis, V.; Lialiaris, T.S. 2010: In vitro and in vivo cytogenetic effects of recombinant human erythropoietin on the frequency of sister chromatid exchanges alone or in combination with mitomycin C. ChemoTherapy 56(3): 239-247

Garzón, I.; Sánchez-Quevedo, M.C.; Moreu, G.; González-Jaranay, M.; González-Andrades, M.; Montalvo, A.; Campos, A.; Alaminos, M. 2009: In vitro and in vivo cytokeratin patterns of expression in bioengineered human periodontal mucosa. Journal of Periodontal Research 44(5): 588-597

Shi, H.; Lambert, J.M.R.; Hautefeuille, A.; Bykov, V.J.N.; Wiman, K.G.; Hainaut, P.; Caron de Fromentel, C. 2008: In vitro and in vivo cytotoxic effects of PRIMA-1 on hepatocellular carcinoma cells expressing mutant p53ser249. Carcinogenesis 29(7): 1428-1434

Fu, S.-Z.; Meng, X.-H.; Fan, J.; Yang, L.-L.; Lin, S.; Wen, Q.-L.; Wang, B.-Q.; Chen, L.-L.; Wu, J.-B.; Chen, Y. 2014: In vitro and in vivo degradation behavior of n-HA/PCL-Pluronic-PCL polyurethane composites. Journal of Biomedical Materials Research. Part a 102(2): 479-486

Ulum, M.F.; Arafat, A.; Noviana, D.; Yusop, A.H.; Nasution, A.K.; Abdul Kadir, M.R.; Hermawan, H. 2014: In vitro and in vivo degradation evaluation of novel iron-bioceramic composites for bone implant applications. Materials Science and Engineering. C Materials for Biological Applications 36: 336-344

Pontoppidan, K.; Glitsoe, V.; Guggenbuhl, P.; Quintana, A.Piñón.; Nunes, C.Simões.; Pettersson, D.; Sandberg, A-Sofie. 2012: In vitro and in vivo degradation of myo-inositol hexakisphosphate by a phytase from Citrobacter braakii. Archives of Animal Nutrition 66(6): 431-444

Bettinger, C.J.; Bruggeman, J.P.; Borenstein, J.T.; Langer, R. 2009: In vitro and in vivo degradation of poly(1,3-diamino-2-hydroxypropane-co-polyol sebacate) elastomers. Journal of Biomedical Materials Research. Part a 91(4): 1077-1088

Ma, X.; Oyamada, S.; Wu, T.; Robich, M.P.; Wu, H.; Wang, X.; Buchholz, B.; McCarthy, S.; Bianchi, C.F.; Sellke, F.W.; Laham, R. 2011: In vitro and in vivo degradation of poly(D, L-lactide-co-glycolide)/amorphous calcium phosphate copolymer coated on metal stents. Journal of Biomedical Materials Research. Part a 96(4): 632-638

Pamula, E.; Menaszek, E. 2008: In vitro and in vivo degradation of poly(L: -lactide-co-glycolide) films and scaffolds. Journal of Materials Science. Materials in Medicine 19(5): 2063-2070

Dånmark, S.; Finne-Wistrand, A.; Schander, K.; Hakkarainen, M.; Arvidson, K.; Mustafa, K.; Albertsson, A.-C. 2011: In vitro and in vivo degradation profile of aliphatic polyesters subjected to electron beam sterilization. Acta Biomaterialia 7(5): 2035-2046

Tao, P.; Mahalingam, M.; Marasa, B.S.; Zhang, Z.; Chopra, A.K.; Rao, V.B. 2013: In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine. Proceedings of the National Academy of Sciences of the United States of America 110(15): 5846-5851

Lee, B.Hoon.; Beart, H.H.; Cheng, V.; McLemore, R.; Robb, S.A.; Cui, Z.; Dovigi, A.; Vernon, B.L. 2013: In vitro and in vivo demonstration of physically and chemically in situ gelling NIPAAm-based copolymer system. Journal of Biomaterials Science. Polymer Edition 24(13): 1575-1588

Dragavon, J.; Rekiki, A.; Theodorou, I.; Samson, C.; Blazquez, S.; Rogers, K.L.; Tournebize, Régis.; Shorte, S. 2014: In vitro and in vivo demonstrations of Fluorescence by Unbound Excitation from Luminescence (FUEL). Methods in Molecular Biology 1098: 259-270

Khatir, H.; Anouassi, A.; Tibary, A. 2009: In vitro and in vivo developmental competence of dromedary (Camelus dromedarius) oocytes following in vitro fertilization or parthenogenetic activation. Animal Reproduction Science 113(1-4): 212-219

Aoki, H.; Hara, A.; Niwa, M.; Yamada, Y.; Kunisada, T. 2009: In vitro and in vivo differentiation of human embryonic stem cells into retina-like organs and comparison with that from mouse pluripotent epiblast stem cells. Developmental Dynamics: An Official Publication of the American Association of Anatomists 238(9): 2266-2279

Kruglyakov, P.V.; Sokolova, I.B.; Zin'kova, N.N.; Viide, S.K.; Aleksandrov, G.V.; Petrov, N.S.; Polyntsev, D.G. 2006: In vitro and in vivo differentiation of mesenchymal stem cells in the cardiomyocyte direction. Bulletin of Experimental Biology and Medicine 142(4): 503-506

Morita, T.; Ito, Y.; Brown, I.L.; Ando, R.; Kiriyama, S. 2007: In vitro and in vivo digestibility of native maize starch granules varying in amylose contents. Journal - Association of Official Analytical Chemists 90(6): 1628-1634

Ai, Y.; Nelson, B.; Birt, D.F.; Jane, J.-L. 2013: In vitro and in vivo digestion of octenyl succinic starch. Carbohydrate Polymers 98(2): 1266-1271

Tu, Y.; Wan, L.; Zhao, D.; Bu, L.; Dong, D.; Yin, Z.; Cheng, Z.; Shen, B. 2014: In vitro and in vivo direct monitoring of miRNA-22 expression in isoproterenol-induced cardiac hypertrophy by bioluminescence imaging. European Journal of Nuclear Medicine and Molecular Imaging 41(5): 972-984

Gil-Guerrero, L.ía.; Dotor, J.; Huibregtse, I.L.; Casares, N.; López-Vázquez, A.B.én.; Rudilla, F.; Riezu-Boj, J.é I.; López-Sagaseta, J.; Hermida, J.é; Van Deventer, S.; Bezunartea, J.; Llopiz, D.; Sarobe, P.; Prieto, J.ús.; Borrás-Cuesta, F.; Lasarte, J.J.é 2008: In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1. Journal of Immunology 181(1): 126-135

Chai, L.-P.; Wang, Z.-F.; Liang, W.-Y.; Chen, L.; Chen, D.; Wang, A.-X.; Zhang, Z.-Q. 2013: In vitro and in vivo effect of 5-FC combined gene therapy with TNF-α and CD suicide gene on human laryngeal carcinoma cell line Hep-2. Plos one 8(4): E61136

Martínez Conesa, C.; Alvarez Sánchez, N.; Vicente Ortega, V.; García Reverte, J.; Pascual Carpe, F.; Campos Aranda, M. 2009: In vitro and in vivo effect of IFNalpha on B16F10 melanoma in two models: subcutaneous (C57BL6J mice) and lung metastasis (Swiss mice). Biomedicine and PharmacoTherapy 63(4): 305-312

Ni, H.; De Waele, K.; Walia, P.; Chanoine, J-Pierre. 2010: In vitro and in vivo effect of acylated and unacylated ghrelin on neonatal glucose homeostasis. Pediatric Research 67(6): 609-613

Kim, D.K.; Jankowski, R.J.; Pruchnic, R.; de Miguel, F.; Yoshimura, N.; Honda, M.; Furuta, A.; Chancellor, M.B. 2009: In vitro and in vivo effect of lidocaine on rat muscle-derived cells for treatment of stress urinary incontinence. Urology 73(2): 437-441

Jiang, H.; Han, S.; Guo, C.; Liu, T.; Wu, X. 2014: In vitro and in vivo effectiveness evaluation of balofloxacin in experimental Staphylococcus aureus keratitis. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 30(6): 482-488

Inacio, J.D.F.; Canto-Cavalheiro, M.M.; Almeida-Amaral, E.E. 2013: In vitro and in vivo effects of (-)-epigallocatechin 3-O-gallate on Leishmania amazonensis. Journal of Natural Products 76(10): 1993-1996

Olbert, P.J.; Schrader, A.J.; Simon, C.; Dalpke, A.; Barth, P.; Hofmann, R.; Hegele, A. 2009: In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall. Anticancer Research 29(6): 2067-2076

Hoshikawa, H.; Mori, T.; Mori, N. 2010: In vitro and in vivo effects of D-allose: up-regulation of thioredoxin-interacting protein in head and neck cancer cells. Annals of Otology Rhinology and Laryngology 119(8): 567-571

Chiodo, P.G.; Sparo, M.ón.D.; Pezzani, B.C.; Minvielle, M.C.; Basualdo, J.A. 2010: In vitro and in vivo effects of Enterococcus faecalis CECT7121 on Toxocara canis. Memorias do Instituto Oswaldo Cruz 105(5): 615-620

Yin, J.; Li, G.; Li, J.; Yang, Q.; Ren, X. 2011: In vitro and in vivo effects of Houttuynia cordata on infectious bronchitis virus. Avian Pathology: Journal of the W.V.P.A 40(5): 491-498

Kim, R.J.; Vaghani, S.; Zifchak, L.M.; Quinn, J.H.; He, W.; Tebas, P.; Frank, I. 2013: In vitro and in vivo effects of IGF-I on adiposity in HIV-associated metabolic disease: a pilot study. Archives of Medical Research 44(5): 361-369

Kaurinovic, B.; Popovic, M.; Vlaisavljevic, S. 2010: In vitro and in vivo effects of Laurus nobilis L. leaf extracts. Molecules 15(5): 3378-3390

Richards, S.L.; Anderson, S.L.; Yost, S.A. 2010: In vitro and in vivo effects of West Nile virus propagated in cells of different passage. Journal of the American Mosquito Control Association 26(4): 436-440

Shin, K.; Horigome, A.; Wakabayashi, H.; Yamauchi, K.; Yaeshima, T.; Iwatsuki, K. 2008: In vitro and in vivo effects of a composition containing lactoperoxidase on oral bacteria and breath odor. Journal of Breath Research 2(1): 017014

Zhong, B.; Cai, X.; Yi, X.; Zhou, A.; Chen, S.; Su, B. 2011: In vitro and in vivo effects of a cyclooxygenase-2 inhibitor nimesulide analog JCC76 in aromatase inhibitors-insensitive breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 126(1-2): 10-18

Kubo, S.; Kakuta, M.; Yamashita, M. 2010: In vitro and in vivo effects of a long-acting anti-influenza agent CS-8958 (laninamivir octanoate, Inavir) against pandemic (H1N1) 2009 influenza viruses. Japanese Journal of Antibiotics 63(5): 337-346

Roomi, M.W.; Kalinovsky, T.; Roomi, N.M.; Cha, J.; Rath, M.; Niedzwiecki, A. 2014: In vitro and in vivo effects of a nutrient mixture on breast cancer progression. International Journal of Oncology 44(6): 1933-1944

Williams, G.A.; Wang, Y.; Callon, K.E.; Watson, M.; Lin, J.-m.; Lam, J.B.B.; Costa, J.L.; Orpe, A.; Broom, N.; Naot, D.; Reid, I.R.; Cornish, J. 2009: In vitro and in vivo effects of adiponectin on bone. Endocrinology 150(8): 3603-3610

Kallala, R.; Graham, S.M.; Nikkhah, D.; Kyrkos, M.; Heliotis, M.; Mantalaris, A.; Tsiridis, E. 2012: In vitro and in vivo effects of antibiotics on bone cell metabolism and fracture healing. Expert Opinion on Drug Safety 11(1): 15-32

Pastene, E.; Speisky, H.án.; García, A.; Moreno, J.; Troncoso, M.; Figueroa, G. 2010: In vitro and in vivo effects of apple peel polyphenols against Helicobacter pylori. Journal of Agricultural and Food Chemistry 58(12): 7172-7179

De Gregorio, P.R.; Tomás, M.ía.S.J.ár.; Terraf, M.ía.C.L.; Nader-Macías, M.ía.E.F.át. 2014: In vitro and in vivo effects of beneficial vaginal lactobacilli on pathogens responsible for urogenital tract infections. Journal of Medical Microbiology 63(Part 5): 685-696

Ukai, M.; Yuyama, H.; Fujimori, A.; Koakutsu, A.; Sanagi, M.; Ohtake, A.; Sato, S.; Sudoh, K.; Sasamata, M.; Miyata, K. 2008: In vitro and in vivo effects of endothelin-1 and YM598, a selective endothelin ET a receptor antagonist, on the lower urinary tract. European Journal of Pharmacology 580(3): 394-400

Winter, E.; Pizzol, C.D.; Locatelli, C.; Silva, A.H.; Conte, A.; Chiaradia-Delatorre, L.D.; Nunes, R.J.; Yunes, R.A.; Creckzynski-Pasa, T.ân.B. 2014: In vitro and in vivo effects of free and chalcones-loaded nanoemulsions: insights and challenges in targeted cancer chemotherapies. International Journal of Environmental Research and Public Health 11(10): 10016-10035

Allam, G.; Abuelsaad, A.S.A. 2014: In vitro and in vivo effects of hesperidin treatment on adult worms of Schistosoma mansoni. Journal of Helminthology 88(3): 362-370

Czepluch, F.S.; Bernhardt, M.; Kuschicke, H.; Gogiraju, R.; Schroeter, M.R.; Riggert, J.; Hasenfuss, G.; Schäfer, K. 2014: In vitro and in vivo effects of human monocytes and their subsets on new vessel formation. Microcirculation 21(2): 148-158

Zarubaev, V.V.; Beliaevskaia, S.V.; Sirotkin, A.K.; Anfimov, P.M.; Nebol'sin, V.E.; Kiselev, O.I.; Reĭkhart, D.V. 2011: In vitro and in vivo effects of ingavirin on the ultrastructure and infectivity of influenza virus. Voprosy Virusologii 56(5): 21-25

Zeng, J.; Xia, S.; Zhong, W.; Li, J.; Lin, L. 2011: In vitro and in vivo effects of ketamine on generation and function of dendritic cells. Journal of Pharmacological Sciences 117(3): 170-179

Zulian, A.; Cancello, R.; Girola, A.; Gilardini, L.; Alberti, L.; Croci, M.; Micheletto, G.; Danelli, P.; Invitti, C. 2011: In vitro and in vivo effects of metformin on human adipose tissue adiponectin. Obesity Facts 4(1): 27-33

Matthews, H.J.; Audsley, N.; Weaver, R.J. 2008: In vitro and in vivo effects of myo-active peptides on larvae of the tomato moth Lacanobia oleracea and the cotton leaf worm Spodoptera littoralis (Lepidoptera; Noctuidae). Archives of Insect Biochemistry and Physiology 69(2): 60-69

Cepeda-Palacios, R.; Servín, R.; Ramírez-Orduña, J.M.; Ascencio, F.; Dorchies, P.; Angulo-Valadez, C.E. 2014: In vitro and in vivo effects of neem tree (Azadirachta indica A. Juss) products on larvae of the sheep nose bot fly (Oestrus ovis L. Díptera: Oestridae). Veterinary Parasitology 200(1-2): 225-228

Sakao, K.; Hahm, E-Ryeong.; Singh, S.V. 2013: In vitro and in vivo effects of phenethyl isothiocyanate treatment on vimentin protein expression in cancer cells. Nutrition and Cancer 65 Suppl. 1: 61-67

Akens, M.K.; Wise-Milestone, L.; Won, E.; Schwock, J.; Yee, A.J.M.; Wilson, B.C.; Whyne, C.M. 2014: In vitro and in vivo effects of photodynamic therapy on metastatic breast cancer cells pre-treated with zoledronic acid. Photodiagnosis and Photodynamic Therapy 11(3): 426-433

Cleveland, B.M. 2014: In vitro and in vivo effects of phytoestrogens on protein turnover in rainbow trout (Oncorhynchus mykiss) white muscle. Comparative Biochemistry and Physiology. Toxicology and Pharmacology: Cbp 165: 9-16

Gjetting, T.; Arildsen, N.S.; Christensen, C.L.; Poulsen, T.T.; Roth, J.A.; Handlos, V.N.; Poulsen, H.S. 2010: In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection. International Journal of Nanomedicine 5: 371-383

Diedrich, B.; Sandgren, P.; Jansson, B.; Gulliksson, H.; Svensson, L.; Shanwell, A. 2008: In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution. Vox Sanguinis 94(2): 96-102

Sun, H.; Qu, Z.; Guo, Y.; Zang, G.; Yang, B. 2007: In vitro and in vivo effects of rat kidney vascular endothelial cells on osteogenesis of rat bone marrow mesenchymal stem cells growing on polylactide-glycoli acid (PLGA) scaffolds. Biomedical Engineering Online 6: 41

Figova, K.; Sobotkova, E.; Duskova, M.; Ludvikova, V.; Vonka, V.; Eckschlager, T. 2010: In vitro and in vivo effects of reovirus on HPV16-transformed mice cells. Neoplasma 57(3): 207-214

Yuan, Y.; Xiao, Y.; Li, Q.; Liu, Z.; Zhang, X.; Qin, C.; Xie, J.; Wang, X.; Xu, T. 2013: In vitro and in vivo effects of short hairpin RNA targeting integrin-linked kinase in prostate cancer cells. Molecular Medicine Reports 8(2): 419-424

Şentürk, M.; Alici, H.A.; Beydemir, Şük.ü; Küfrevioglu, Öm.İr. 2012: In vitro and in vivo effects of some benzodiazepine drugs on human and rabbit erythrocyte carbonic anhydrase enzymes. Journal of Enzyme Inhibition and Medicinal Chemistry 27(5): 680-684

Ali, R.B.; Atangwho, I.J.; Kuar, N.; Ahmad, M.; Mahmud, R.; Asmawi, M.Z. 2013: In vitro and in vivo effects of standardized extract and fractions of Phaleria macrocarpa fruits pericarp on lead carbohydrate digesting enzymes. Bmc Complementary and Alternative Medicine 13: 39

Tsantila, N.; Tsoupras, A.B.; Fragopoulou, E.; Antonopoulou, S.; Iatrou, C.; Demopoulos, C.A. 2011: In vitro and in vivo effects of statins on platelet-activating factor and its metabolism. Angiology 62(3): 209-218

Cirioni, O.; Silvestri, C.; Ghiselli, R.; Kamysz, W.; Minardi, D.; Castelli, P.; Orlando, F.; Kamysz, E.; Provinciali, M.; Muzzonigro, G.; Guerrieri, M.; Giacometti, A. 2013: In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. Le Infezioni in Medicina 21(4): 287-295

Tan, S.; Li, H.; Jin, Y.; Yu, H. 2014: In vitro and in vivo effects of sublethal cadmium on the expression of MT2 and ABCC2 genes in grass carp (Ctenopharyngodon idellus). Ecotoxicology and Environmental Safety 108: 258-264

Sasi, W.; Ye, L.; Jiang, W.G.; Sharma, A.K.; Mokbel, K. 2014: In vitro and in vivo effects of suppressor of cytokine signalling 7 knockdown in breast cancer: the influence on cellular response to hepatocyte growth factor. Biomed Research International 2014: 648040

Nicolao, M.ía.C.; Elissondo, M.ía.C.; Denegri, G.M.; Goya, A.B.; Cumino, A.C. 2014: In vitro and in vivo effects of tamoxifen against larval stage Echinococcus granulosus. Antimicrobial Agents and ChemoTherapy 58(9): 5146-5154

Bai, C.L.; Osaki, T.; Yonezawa, H.; Hanawa, T.; Zaman, C.; Kurata, S.; Kamiya, S.; Tanaka, H. 2010: In vitro and in vivo effects of the Mongolian drug Amu-ru 7 on Helicobacter pylori growth and viability. Microbiology and Immunology 54(9): 508-515

Vadori, M.; Seveso, M.; Besenzon, F.; Bosio, E.; Tognato, E.; Fante, F.; Boldrin, M.; Gavasso, S.; Ravarotto, L.; Mann, B.E.; Simioni, P.; Ancona, E.; Motterlini, R.; Cozzi, E. 2009: In vitro and in vivo effects of the carbon monoxide-releasing molecule, CORM-3, in the xenogeneic pig-to-primate context. Xenotransplantation 16(2): 99-114

Hacker, A.; Marton, L.J.; Sobolewski, M.; Casero, R.A. 2008: In vitro and in vivo effects of the conformationally restricted polyamine analogue CGC-11047 on small cell and non-small cell lung cancer cells. Cancer ChemoTherapy and Pharmacology 63(1): 45-53

Azizi, J.; Ismail, S.; Mordi, M.N.; Ramanathan, S.; Said, M.I.M.; Mansor, S.M. 2010: In vitro and in vivo effects of three different Mitragyna speciosa korth leaf extracts on phase Ii drug metabolizing enzymes--glutathione transferases (GSTs). Molecules 15(1): 432-441

Manohar, V.; Echard, B.; Perricone, N.; Ingram, C.; Enig, M.; Bagchi, D.; Preuss, H.G. 2013: In vitro and in vivo effects of two coconut oils in comparison to monolaurin on Staphylococcus aureus: rodent studies. Journal of Medicinal Food 16(6): 499-503

Lau, D.H.W.; Mumtaz, F.H.; Mikhailidis, D.P.; Thompson, C.S. 2009: In vitro and in vivo effects of vardenafil (a PDE-5 Inhibitor) on corpus cavernosal smooth muscle relaxation in diabetic rabbits. Urologia Internationalis 82(1): 101-107

Peng, L.; Khan, N.; Afaq, F.; Ye, C.; Mukhtar, H. 2010: In vitro and in vivo effects of water extract of white cocoa tea (Camellia ptilophylla) against human prostate cancer. Pharmaceutical Research 27(6): 1128-1137

Noomhorm, N.; Chang, C.-J.; Wen, C.-S.; Wang, J.-Y.; Chen, J.-L.; Tseng, L.-M.; Chen, W.-S.; Chiu, J.-H.; Shyr, Y.-M. 2014: In vitro and in vivo effects of xanthorrhizol on human breast cancer MCF-7 cells treated with tamoxifen. Journal of Pharmacological Sciences 125(4): 375-385

Kanaykina, N.; Abelson, K.; King, D.; Liakhovitskaia, A.; Schreiner, S.; Wegner, M.; Kozlova, E.N. 2010: In vitro and in vivo effects on neural crest stem cell differentiation by conditional activation of Runx1 short isoform and its effect on neuropathic pain behavior. Upsala Journal of Medical Sciences 115(1): 56-64

Dutta, N.K.; Mazumdar, K.; DasGupta, A.; Dastidar, S.G. 2009: In vitro and in vivo efficacies of amlodipine against Listeria monocytogenes. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 28(7): 849-853

Sajid, M.S.; Iqbal, Z.; Khan, M.N.; Muhammad, G. 2009: In vitro and in vivo efficacies of ivermectin and cypermethrin against the cattle tick Hyalomma anatolicum anatolicum (Acari: Ixodidae). Parasitology Research 105(4): 1133-1138

Küster, T.; Stadelmann, B.; Hermann, C.; Scholl, S.; Keiser, J.; Hemphill, A. 2011: In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis. Antimicrobial Agents and ChemoTherapy 55(2): 713-721

Pellizzari Tregno, F.; Sau, A.; Pezzola, S.; Geroni, C.; Lapenta, C.; Spada, M.; Filomeni, G.; Bonanno, E.; Federici, G.; Caccuri, A.M. 2009: In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma. European Journal of Cancer 45(14): 2606-2617

Shishkina, L.N.; Nebol'sin, V.E.; Kabanov, A.S.; Skarnovich, M.O.; Mazurkova, N.A.; Sergeev, A.A.; Serova, O.A.; Stavskiĭ, E.A.; Drozdov, I.G. 2011: In vitro and in vivo efficacy of Ingavirin against strains of pandemic influenza virus A(H1N1/09)v. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 93-96

Tritten, L.; Silbereisen, A.; Keiser, J. 2011: In vitro and in vivo efficacy of Monepantel (AAD 1566) against laboratory models of human intestinal nematode infections. Plos Neglected Tropical Diseases 5(12): E1457

Neeff, D.V.; Ledoux, D.R.; Rottinghaus, G.E.; Bermudez, A.J.; Dakovic, A.; Murarolli, R.A.; Oliveira, C.A.F. 2013: In vitro and in vivo efficacy of a hydrated sodium calcium aluminosilicate to bind and reduce aflatoxin residues in tissues of broiler chicks fed aflatoxin B1. Poultry Science 92(1): 131-137

Malki, A.; El Ashry, E.S. 2014: In vitro and in vivo efficacy of a novel quinuclidinone derivative against breast cancer. Anticancer Research 34(3): 1367-1376

Jaiswal, M.; Naz, F.; Dinda, A.K.; Koul, V. 2013: In vitro and in vivo efficacy of doxorubicin loaded biodegradable semi-interpenetrating hydrogel implants of poly (acrylic acid)/gelatin for post surgical tumor treatment. Biomedical Materials 8(4): 045004

Park, K.H.; Zeon, S.-R.; Lee, J.-G.; Choi, S.-H.; Shin, Y.K.; Park, K.-I. 2014: In vitro and in vivo efficacy of drugs against the protozoan parasite Azumiobodo hoyamushi that causes soft tunic syndrome in the edible ascidian Halocynthia roretzi (Drasche). Journal of Fish Diseases 37(4): 309-317

Varela-M, R.én.E.; Villa-Pulgarin, J.A.; Yepes, E.; Müller, I.; Modolell, M.; Muñoz, D.L.; Robledo, S.M.; Muskus, C.E.; López-Abán, J.; Muro, A.; Vélez, I.án.D.; Mollinedo, F. 2012: In vitro and in vivo efficacy of ether lipid edelfosine against Leishmania spp. and SbV-resistant parasites. Plos Neglected Tropical Diseases 6(4): E1612

Kanojiya, D.; Shanker, D.; Sudan, V.; Jaiswal, A.K.; Parashar, R. 2015: In vitro and in vivo efficacy of extracts of leaves of Eucalyptus globulus on ovine gastrointestinal nematodes. Parasitology Research 114(1): 141-148

Soto, E.; Endris, R.G.; Hawke, J.P. 2010: In vitro and in vivo efficacy of florfenicol for treatment of Francisella asiatica infection in tilapia. Antimicrobial Agents and ChemoTherapy 54(11): 4664-4670

Kumaki, Y.; Day, C.W.; Smee, D.F.; Morrey, J.D.; Barnard, D.L. 2011: In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections. Antiviral Research 92(2): 329-340

Schelkle, B.; Snellgrove, D.; Cable, J. 2013: In vitro and in vivo efficacy of garlic compounds against Gyrodactylus turnbulli infecting the guppy (Poecilia reticulata). Veterinary Parasitology 198(1-2): 96-101

Wong, I.L.K.; Chan, K.-F.; Chen, Y.-F.; Lun, Z.-R.; Chan, T.H.; Chow, L.M.C. 2014: In vitro and in vivo efficacy of novel flavonoid dimers against cutaneous leishmaniasis. Antimicrobial Agents and ChemoTherapy 58(6): 3379-3388

Vogelgesang, B.; Bonnet, I.; Godard, N.; Sohm, B.; Perrier, E. 2011: In vitro and in vivo efficacy of sulfo-carrabiose, a sugar-based cosmetic ingredient with anti-cellulite properties. International Journal of Cosmetic Science 33(2): 120-125

Tritten, L.; Nwosu, U.; Vargas, M.; Keiser, J. 2012: In vitro and in vivo efficacy of tribendimidine and its metabolites alone and in combination against the hookworms Heligmosomoides bakeri and Ancylostoma ceylanicum. Acta Tropica 122(1): 101-107

Solapure, S.; Dinesh, N.; Shandil, R.; Ramachandran, V.; Sharma, S.; Bhattacharjee, D.; Ganguly, S.; Reddy, J.; Ahuja, V.; Panduga, V.; Parab, M.; Vishwas, K.G.; Kumar, N.; Balganesh, M.; Balasubramanian, V. 2013: In vitro and in vivo efficacy of β-lactams against replicating and slowly growing/nonreplicating Mycobacterium tuberculosis. Antimicrobial Agents and ChemoTherapy 57(6): 2506-2510

Musa, S.; Welkenhuysen, M.; Prodanov, D.; Eberle, W.; Bartic, C.; Nuttin, B.; Borghs, G. 2009: In vitro and in vivo electrochemical characterization of a microfabricated neural probe. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2009: 7143-7146

Courtois, E.T.; Castillo, C.G.; Seiz, E.G.; Ramos, M.; Bueno, C.; Liste, I.; Martínez-Serrano, A. 2010: In vitro and in vivo enhanced generation of human A9 dopamine neurons from neural stem cells by Bcl-XL. Journal of Biological Chemistry 285(13): 9881-9897

Valan Arasu, M.; Ilavenil, S.; Kim, D.Hye.; Gun Roh, S.; Lee, J-Chae.; Choi, K.Choon. 2014: In vitro and in vivo enhancement of adipogenesis by Italian ryegrass (Lolium multiflorum) in 3T3-L1 cells and mice. Plos one 9(1): E85297

Shelton, J.W.; Waxweiler, T.V.; Landry, J.; Gao, H.; Xu, Y.; Wang, L.; El-Rayes, B.; Shu, H-Kuo.G. 2013: In vitro and in vivo enhancement of chemoradiation using the oral PARP inhibitor ABT-888 in colorectal cancer cells. International Journal of Radiation Oncology Biology Physics 86(3): 469-476

Litonius, E.; Lokajova, J.; Yohannes, G.; Neuvonen, P.J.; Holopainen, J.M.; Rosenberg, P.H.; Wiedmer, S.K. 2012: In vitro and in vivo entrapment of bupivacaine by lipid dispersions. Journal of Chromatography. a 1254: 125-131

Ito, H.; Chiba, Y.; Kameyama, A.; Sato, T.; Narimatsu, H. 2010: In vitro and in vivo enzymatic syntheses and mass spectrometric database for N-glycans and o-glycans. Methods in Enzymology 478: 127-149

Kim, H.S.; Yoo, H.S. 2013: In vitro and in vivo epidermal growth factor gene therapy for diabetic ulcers with electrospun fibrous meshes. Acta Biomaterialia 9(7): 7371-7380

Tsujikawa, T.; Zoghbi, S.S.; Hong, J.; Donohue, S.R.; Jenko, K.J.; Gladding, R.L.; Halldin, C.; Pike, V.W.; Innis, R.B.; Fujita, M. 2014: In vitro and in vivo evaluation of (11)C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB1 receptors. Neuroimage 84: 733-741

Mishra, G.; Hazari, P.P.; Kumar, N.; Mishra, A.K. 2011: In vitro and in vivo evaluation of (99m)Tc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors. Journal of Drug Targeting 19(9): 761-769

Bandyopadhyay, B.; Shah, V.; Soram, M.; Viswanathan, C.; Ghosh, D. 2013: In vitro and in vivo evaluation of (L)-lactide/ε-caprolactone copolymer scaffold to support myoblast growth and differentiation. Biotechnology Progress 29(1): 197-205

Wenzler, T.; Yang, S.; Patrick, D.A.; Braissant, O.; Ismail, M.A.; Tidwell, R.R.; Boykin, D.W.; Wang, M.Z.; Brun, R. 2014: In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness. Antimicrobial Agents and ChemoTherapy 58(8): 4452-4463

Wang, T.; Ioannidis, S.; Almeida, L.; Block, M.H.; Davies, A.M.; Lamb, M.L.; Scott, D.A.; Su, M.; Zhang, H.-J.; Alimzhanov, M.; Bebernitz, G.; Bell, K.; Zinda, M. 2011: In vitro and in vivo evaluation of 6-aminopyrazolyl-pyridine-3-carbonitriles as JAK2 kinase inhibitors. Bioorganic and Medicinal Chemistry Letters 21(10): 2958-2961

Parry, J.J.; Kelly, T.S.; Andrews, R.; Rogers, B.E. 2007: In vitro and in vivo evaluation of 64Cu-labeled DOTA-linker-bombesin(7-14) analogues containing different amino acid linker moieties. Bioconjugate Chemistry 18(4): 1110-1117

Lears, K.A.; Ferdani, R.; Liang, K.; Zheleznyak, A.; Andrews, R.; Sherman, C.D.; Achilefu, S.; Anderson, C.J.; Rogers, B.E. 2011: In vitro and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 52(3): 470-477

Ma, L.; Yu, P.; Veerendra, B.; Rold, T.L.; Retzloff, L.; Prasanphanich, A.; Sieckman, G.; Hoffman, T.J.; Volkert, W.A.; Smith, C.J. 2007: In vitro and in vivo evaluation of Alexa Fluor 680-bombesin[7-14]NH2 peptide conjugate, a high-affinity fluorescent probe with high selectivity for the gastrin-releasing peptide receptor. Molecular Imaging 6(3): 171-180

Ahmad, M.Z.; Akhter, S.; Ahmad, I.; Singh, A.; Anwar, M.; Shamim, M.; Ahmad, F.J. 2012: In vitro and in vivo evaluation of Assam Bora rice starch-based bioadhesive microsphere as a drug carrier for colon targeting. Expert Opinion on Drug Delivery 9(2): 141-149

Thiara, A.S.; Eggereide, V.; Pedersen, T.; Lindberg, H.; Fiane, A.E. 2010: In vitro and in vivo evaluation of Dideco's paediatric cardiopulmonary circuit for neonates weighing less than five kilograms. Perfusion 25(4): 229-235

Song, C.K.; Lee, J.-H.; Jahn, A.; Choi, M.J.; Namgoong, S.K.; Hong, S.-S.; Chong, S.; Shim, C.-K.; Chung, S.-J.; Kim, D.-D. 2012: In vitro and in vivo evaluation of N,N,N-trimethylphytosphingosine-iodide (TMP) in liposomes for the treatment of angiogenesis and metastasis. International Journal of Pharmaceutics 434(1-2): 191-198

Leopoldo, M.; Selivanova, S.V.; Müller, A.; Lacivita, E.; Schetz, J.A.; Ametamey, S.M. 2014: In vitro and in vivo evaluation of N-{2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl}-3-[(11) C]methoxybenz-amide, a positron emission tomography (PET) radioligand for dopamine D4 receptors, in rodents. Chemistry and Biodiversity 11(9): 1298-1308

Venkatraman, S.; Hendricks, J.; King, Z.A.; Sereno, A.J.; Richardson-Burns, S.; Martin, D.; Carmena, J.M. 2011: In vitro and in vivo evaluation of PEDOT microelectrodes for neural stimulation and recording. IEEE Transactions on Neural Systems and Rehabilitation Engineering: a Publication of the IEEE Engineering in Medicine and Biology Society 19(3): 307-316

Douillard, S.; Olivier, D.; Patrice, T. 2009: In vitro and in vivo evaluation of Radachlorin(R) sensitizer for photodynamic therapy. Photochemical and Photobiological Sciences: Official Journal of the European Photochemistry Association and the European Society for Photobiology 8(3): 405-413

Zhang, E.W.; Wang, Y.B.; Shuai, K.G.; Gao, F.; Bai, Y.J.; Cheng, Y.; Xiong, X.L.; Zheng, Y.F.; Wei, S.C. 2011: In vitro and in vivo evaluation of SLA titanium surfaces with further alkali or hydrogen peroxide and heat treatment. Biomedical Materials 6(2): 025001

Nemani, K.V.; Moodie, K.L.; Brennick, J.B.; Su, A.; Gimi, B. 2013: In vitro and in vivo evaluation of SU-8 biocompatibility. Materials Science and Engineering. C Materials for Biological Applications 33(7): 4453-4459

Makhlof, A.; Fujimoto, S.; Tozuka, Y.; Takeuchi, H. 2011: In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 77(2): 216-224

Wuest, M.; Kumar, P.; Wang, M.; Yang, J.; Jans, H.-S.; Wiebe, L.I. 2012: In vitro and in vivo evaluation of [(18)F]F-GAZ, a novel oxygen-mimetic azomycin-glucose conjugate, for imaging hypoxic tumor. Cancer BioTherapy and Radiopharmaceuticals 27(8): 473-480

Wanger-Baumann, C.A.; Mu, L.; Honer, M.; Belli, S.; Alf, M.F.; Schubiger, P.A.; Krämer, S.D.; Ametamey, S.M. 2011: In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5). Neuroimage 56(3): 984-991

Vangestel, C.; Peeters, M.; Oltenfreiter, R.; D'Asseler, Y.; Staelens, S.; Van Steenkiste, M.; Philippé, J.; Kusters, D.; Reutelingsperger, C.; Van Damme, N.; Van de Wiele, C. 2010: In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells. Nuclear Medicine and Biology 37(8): 965-975

Varasteh, Z.; Aberg, O.; Velikyan, I.; Lindeberg, G.; Sörensen, J.; Larhed, M.; Antoni, G.; Sandström, M.; Tolmachev, V.; Orlova, A. 2013: In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging. Plos one 8(12): E81932

Roy, J.; Fournier, M.-A.; Maltais, R.é; Kenmogne, L.C.; Poirier, D. 2014: In vitro and in vivo evaluation of a 3β-androsterone derivative as inhibitor of 17β-hydroxysteroid dehydrogenase type 3. Journal of Steroid Biochemistry and Molecular Biology 141: 44-51

Craft, J.M.; De Silva, R.A.; Lears, K.A.; Andrews, R.; Liang, K.; Achilefu, S.; Rogers, B.E. 2012: In vitro and in vivo evaluation of a 64Cu-labeled NOTA-Bn-SCN-Aoc-bombesin analogue in gastrin-releasing peptide receptor expressing prostate cancer. Nuclear Medicine and Biology 39(5): 609-616

Xie, F.; Li, Q.F.; Gu, B.; Liu, K.; Shen, G.X. 2008: In vitro and in vivo evaluation of a biodegradable chitosan-PLA composite peripheral nerve guide conduit material. Microsurgery 28(6): 471-479

Duret, C.; Wauthoz, N.; Merlos, R.; Goole, J.; Maris, C.; Roland, I.; Sebti, T.; Vanderbist, F.; Amighi, K. 2012: In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 81(3): 627-634

Hütten, M.; Dhanasingh, A.; Hessler, R.; Stöver, T.; Esser, K.-H.; Möller, M.; Lenarz, T.; Jolly, C.; Groll, J.ür.; Scheper, V. 2014: In vitro and in vivo evaluation of a hydrogel reservoir as a continuous drug delivery system for inner ear treatment. Plos one 9(8): E104564

Nair, A.B.; Vaka, S.R.K.; Gupta, S.; Repka, M.A.; Murthy, S.N. 2012: In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride. Pharmaceutical Development and Technology 17(2): 158-163

Kim, Y.-H.; Jyoti, M.A.; Youn, M.-H.; Youn, H.-S.; Seo, H.-S.; Lee, B.-T.; Song, H.-Y. 2010: In vitro and in vivo evaluation of a macro porous β-TCP granule-shaped bone substitute fabricated by the fibrous monolithic process. Biomedical Materials 5(3): 35007

Zhu, L.; Yang, J.; Zhang, J.; Lei, D.; Xiao, L.; Cheng, X.; Lin, Y.; Peng, B. 2014: In vitro and in vivo evaluation of a nanoparticulate bioceramic paste for dental pulp repair. Acta Biomaterialia 10(12): 5156-5168

Ambrisko, T.D.; Lammer, V.; Schramel, J.P.; Moens, Y.P.S. 2014: In vitro and in vivo evaluation of a new large animal spirometry device using mainstream CO2 flow sensors. Equine Veterinary Journal 46(4): 507-511

Pourdanesh, F.; Jebali, A.; Hekmatimoghaddam, S.; Allaveisie, A. 2014: In vitro and in vivo evaluation of a new nanocomposite, containing high density polyethylene, tricalcium phosphate, hydroxyapatite, and magnesium oxide nanoparticles. Materials Science and Engineering. C Materials for Biological Applications 40: 382-388

Stefano, J.E.; Hou, L.; Honey, D.; Kyazike, J.; Park, A.; Zhou, Q.; Pan, C.Q.; Edmunds, T. 2009: In vitro and in vivo evaluation of a non-carbohydrate targeting platform for lysosomal proteins. Journal of Controlled Release: Official Journal of the Controlled Release Society 135(2): 113-118

Alves, S.; Correia, J.ão.D.G.; Gano, L.; Rold, T.L.; Prasanphanich, A.; Haubner, R.; Rupprich, M.; Alberto, R.; Decristoforo, C.; Santos, I.; Smith, C.J. 2007: In vitro and in vivo evaluation of a novel 99mTc(CO)3-pyrazolyl conjugate of cyclo-(Arg-Gly-Asp-d-Tyr-Lys). Bioconjugate Chemistry 18(2): 530-537

Hayashi, K.; Iinuma, M.; Sasaki, K.; Hayashi, T. 2012: In vitro and in vivo evaluation of a novel antiherpetic flavonoid, 4'-phenylflavone, and its synergistic actions with acyclovir. Archives of Virology 157(8): 1489-1498

Han, M.; Fang, Q.-L.; Zhan, H.-W.; Luo, T.; Liang, W.-Q.; Gao, J.-Q. 2009: In vitro and in vivo evaluation of a novel capsule for colon-specific drug delivery. Journal of Pharmaceutical Sciences 98(8): 2626-2635

Li, W.; Lan, Y.; Guo, R.; Zhang, Y.; Xue, W.; Zhang, Y. 2015: In vitro and in vivo evaluation of a novel collagen/cellulose nanocrystals scaffold for achieving the sustained release of basic fibroblast growth factor. Journal of Biomaterials Applications 29(6): 882-893

Sun, C.; Liu, H.; Zhao, X.; He, H.; Pan, W. 2013: In vitro and in vivo evaluation of a novel diltiazem hydrochloride polydispersity sustained-release system. Drug Development and Industrial Pharmacy 39(1): 62-66

Timchalk, C.; Creim, J.A.; Sukwarotwat, V.; Wiacek, R.; Addleman, R.S.; Fryxell, G.E.; Yantasee, W. 2010: In vitro and in vivo evaluation of a novel ferrocyanide functionalized nanopourous silica decorporation agent for cesium in rats. Health Physics 99(3): 420-429

Laschke, M.W.; Strohe, A.; Menger, M.D.; Alini, M.; Eglin, D. 2010: In vitro and in vivo evaluation of a novel nanosize hydroxyapatite particles/poly(ester-urethane) composite scaffold for bone tissue engineering. Acta Biomaterialia 6(6): 2020-2027

Khan, Y.; El-Amin, S.F.; Laurencin, C. T. 2006: In vitro and in vivo evaluation of a novel polymer-ceramic composite scaffold for bone tissue engineering. Conference Proceedings: . Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2006: 529-530

Li, W.; Du, G.; Yang, X.; Zhang, Z.; Nie, S.; Peng, B.; Pan, W. 2008: In vitro and in vivo evaluation of a novel push-pull osmotic pump with orifices on both side surfaces. Drug Development and Industrial Pharmacy 34(12): 1350-1355

Hemenway, J.N.; Stella, V.J. 2010: In vitro and in vivo evaluation of a novel water-soluble N-glycyl prodrug (N-GLY-CBZ) of carbamazepine. Journal of Pharmaceutical Sciences 99(11): 4565-4575

Yu, L.; Li, K.; Liu, X.; Chen, C.; Bao, Y.; Ci, T.; Chen, Q.; Ding, J. 2013: In vitro and in vivo evaluation of a once-weekly formulation of an antidiabetic peptide drug exenatide in an injectable thermogel. Journal of Pharmaceutical Sciences 102(11): 4140-4149

Ryppa, C.; Mann-Steinberg, H.; Biniossek, M.L.; Satchi-Fainaro, R.; Kratz, F. 2009: In vitro and in vivo evaluation of a paclitaxel conjugate with the divalent peptide E-[c(RGDfK)2] that targets integrin alpha v beta 3. International Journal of Pharmaceutics 368(1-2): 89-97

Hensel, P.; Austel, M.; Wooley, R.E.; Keys, D.; Ritchie, B.W. 2009: In vitro and in vivo evaluation of a potentiated miconazole aural solution in chronic Malassezia otitis externa in dogs. Veterinary Dermatology 20(5-6): 429-434

Liang, H.; Baudouin, C.; Daull, P.; Garrigue, J.-S.éb.; Buggage, R.; Brignole-Baudouin, F.ço. 2012: In vitro and in vivo evaluation of a preservative-free cationic emulsion of latanoprost in corneal wound healing models. Cornea 31(11): 1319-1329

Davanço, M.G.; Campos, M.L.; Nogueira, M.A.; Campos, S.L.; Marques, R.V.; dos Santos, J.L.; Chin, C.M.; da Fonseca, L.M.; Peccinini, R.ân.G.ça. 2012: In vitro and in vivo evaluation of a primaquine prodrug without red blood cell membrane destabilization property. Biopharmaceutics and Drug Disposition 33(8): 437-445

Li, G.; Fan, Y.; Li, X.; Wang, X.; Li, Y.; Liu, Y.; Li, M. 2012: In vitro and in vivo evaluation of a simple microemulsion formulation for propofol. International Journal of Pharmaceutics 425(1-2): 53-61

Lim, S.C.B.; Paech, M.J.; Sunderland, B.; Liu, Y. 2013: In vitro and in vivo evaluation of a sublingual fentanyl wafer formulation. Drug Design Development and Therapy 7: 317-324

Huttunen, K.M.; Leppänen, J.; Vepsäläinen, J.; Sirviö, J.; Laine, K.; Rautio, J. 2012: In vitro and in vivo evaluation of a sulfenamide prodrug of basic metformin. Journal of Pharmaceutical Sciences 101(8): 2854-2860

Snyder, E.L.; Whitley, P.; Kingsbury, T.; Miripol, J.; Tormey, C.A. 2010: In vitro and in vivo evaluation of a whole blood platelet-sparing leukoreduction filtration system. Transfusion 50(10): 2145-2151

Conconi, M.T.; Bellini, S.; Teoli, D.; de Coppi, P.; Ribatti, D.; Nico, B.; Simonato, E.; Gamba, P.G.; Nussdorfer, G.G.; Morpurgo, M.; Parnigotto, P.P. 2009: In vitro and in vivo evaluation of acellular diaphragmatic matrices seeded with muscle precursors cells and coated with VEGF silica gels to repair muscle defect of the diaphragm. Journal of Biomedical Materials Research. Part a 89(2): 304-316

Zhang, Y.; Fan, W.; Nothdurft, L.; Wu, C.; Zhou, Y.; Crawford, R.; Xiao, Y. 2011: In vitro and in vivo evaluation of adenovirus combined silk fibroin scaffolds for bone morphogenetic protein-7 gene delivery. Tissue Engineering. Part C Methods 17(8): 789-797

Huang, Y.; Jin, X.; Zhang, X.; Sun, H.; Tu, J.; Tang, T.; Chang, J.; Dai, K. 2009: In vitro and in vivo evaluation of akermanite bioceramics for bone regeneration. Biomaterials 30(28): 5041-5048

Roualdes, O.; Duclos, M.-E.; Gutknecht, D.; Frappart, L.; Chevalier, J.ér.ôm.; Hartmann, D.J. 2010: In vitro and in vivo evaluation of an alumina-zirconia composite for arthroplasty applications. Biomaterials 31(8): 2043-2054

Yu, Z.-G.; Geng, Z.-X.; Liu, T.-F.; Jiang, F. 2015: In vitro and in vivo evaluation of an in situ forming gel system for sustained delivery of Florfenicol. Journal of Veterinary Pharmacology and Therapeutics 38(3): 271-277

Erfani Jabarian, L.; Rouini, M.R.; Atyabi, F.; Foroumadi, A.; Nassiri, S.M.; Dinarvand, R. 2013: In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 48(1-2): 87-96

Müller, C.; Reber, J.; Schlup, C.; Leamon, C.P.; Schibli, R. 2013: In vitro and in vivo evaluation of an innocuous drug cocktail to improve the quality of folic acid targeted nuclear imaging in preclinical research. Molecular Pharmaceutics 10(3): 967-974

You, P.; Xing, F.; Huo, J.; Wang, B.; Di, J.; Zeng, S.; Liu, J. 2013: In vitro and in vivo evaluation of anisomycin against Ehrlich ascites carcinoma. Oncology Reports 29(6): 2227-2236

Jayant, R.D.; McShane, M.J.; Srivastava, R. 2011: In vitro and in vivo evaluation of anti-inflammatory agents using nanoengineered alginate carriers: towards localized implant inflammation suppression. International Journal of Pharmaceutics 403(1-2): 268-275

Dassprakash, M.V.; Arun, R.; Abraham, S.K.; Premkumar, K. 2012: In vitro and in vivo evaluation of antioxidant and antigenotoxic potential of Punica granatum leaf extract. Pharmaceutical Biology 50(12): 1523-1530

Zhang, H.; Hou, L.; Jiao, X.; Yandan, J.; Zhu, X.; Hongji, L.; Chen, X.; Ren, J.; Xia, Y.; Zhang, Z. 2014: In vitro and in vivo evaluation of antitumor drug-loaded aptamer targeted single-walled carbon nanotubes system. Current Pharmaceutical Biotechnology 14(13): 1105-1117

Vassallo, R.R.; Adamson, J.W.; Gottschall, J.L.; Snyder, E.L.; Lee, W.; Houghton, J.; Elfath, M.D. 2010: In vitro and in vivo evaluation of apheresis platelets stored for 5 days in 65% platelet additive solution/35% plasma. Transfusion 50(11): 2376-2385

Bonnitcha, P.D.; Vāvere, A.L.; Lewis, J.S.; Dilworth, J.R. 2008: In vitro and in vivo evaluation of bifunctional bisthiosemicarbazone 64Cu-complexes for the positron emission tomography imaging of hypoxia. Journal of Medicinal Chemistry 51(10): 2985-2991

Weng, L.; Rostamzadeh, P.; Nooryshokry, N.; Le, H.C.; Golzarian, J. 2013: In vitro and in vivo evaluation of biodegradable embolic microspheres with tunable anticancer drug release. Acta Biomaterialia 9(6): 6823-6833

Bobe, K.; Willbold, E.; Morgenthal, I.; Andersen, O.; Studnitzky, T.; Nellesen, J.; Tillmann, W.; Vogt, C.; Vano, K.; Witte, F. 2013: In vitro and in vivo evaluation of biodegradable, open-porous scaffolds made of sintered magnesium W4 short fibres. Acta Biomaterialia 9(10): 8611-8623

Alexandre, N.; Costa, E.ís.; Coimbra, S.; Silva, A.; Lopes, A.ão.; Rodrigues, M.; Santos, M.; Maurício, A.C.; Santos, J.é D.; Luís, A.L.úc. 2015: In vitro and in vivo evaluation of blood coagulation activation of polyvinyl alcohol hydrogel plus dextran-based vascular grafts. Journal of Biomedical Materials Research. Part a 103(4): 1366-1379

Kim, T.-H.; Yun, Y.-P.; Park, Y.-E.; Lee, S.-H.; Yong, W.; Kundu, J.; Jung, J.W.; Shim, J.-H.; Cho, D.-W.; Kim, S.E.; Song, H.-R. 2014: In vitro and in vivo evaluation of bone formation using solid freeform fabrication-based bone morphogenic protein-2 releasing PCL/PLGA scaffolds. Biomedical Materials 9(2): 025008

Singh, S.; Soni, R.; Rawat, M.K.; Jain, A.; Deshpande, S.B.; Deshpande, S.B.; Singh, S.K.; Muthu, M.S. 2010: In vitro and in vivo evaluation of buccal bioadhesive films containing salbutamol sulphate. Chemical and Pharmaceutical Bulletin 58(3): 307-311

Yao, L.; Zhao, X.; Li, Q.; Zu, Y.; Fu, Y.; Zu, B.; Meng, X.; Liu, C. 2012: In vitro and in vivo evaluation of camptothecin nanosuspension: a novel formulation with high antitumor efficacy and low toxicity. International Journal of Pharmaceutics 423(2): 586-588

Zhu, Y.; Zhang, J.; Zheng, Q.; Wang, M.; Deng, W.; Li, Q.; Firempong, C.K.; Wang, S.; Tong, S.; Xu, X.; Yu, J. 2015: In vitro and in vivo evaluation of capsaicin-loaded microemulsion for enhanced oral bioavailability. Journal of the Science of Food and Agriculture 95(13): 2678-2685

Eljarrat-Binstock, E.; Domb, A.J.; Orucov, F.; Dagan, A.; Frucht-Pery, J.; Pe'er, J. 2008: In vitro and in vivo evaluation of carboplatin delivery to the eye using hydrogel-iontophoresis. Current Eye Research 33(3): 269-275

Björses, K.; Faxälv, L.; Montan, C.; Wildt-Persson, K.; Fyhr, P.; Holst, J.; Lindahl, T.L. 2011: In vitro and in vivo evaluation of chemically modified degradable starch microspheres for topical haemostasis. Acta Biomaterialia 7(6): 2558-2565

Koland, M.; Charyulu, R.N.; Vijayanarayana, K.; Prabhu, P. 2011: In vitro and in vivo evaluation of chitosan buccal films of ondansetron hydrochloride. International Journal of Pharmaceutical Investigation 1(3): 164-171

Wang, L.; Li, L.; Sun, Y.; Ding, J.; Li, J.; Duan, X.; Li, Y.; Junyaprasert, V.B.; Mao, S. 2014: In vitro and in vivo evaluation of chitosan graft glyceryl monooleate as peroral delivery carrier of enoxaparin. International Journal of Pharmaceutics 471(1-2): 391-399

Zhou, X.; Kong, M.; Cheng, X.J.; Feng, C.; Li, J.; Li, J.J.; Chen, X.G. 2014: In vitro and in vivo evaluation of chitosan microspheres with different deacetylation degree as potential embolic agent. Carbohydrate Polymers 113: 304-313

Whu, S.W.; Hung, K.-C.; Hsieh, K.-H.; Chen, C.-H.; Tsai, C.-L.; Hsu, S.-h. 2013: In vitro and in vivo evaluation of chitosan-gelatin scaffolds for cartilage tissue engineering. Materials Science and Engineering. C Materials for Biological Applications 33(5): 2855-2863

Cui, J.; Liang, J.; Wen, Y.; Sun, X.; Li, T.; Zhang, G.; Sun, K.; Xu, X. 2014: In vitro and in vivo evaluation of chitosan/β-glycerol phosphate composite membrane for guided bone regeneration. Journal of Biomedical Materials Research. Part a 102(9): 2911-2917

Shelma, R.; Sharma, C.P. 2013: In vitro and in vivo evaluation of curcumin loaded lauroyl sulphated chitosan for enhancing oral bioavailability. Carbohydrate Polymers 95(1): 441-448

Jackson, D.; Atkinson, J.; Guevara, C.I.; Zhang, C.; Kery, V.; Moon, S.-J.; Virata, C.; Yang, P.; Lowe, C.; Pinkstaff, J.; Cho, H.; Knudsen, N.; Manibusan, A.; Tian, F.; Sun, Y.; Lu, Y.; Sellers, A.; Jia, X.-C.; Joseph, I.; Anand, B.; Morrison, K.; Pereira, D.S.; Stover, D. 2014: In vitro and in vivo evaluation of cysteine and site specific conjugated herceptin antibody-drug conjugates. Plos one 9(1): E83865

Upadhyay, K.K.; Bhatt, A.N.; Castro, E.; Mishra, A.K.; Chuttani, K.; Dwarakanath, B.S.; Schatz, C.; Le Meins, J.-F.ço.; Misra, A.; Lecommandoux, S.éb. 2010: In vitro and in vivo evaluation of docetaxel loaded biodegradable polymersomes. Macromolecular Bioscience 10(5): 503-512

Ryppa, C.; Mann-Steinberg, H.; Fichtner, I.; Weber, H.; Satchi-Fainaro, R.; Biniossek, M.L.; Kratz, F. 2008: In vitro and in vivo evaluation of doxorubicin conjugates with the divalent peptide E-[c(RGDfK)2] that targets integrin alphavbeta3. Bioconjugate Chemistry 19(7): 1414-1422

Aydin, O.; Korkusuz, F.; Korkusuz, P.; Tezcaner, A.; Bilgic, E.; Yaprakci, V.; Keskin, D. 2015: In vitro and in vivo evaluation of doxycycline-chondroitin sulfate/PCLmicrospheres for intraarticular treatment of osteoarthritis. Journal of Biomedical Materials Research. Part B Applied Biomaterials 103(6): 1238-1248

Petró, E.; Balogh, A.; Blazsó, G.; Erös, I.; Csóka, I. 2011: In vitro and in vivo evaluation of drug release from semisolid dosage forms. Die Pharmazie 66(12): 936-941

Steczko, J.; Ash, S.R.; Brewer, L.; Guillem, A. 2010: In vitro and in vivo evaluation of efficacy of citrate/methylene blue/parabens/IPA solution as a skin disinfectant. Journal of Infection 60(1): 36-43

He, H.; Yang, R.; Tang, X. 2010: In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion. Drug Development and Industrial Pharmacy 36(6): 681-687

Cribb, N.C.; Bouré, L.P.; Hanna, W.J.B.; Akens, M.K.; Mattson, S.E.; Monteith, G.J.; Weese, J.S. 2009: In vitro and in vivo evaluation of ferric-hyaluronate implants for delivery of amikacin sulfate to the tarsocrural joint of horses. Veterinary Surgery: Vs 38(4): 498-505

Sebatjane, S.I.; Pretorius, A.; Liebenberg, J.; Steyn, H.; Van Kleef, M. 2010: In vitro and in vivo evaluation of five low molecular weight proteins of Ehrlichia ruminantium as potential vaccine components. Veterinary Immunology and Immunopathology 137(3-4): 217-225

Li, X.; Tian, X.; Zhang, J.; Zhao, X.; Chen, X.; Jiang, Y.; Wang, D.; Pan, W. 2011: In vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxel. International Journal of Nanomedicine 6: 1167-1184

Tang, X.; Tai, L.-y.; Yang, X.-g.; Chen, F.; Xu, H.-m.; Pan, W.-s. 2013: In vitro and in vivo evaluation of gliclazide push-pull osmotic pump coated with aqueous colloidal polymer dispersions. Drug Development and Industrial Pharmacy 39(1): 67-76

Leong, N.L.; Arshi, A.; Kabir, N.; Nazemi, A.; Petrigliano, F.A.; Wu, B.M.; McAllister, D.R. 2015: In vitro and in vivo evaluation of heparin mediated growth factor release from tissue-engineered constructs for anterior cruciate ligament reconstruction. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society 33(2): 229-236

Tamilvanan, S.; Venkatesh Babu, R.; Nappinai, A.; Sivaramakrishnan, G. 2011: In vitro and in vivo evaluation of hydrophilic and hydrophobic polymers-based nicorandil-loaded peroral tablet compared with its once-daily commercial sustained-release tablet. Drug Development and Industrial Pharmacy 37(4): 436-445

Wu, D.; Ao, G.; Cao, Q.; Chen, D.; Cui, J. 2011: In vitro and in vivo evaluation of ibuprofen-paeonol conjugate. Journal of Controlled Release: Official Journal of the Controlled Release Society 152(Suppl 1): E98-100

El-Leithy, E.S.; Ibrahim, H.K.; Sorour, R.M. 2015: In vitro and in vivo evaluation of indomethacin nanoemulsion as a transdermal delivery system. Drug Delivery 22(8): 1010-1017

Huang, B.; Zhu, L.; Liu, S.; Li, D.; Chen, Y.; Ma, B.; Wang, Y. 2013: In vitro and in vivo evaluation of inhibition activity of lotus (Nelumbo nucifera Gaertn.) leaves against ultraviolet B-induced phototoxicity. Journal of Photochemistry and Photobiology. B Biology 121: 1-5

Kunze, D.; Füssel, S.; Meye, A.; Wuttig, D.; Krämer, K.; Kotzsch, M.; Toma, M.; Schwenzer, B.; Kausch, I.; Jocham, D.; Hakenberg, O.W.; Grimm, M.O.; Wirth, M.P. 2007: In vitro and in vivo evaluation of inhibitory nucleic acid constructs for specific therapy of human urinary bladder carcinoma. Der Urologe. Ausg. a 46(9): 1289

Chen, W.; Wu, Z.; Yang, H.; Guo, S.; Li, D.; Cheng, L. 2014: In vitro and in vivo evaluation of injectable implants for intratumoral delivery of 5-fluorouracil. Pharmaceutical Development and Technology 19(2): 223-231

Mugabe, C.; Matsui, Y.; So, A.I.; Gleave, M.E.; Heller, M.; Zeisser-Labouèbe, M.; Heller, L.; Chafeeva, I.; Brooks, D.E.; Burt, H.M. 2011: In vitro and in vivo evaluation of intravesical docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols in an orthotopic model of bladder cancer. Biomacromolecules 12(4): 949-960

Xu, J.; Li, X.; Sun, F. 2011: In vitro and in vivo evaluation of ketotifen fumarate-loaded silicone hydrogel contact lenses for ocular drug delivery. Drug Delivery 18(2): 150-158

Huang, F.-Y.J.; Chen, W.-J.; Lee, W.-Y.; Lo, S.-T.; Lee, T.-W.; Lo, J.-M. 2013: In vitro and in vivo evaluation of lactoferrin-conjugated liposomes as a novel carrier to improve the brain delivery. International Journal of Molecular Sciences 14(2): 2862-2874

Yin, L.-F.; Huang, S.-J.; Jiang, S.-G.; Zhao, C.-J.; Pei, Z.-Q.; Zhang, Q. 2011: In vitro and in vivo evaluation of levofloxacin sustained-release capsules. Drug Development and Industrial Pharmacy 37(1): 33-40

Goyal, R.; Tripathi, S.K.; Tyagi, S.; Sharma, A.; Kumar, P.; Ram, K.Ravi.; Chowdhuri, D.K.; Shukla, Y.; Gupta, K.C. 2011: In vitro and in vivo evaluation of linear polyethylenimine nanoparticles. Journal of Biomedical Nanotechnology 7(1): 52-53

Fanciullino, R.; Mollard, S.év.; Giacometti, S.; Berda-Haddad, Y.; Chefrour, M.; Aubert, C.; Iliadis, A.; Ciccolini, J. 2013: In vitro and in vivo evaluation of lipofufol, a new triple stealth liposomal formulation of modulated 5-fu: impact on efficacy and toxicity. Pharmaceutical Research 30(5): 1281-1290

Galia, C.R.; Macedo, C.A.; Rosito, R.; Mello, T.M.d.; Camargo, L.M.A.új.Q.; Moreira, L.F. 2008: In vitro and in vivo evaluation of lyophilized bovine bone biocompatibility. Clinics 63(6): 801-806

Lu, Y.; Li, J.; Wang, G. 2008: In vitro and in vivo evaluation of mPEG-PLA modified liposomes loaded glycyrrhetinic acid. International Journal of Pharmaceutics 356(1-2): 274-281

Ballard, B.; Jiang, Z.; Soll, C.E.; Revskaya, E.; Cutler, C.S.; Dadachova, E.; Francesconi, L.C. 2011: In vitro and in vivo evaluation of melanin-binding decapeptide 4B4 radiolabeled with 177Lu, 166Ho, and 153Sm radiolanthanides for the purpose of targeted radionuclide therapy of melanoma. Cancer BioTherapy and Radiopharmaceuticals 26(5): 547-556

Onishi, H.; Machida, Y. 2008: In vitro and in vivo evaluation of microparticulate drug delivery systems composed of macromolecular prodrugs. Molecules 13(9): 2136-2155

Sudheesh Kumar, P.T.; Raj, N.M.; Praveen, G.; Chennazhi, K.P.; Nair, S.V.; Jayakumar, R. 2013: In vitro and in vivo evaluation of microporous chitosan hydrogel/nanofibrin composite bandage for skin tissue regeneration. Tissue Engineering. Part a 19(3-4): 380-392

Shukla, D.; Chakraborty, S.; Mishra, B. 2012: In vitro and in vivo evaluation of multilayered pastilles for chronotherapeutic management of nocturnal asthma. Expert Opinion on Drug Delivery 9(1): 9-18

Beppu, F.; Niwano, Y.; Sato, E.; Kohno, M.; Tsukui, T.; Hosokawa, M.; Miyashita, K. 2009: In vitro and in vivo evaluation of mutagenicity of fucoxanthin (FX) and its metabolite fucoxanthinol (FXOH). Journal of Toxicological Sciences 34(6): 693-698

Ward, W.K.; Massoud, R.G.; Szybala, C.J.; Engle, J.M.; El Youssef, J.; Carroll, J.M.; Roberts, C.T.; DiMarchi, R.D. 2010: In vitro and in vivo evaluation of native glucagon and glucagon analog (MAR-D28) during aging: lack of cytotoxicity and preservation of hyperglycemic effect. Journal of Diabetes Science and Technology 4(6): 1311-1321

Shoukri, R.A.; Ahmed, I.S.; Shamma, R.N. 2009: In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 73(1): 162-171

Johnson, K.P.; Yearby, L.A.; Stoute, D.; Burow, M.E.; Rhodes, L.V.; Gray, M.; Carriere, P.; Tilghman, S.L.; McLachlan, J.A.; Ochieng, J. 2013: In vitro and in vivo evaluation of novel anticancer agents in triple negative breast cancer models. Journal of Health Care for the Poor and Underserved 24(1 Suppl): 104-111

Hui, A.; Willcox, M.; Jones, L. 2014: In vitro and in vivo evaluation of novel ciprofloxacin-releasing silicone hydrogel contact lenses. Investigative Ophthalmology and Visual Science 55(8): 4896-4904

Kou, W.; Cai, C.; Xu, S.; Wang, H.; Liu, J.; Yang, D.; Zhang, T. 2011: In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC. International Journal of Pharmaceutics 409(1-2): 75-80

Kulkarni, R.V.; Patel, F.S.; Nanjappaiah, H.M.; Naikawadi, A.A. 2014: In vitro and in vivo evaluation of novel interpenetrated polymer network microparticles containing repaglinide. International Journal of Biological Macromolecules 69: 514-522

Li, X.; Jiang, Q.; Du, L.; Wang, C.; Chi, Q. 2012: In vitro and in vivo evaluation of novel osmotic pump tablets of isosorbide-5-mononitrate containing polyvinyl pyrrolidone (PVP) for controlled release. Die Pharmazie 67(8): 695-700

Cui, Y.; Zhang, Y.; Tang, X. 2008: In vitro and in vivo evaluation of ofloxacin sustained release pellets. International Journal of Pharmaceutics 360(1-2): 47-52

Taneri, F.; Ozcan, I.; Guneri, T. 2010: In vitro and in vivo evaluation of oral tablet formulations prepared with ketoconazole and hydroxypropyl-beta-cyclodextrin. Drug Delivery 17(3): 152-157